"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2019/0079002 A1,099-175-470-149-026,2019-03-14,2019,US 201816043583 A,2018-07-24,US 201816043583 A;;US 201762556803 P,2017-09-11,FILTRATION AND TESTING DEVICE,"A floating vessel with a filtration and testing device integral thereon, for simultaneously performing cleaning of fluid used in the oil and natural gas industry for completions, workovers, and commissioning of wells while simultaneously pressure testing of two separate groups of pressurized equipment using fluid cleaned by the filtration and testing device. The floating vessel having a hull with a support structure mounted thereto which contains a cleaning cycle assembly and a pressure testing cycle assembly connected in parallel to a controller for cleaning fluid and regulating pressure by comparing fluid pressures to preset limits. The controller regulates cleaning of first and second dirty hydraulic fluids and regulates pressure of cleaned hydraulic fluids and secondary fluids for pressure testing of the two different groups of pressurized equipment simultaneously.",DAVIES JASON,DAVIES JASON,DVZ HYDRAULICS LLC (2018-07-19),https://lens.org/099-175-470-149-026,Patent Application,yes,0,0,4,4,0,B63B35/00;;F04B9/12;;F04B23/00;;F04B23/04;;F04B53/06;;F04B53/20;;E21B21/063;;Y10T137/0424;;G01N33/2823;;F04B1/00;;E21B21/001;;E21B21/001;;Y10T137/0424;;B08B9/0325;;G01M3/2815;;E21B21/065;;E21B49/084;;E21B43/0107;;B01D29/56;;B01D2221/08;;B01D2221/04;;B01D2201/202;;B01D2201/265;;G01N2001/1427;;G01N33/2823;;G01N1/14;;B63B35/4413;;B63B35/44;;B63B2035/448;;F04B9/12;;F04B1/00;;F04B53/20;;F04B23/00;;E21B21/063;;B63B35/00;;F04B23/04;;F04B53/06;;E21B47/117,G01N19/08;;B63B35/32,,0,0,,,,ACTIVE
2,US,A1,US 2019/0145199 A1,121-342-564-980-030,2019-05-16,2019,US 201916244790 A,2019-01-10,US 201916244790 A;;US 201816043583 A;;US 201762556803 P,2017-09-11,FILTRATION AND TESTING DEVICE,"A filtration and testing device integral thereon, for simultaneously performing cleaning of fluid used in the oil and natural gas industry for completions, workovers, and commissioning of wells while simultaneously pressure testing of two separate groups of pressurized equipment using fluid cleaned by the filtration and testing device. A support structure has a cleaning cycle assembly and a pressure testing cycle assembly connected in parallel to a controller for cleaning fluid and regulating pressure by comparing fluid pressures to preset limits. The controller regulates cleaning of first and second dirty hydraulic fluids and regulates pressure of cleaned hydraulic fluids and secondary fluids for pressure testing of the two different groups of pressurized equipment simultaneously.",DAVIES JASON,DAVIES JASON,DVZ HYDRAULICS LLC (2019-01-10),https://lens.org/121-342-564-980-030,Patent Application,yes,6,0,4,4,0,B63B35/00;;F04B9/12;;F04B23/00;;F04B23/04;;F04B53/06;;F04B53/20;;E21B21/063;;Y10T137/0424;;G01N33/2823;;F04B1/00;;E21B21/001;;E21B21/001;;Y10T137/0424;;B08B9/0325;;G01M3/2815;;E21B21/065;;E21B49/084;;E21B43/0107;;B01D29/56;;B01D2221/08;;B01D2221/04;;B01D2201/202;;B01D2201/265;;G01N2001/1427;;G01N33/2823;;G01N1/14;;B63B35/4413;;B63B35/44;;B63B2035/448;;F04B9/12;;F04B1/00;;F04B53/20;;F04B23/00;;E21B21/063;;B63B35/00;;F04B23/04;;F04B53/06;;E21B47/117,E21B21/00;;B08B9/032;;B63B35/44;;E21B21/06;;E21B43/01;;E21B47/10;;G01M3/28,,0,0,,,,ACTIVE
3,US,A1,US 2008/0271529 A1,039-424-928-639-317,2008-11-06,2008,US 10899408 A,2008-04-24,GB 0708684 A;;GB 0717414 A,2007-05-04,Water Meter Shroud,"A shroud for a water meter is disclosed, comprising a body and a cover. The body of the shroud comprises a base having an aperture and upstanding side walls, which define a cavity for receiving the water meter. The shroud is captively retained around the water meter preventing the removal of the water meter from its mounting.",DAVIES JASON,DAVIES JASON,,https://lens.org/039-424-928-639-317,Patent Application,yes,11,2,6,6,0,E03B7/07;;G01F15/007;;G01F15/14;;G01F15/18;;G01F15/007;;G01F15/007;;G01F15/14;;G01F15/14;;G01F15/18;;G01F15/18,G01D11/24,73/431,0,0,,,,DISCONTINUED
4,GB,B,GB 2448948 B,029-540-081-721-790,2012-11-28,2012,GB 0717414 A,2007-09-07,GB 0708684 A,2007-05-04,Shroud,,DAVIES JASON,DAVIES JASON,,https://lens.org/029-540-081-721-790,Granted Patent,no,6,0,6,6,0,E03B7/07;;G01F15/007;;G01F15/14;;G01F15/18;;G01F15/007;;G01F15/007;;G01F15/14;;G01F15/14;;G01F15/18;;G01F15/18,G01F15/00;;G01F15/14;;G01F15/18,,0,0,,,,INACTIVE
5,GB,A,GB 2448948 A,064-796-983-556-796,2008-11-05,2008,GB 0717414 A,2007-09-07,GB 0708684 A,2007-05-04,A shroud for a water meter,"A shroud 7 for a water meter 1, the shroud comprising a body 8 and a cover 9. The body 8 of the shroud 7 comprises side walls 10 and a base section 11 arranged at its lower end having an aperture 12 that is arranged to fit over a mounting 5 for the water meter, the side walls 10 and base section 11 define a cavity for receiving the water meter 1. The shroud 7 is captively retained around the water meter 1 via a series of retaining clips (not shown) formed integrally with the base section 11 and which are resiliently biased to clip under a flange 13 of the mounting 5, thus preventing the removal of the water meter from its mounting. Reference is also made to a tool 21 for removing the cover 9, the tool comprising a handle 22 and at least one hooked member 23 extending from the handle 22.",DAVIES JASON,DAVIES JASON,,https://lens.org/064-796-983-556-796,Patent Application,no,4,3,6,6,0,E03B7/07;;G01F15/007;;G01F15/14;;G01F15/18;;G01F15/007;;G01F15/007;;G01F15/14;;G01F15/14;;G01F15/18;;G01F15/18,G01F15/14;;E03B7/07,,0,0,,,,INACTIVE
6,EP,A1,EP 1988371 A1,148-503-244-090-156,2008-11-05,2008,EP 08200014 A,2008-04-11,GB 0708684 A;;GB 0717414 A,2007-05-04,Shroud for preventing removal of a water meter,"A shroud for a water meter is disclosed, comprising a body and a cover. The body of the shroud comprises a base having an aperture and upstanding side walls, which define a cavity for receiving the water meter. The shroud is captively retained around the water meter preventing the removal of the water meter from its mounting.
",DAVIES JASON,DAVIES JASON,,https://lens.org/148-503-244-090-156,Patent Application,yes,3,0,6,6,0,E03B7/07;;G01F15/007;;G01F15/14;;G01F15/18;;G01F15/007;;G01F15/007;;G01F15/14;;G01F15/14;;G01F15/18;;G01F15/18,G01F15/00;;G01F15/14;;G01F15/18,,0,0,,,,DISCONTINUED
7,US,B2,US 10392881 B2,018-696-976-324-229,2019-08-27,2019,US 201916244790 A,2019-01-10,US 201916244790 A;;US 201816043583 A;;US 201762556803 P,2017-09-11,Hydraulic filtration and pressure testing device,"A filtration and testing device integral thereon, for simultaneously performing cleaning of fluid used in the oil and natural gas industry for completions, workovers, and commissioning of wells while simultaneously pressure testing of two separate groups of pressurized equipment using fluid cleaned by the filtration and testing device. A support structure has a cleaning cycle assembly and a pressure testing cycle assembly connected in parallel to a controller for cleaning fluid and regulating pressure by comparing fluid pressures to preset limits. The controller regulates cleaning of first and second dirty hydraulic fluids and regulates pressure of cleaned hydraulic fluids and secondary fluids for pressure testing of the two different groups of pressurized equipment simultaneously.",DAVIES JASON;;DVZ HYDRAULICS LLC,DAVIES JASON,DVZ HYDRAULICS LLC (2019-01-10),https://lens.org/018-696-976-324-229,Granted Patent,yes,6,0,4,4,0,B63B35/00;;F04B9/12;;F04B23/00;;F04B23/04;;F04B53/06;;F04B53/20;;E21B21/063;;Y10T137/0424;;G01N33/2823;;F04B1/00;;E21B21/001;;E21B21/001;;Y10T137/0424;;B08B9/0325;;G01M3/2815;;E21B21/065;;E21B49/084;;E21B43/0107;;B01D29/56;;B01D2221/08;;B01D2221/04;;B01D2201/202;;B01D2201/265;;G01N2001/1427;;G01N33/2823;;G01N1/14;;B63B35/4413;;B63B35/44;;B63B2035/448;;F04B9/12;;F04B1/00;;F04B53/20;;F04B23/00;;E21B21/063;;B63B35/00;;F04B23/04;;F04B53/06;;E21B47/117,G01M3/28;;B01D29/56;;B08B9/032;;B63B35/44;;E21B21/00;;E21B21/06;;E21B43/01;;E21B47/10;;E21B49/08;;G01N1/14;;G01N33/28,,0,0,,,,ACTIVE
8,US,B1,US 10240410 B1,099-168-741-844-181,2019-03-26,2019,US 201816043583 A,2018-07-24,US 201816043583 A;;US 201762556803 P,2017-09-11,Hydraulic filtration and pressure testing device,"A floating vessel with a filtration and testing device integral thereon, for simultaneously performing cleaning of fluid used in the oil and natural gas industry for completions, workovers, and commissioning of wells while simultaneously pressure testing of two separate groups of pressurized equipment using fluid cleaned by the filtration and testing device. The floating vessel having a hull with a support structure mounted thereto which contains a cleaning cycle assembly and a pressure testing cycle assembly connected in parallel to a controller for cleaning fluid and regulating pressure by comparing fluid pressures to preset limits. The controller regulates cleaning of first and second dirty hydraulic fluids and regulates pressure of cleaned hydraulic fluids and secondary fluids for pressure testing of the two different groups of pressurized equipment simultaneously.",DAVIES JASON,DAVIES JASON,DVZ HYDRAULICS LLC (2018-07-19),https://lens.org/099-168-741-844-181,Granted Patent,yes,6,1,4,4,0,B63B35/00;;F04B9/12;;F04B23/00;;F04B23/04;;F04B53/06;;F04B53/20;;E21B21/063;;Y10T137/0424;;G01N33/2823;;F04B1/00;;E21B21/001;;E21B21/001;;Y10T137/0424;;B08B9/0325;;G01M3/2815;;E21B21/065;;E21B49/084;;E21B43/0107;;B01D29/56;;B01D2221/08;;B01D2221/04;;B01D2201/202;;B01D2201/265;;G01N2001/1427;;G01N33/2823;;G01N1/14;;B63B35/4413;;B63B35/44;;B63B2035/448;;F04B9/12;;F04B1/00;;F04B53/20;;F04B23/00;;E21B21/063;;B63B35/00;;F04B23/04;;F04B53/06;;E21B47/117,G01M3/28;;B01D29/56;;B08B9/032;;B63B35/44;;E21B21/00;;E21B21/06;;E21B43/01;;E21B47/10;;E21B49/08;;G01N1/14;;G01N33/28,,0,0,,,,ACTIVE
9,US,A1,US 2021/0326699 A1,162-128-858-492-702,2021-10-21,2021,US 202117158108 A,2021-01-26,US 202117158108 A;;US 202063012938 P,2020-04-21,TRAVEL SPEED PREDICTION,One or more techniques and/or systems are provided for travel speed prediction. A spatial context of a prediction segment of a travel network for which a speed prediction is to be made is identified. The spatial context comprises one or more segments of the travel network that are part of trajectories of objects passing through the predication segment and that have predicted likelihoods of influencing travel speed along the prediction segment above a threshold. Features of the spatial context are formatted into a format compatible for input into the model based upon a structure of the model. The features are input into the model for processing using machine learning functionality to output the speed prediction for the prediction segment.,INRIX INC,DAVIES ANDREW;;JORDAN DOMINIC JASON,INRIX INC (2021-01-19),https://lens.org/162-128-858-492-702,Patent Application,yes,0,5,2,2,0,G06N3/08;;G06Q10/047;;G06N3/04,G06N3/08;;G06N3/04,,0,0,,,,PENDING
10,GB,A,GB 2597375 A,034-263-659-317-312,2022-01-26,2022,GB 202109725 A,2021-07-06,GB 202010383 A,2020-07-07,Data protection,"A method of sealing a document by a Notarising Authority, where a seal is an addition to the document that makes it unique preventing any subsequent alteration. The authority is one that has the legal power to add a notarising seal. The Authority creates a hash of the document by a method which requires knowledge of two secret 2400-bit keys, and in which the hash plus the date of hashing becomes a seal. The seal may augment the title of the document. The method may also include the creation of a password and the password may be created using a 2160-bit key.",WILLIAM MCMULLEN HAWTHORNE;;JASON PROCTOR DAVIES,WILLIAM MCMULLEN HAWTHORNE;;JASON PROCTOR DAVIES,,https://lens.org/034-263-659-317-312,Patent Application,no,6,1,3,3,0,G06F21/64;;G06F21/45;;G06F21/645,G06F21/64,,0,0,,,,PENDING
11,CA,A1,CA 2329424 A1,062-431-893-944-029,1999-10-28,1999,CA 2329424 A,1999-04-20,GB 9808339 A;;GB 9901198 W,1998-04-20,GYPSUM PLASTER,"An extrudable gypsum plaster paste is disclosed comprising: .alpha. gypsum plaster; water in a substantially stoichiometric amount; a binder; and a clay or another rheology modifier functionally equivalent to a clay. Such pastes can have a yield stress sufficient to make the paste self supporting. The invention also provides a method for making an extrudable gypsum plaster paste comprising: mixing .alpha. gypsum plaster, water in a substantially stoichiometric amount and a binder; and mixing into that mixture a clay or other rheology modifier functionally equivalent to a clay.",BPB PLC,LUKEVICH LYDIA;;DAVIES JASON;;MAYER PETER,,https://lens.org/062-431-893-944-029,Patent Application,no,0,0,8,9,0,C04B28/146;;C04B2111/00068;;C04B2111/00129,C04B28/14,,0,0,,,,DISCONTINUED
12,GB,A8,GB 2336585 A8,145-714-110-930-771,1999-11-15,1999,GB 9808339 A,1998-04-20,GB 9808339 A,1998-04-20,Gypsum plaster,,BPB PLC,LUKEVICH LYDIA;;MAYER PETER;;DAVIES JASON,,https://lens.org/145-714-110-930-771,Patent Application,no,0,0,8,9,0,C04B28/146;;C04B2111/00068;;C04B2111/00129,C04B28/14,C1H HPX           HPX;;C1H HXG           HXG;;C1H H651          HPX;;C1H H651          HXG;;C1H H710          HPX;;C1H H710          HXG;;C1H H712          HPX;;C1H H712          HXG;;C1H H721          HPX;;C1H H721          HXG;;C1H H726          HPX;;C1H H726          HXG;;C1H H742          HPX;;C1H H742          HXG;;C1H H745          HPX;;C1H H745          HXG;;C1H H762          HPX;;C1H H762          HXG;;C1H H766          HPX;;C1H H766          HXG;;C1H H771          HPX;;C1H H771          HXG;;C1H H783          HPX;;C1H H783          HXG;;C1H H795          HPX;;C1H H795          HXG,0,0,,,,EXPIRED
13,EP,A1,EP 1080051 A1,194-180-190-791-284,2001-03-07,2001,EP 99918114 A,1999-04-20,GB 9901198 W;;GB 9808339 A,1998-04-20,GYPSUM PLASTER,,BPB PLC,LUCHKEVICH LYDIA;;MAYER PETER;;DAVIES JASON,,https://lens.org/194-180-190-791-284,Patent Application,yes,0,0,8,9,0,C04B28/146;;C04B2111/00068;;C04B2111/00129,C04B28/14,,1,0,,,See references of WO 9954265A1,DISCONTINUED
14,GB,A,GB 2336585 A,121-129-061-801-974,1999-10-27,1999,GB 9808339 A,1998-04-20,GB 9808339 A,1998-04-20,Gypsum plaster,"An extrudable gypsum plaster paste comprises: α gypsum plaster; water in a substantially stoichiometric amount; a binder; and a clay or another rheology modifier functionally equivalent to a clay. Such pastes can have a yield stress sufficient to make the paste self supporting. A method for making an extrudable gypsum plaster paste comprises: mixing α gypsum plaster, water in a substantially stoichiometric amount and a binder; and mixing into that mixture a clay or other rheology modifier functionally equivalent to a clay.",BPB PLC,LUKEVICH LYDIA;;MAVER PETER;;DAVIES JASON,,https://lens.org/121-129-061-801-974,Patent Application,no,4,5,8,9,0,C04B28/146;;C04B2111/00068;;C04B2111/00129,C04B28/14,C1H HPX           HPX;;C1H HXG           HXG;;C1H H651          HPX;;C1H H651          HXG;;C1H H710          HPX;;C1H H710          HXG;;C1H H712          HPX;;C1H H712          HXG;;C1H H721          HPX;;C1H H721          HXG;;C1H H726          HPX;;C1H H726          HXG;;C1H H742          HPX;;C1H H742          HXG;;C1H H745          HPX;;C1H H745          HXG;;C1H H762          HPX;;C1H H762          HXG;;C1H H766          HPX;;C1H H766          HXG;;C1H H771          HPX;;C1H H771          HXG;;C1H H783          HPX;;C1H H783          HXG;;C1H H795          HPX;;C1H H795          HXG,0,0,,,,EXPIRED
15,US,A1,US 2004/0258901 A1,165-680-910-219-147,2004-12-23,2004,US 82378304 A,2004-04-14,US 82378304 A;;GB 9808339 A;;US 67379600 A,1998-04-20,Gypsum plaster,"
   An extrudable gypsum plaster paste is disclosed comprising: gypsum plaster, water in a substantially stoichiometric amount; a binder; and a clay or another rheology modifier functionally equivalent to a clay. Such pastes can have a yield stress sufficient to make the paste self supporting. The invention also provides a method for making an extrudable gypsum plaster paste comprising: mixing gypsum plaster, water in a substantially stoichiometric amount and a binder; and mixing into that mixture a clay or other rheology modifier functionally equivalent to a clay. 
",BPB PLC,LUCKEVICH LYDIA;;MAYER PETER;;DAVIES JASON,,https://lens.org/165-680-910-219-147,Patent Application,yes,7,21,1,9,0,C04B28/146;;C04B28/146;;C04B2111/00129;;C04B2111/00129;;C04B2111/00137;;C04B2111/00137;;C04B2111/00301;;C04B2111/00301;;Y02W30/91;;Y02W30/91;;Y10T428/249939;;Y10T428/249939,C04B28/14,428/297.1,0,0,,,,DISCONTINUED
16,GB,A,GB 2612191 A,165-891-675-028-163,2023-04-26,2023,GB 202214579 A,2022-10-04,GB 202114151 A,2021-10-04,Data protection,A method of sealing a document in the form of an electronic data file comprises using a seal in the form of a hash of the document added to the name of the electronic data file. The hash value can then be used to detect alterations to the document. Also disclosed is an electronic notarising method of sealing a document by adding a hash to the email title of the document.,WILLIAM MCMULLEN HAWTHORNE;;JASON PROCTOR DAVIES,WILLIAM MCMULLEN HAWTHORNE;;JASON PROCTOR DAVIES,,https://lens.org/165-891-675-028-163,Patent Application,no,1,0,3,3,0,G06F21/64;;G06F21/64;;G06F21/645,G06F21/64,,0,0,,,,PENDING
17,AU,A,AU 1999/036157 A,176-817-442-159-81X,1999-11-08,1999,AU 1999/036157 A,1999-04-20,GB 9808339 A;;GB 9901198 W,1998-04-20,Gypsum plaster,,BPB PLC,LUKEVICH LYDIA;;MAYER PETER;;DAVIES JASON,,https://lens.org/176-817-442-159-81X,Patent Application,no,0,0,8,9,0,C04B28/146;;C04B2111/00068;;C04B2111/00129,C04B28/14,,0,0,,,,DISCONTINUED
18,GB,B,GB 2336585 B,035-534-867-498-232,2002-06-26,2002,GB 9808339 A,1998-04-20,GB 9808339 A,1998-04-20,Gypsum plaster,,BPB PLC,LUCKEVICH LYDIA;;MAYER PETER;;DAVIES JASON,,https://lens.org/035-534-867-498-232,Granted Patent,no,5,0,8,9,0,C04B28/146;;C04B2111/00068;;C04B2111/00129,C04B28/14,C1H HPX           HPX;;C1H HXG           HXG;;C1H H651          HPX;;C1H H651          HXG;;C1H H710          HPX;;C1H H710          HXG;;C1H H712          HPX;;C1H H712          HXG;;C1H H721          HPX;;C1H H721          HXG;;C1H H726          HPX;;C1H H726          HXG;;C1H H742          HPX;;C1H H742          HXG;;C1H H745          HPX;;C1H H745          HXG;;C1H H762          HPX;;C1H H762          HXG;;C1H H766          HPX;;C1H H766          HXG;;C1H H771          HPX;;C1H H771          HXG;;C1H H783          HPX;;C1H H783          HXG;;C1H H795          HPX;;C1H H795          HXG,0,0,,,,EXPIRED
19,GB,A,GB 2546875 A,154-003-997-511-708,2017-08-02,2017,GB 201621071 A,2016-12-12,GB 201521834 A;;GB 201521833 A,2015-12-11,Secure transactions and secure communication systems,"An electronic device for securing Credit/Debit Card transactions, the electronic device acting as a timepiece and including means allowing the entry of a user-specific Device Key, the electronic device also housing a Multiple Fermat Sequence algorithm that uses the Device Key to generate a cryptographically secure pseudo-random stream. Also, a communication system the included a device that is capable of sending and receiving text messages and is provided with a unit of Application software that contains an encryption algorithm. Said algorithm may be a stream cipher algorithm capable of generating a crypt image using printable characters.",HAWTHORNE DAVIES LTD,WILLIAM MCMULLEN HAWTHORNE;;JASON PROCTOR DAVIES,,https://lens.org/154-003-997-511-708,Patent Application,no,6,0,2,4,0,G06F21/34;;G06F21/34;;H04L9/0656;;H04L9/0838;;H04L9/0891;;H04L2209/56,G06F21/34,,0,0,,,,DISCONTINUED
20,US,A1,US 2017/0126886 A1,058-372-998-366-729,2017-05-04,2017,US 201615295469 A,2016-10-17,US 201615295469 A;;US 201562248971 P,2015-10-30,System For Direct Control By The Caller Of The On-Hold Experience.,Calling parties are provided a system which supplants and replaces their on hold phone signal sent by the phone call receiving party. The on hold signal is monitored and controlled. During the holding time the calling party is allowed to use their own phone to pursue other tasks. Upon its termination the calling party is returned to the phone call.,MUSICROGUE,SHAPIRO JOEL NATHAN;;DAVIES JASON WELLS,,https://lens.org/058-372-998-366-729,Patent Application,yes,6,0,1,1,0,H04M3/4286;;H04M3/4285;;H04M1/72406;;H04M1/72448;;H04M3/4286;;H04M3/4285;;H04M1/72406;;H04M1/72448,H04M3/428;;H04M1/72406;;H04M1/72448,,0,0,,,,DISCONTINUED
21,US,B1,US 8570047 B1,146-509-910-526-252,2013-10-29,2013,US 85538410 A,2010-08-12,US 85538410 A;;US 37002109 A,2009-02-12,Battery fault detection with saturating transformers,"A battery monitoring system utilizes a plurality of transformers interconnected with a battery having a plurality of battery cells. Windings of the transformers are driven with an excitation waveform whereupon signals are responsively detected, which indicate a health of the battery. In one embodiment, excitation windings and sense windings are separately provided for the plurality of transformers such that the excitation waveform is applied to the excitation windings and the signals are detected on the sense windings. In one embodiment, the number of sense windings and/or excitation windings is varied to permit location of underperforming battery cells utilizing a peak voltage detector.",DAVIES FRANCIS J;;GRAIKA JASON R;;NASA,DAVIES FRANCIS J;;GRAIKA JASON R,UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (2010-08-12),https://lens.org/146-509-910-526-252,Granted Patent,yes,23,38,1,3,0,H01M10/4207;;H01M10/482;;H02J7/0016;;H02J7/0019;;G01R31/382;;G01R31/392;;G01R31/396;;Y02E60/10;;H01M10/4207;;H01M10/482;;H02J7/0016;;H02J7/0019;;G01R31/396;;G01R31/392;;G01R31/382,G08B21/00;;G01N27/416;;H02J3/00,324/434;;324/426;;324/427;;324/429;;324/430;;307/17;;307/83;;340/646;;340/636.2,0,0,,,,ACTIVE
22,WO,A1,WO 1999/054265 A1,169-055-586-696-452,1999-10-28,1999,GB 9901198 W,1999-04-20,GB 9808339 A,1998-04-20,GYPSUM PLASTER,"An extrudable gypsum plaster paste is disclosed comprising: α gypsum plaster; water in a substantially stoichiometric amount; a binder; and a clay or another rheology modifier functionally equivalent to a clay. Such pastes can have a yield stress sufficient to make the paste self supporting. The invention also provides a method for making an extrudable gypsum plaster paste comprising: mixing α gypsum plaster, water in a substantially stoichiometric amount and a binder; and mixing into that mixture a clay or other rheology modifier functionally equivalent to a clay.",BPB PLC;;LUKEVICH LYDIA;;MAYER PETER;;DAVIES JASON,LUKEVICH LYDIA;;MAYER PETER;;DAVIES JASON,,https://lens.org/169-055-586-696-452,Patent Application,yes,8,7,8,9,0,C04B28/146;;C04B2111/00068;;C04B2111/00129,C04B28/14,,1,0,,,"CHEMICAL ABSTRACTS, vol. 82, no. 4, 27 January 1975, Columbus, Ohio, US; abstract no. 21125c, T. YANO ET AL. page 297; XP000152136",PENDING
23,WO,A1,WO 2018/196983 A1,181-697-449-033-934,2018-11-01,2018,EP 2017060107 W,2017-04-27,EP 2017060107 W,2017-04-27,SECURE COMMUNICATION SYSTEMS,"A communication system includes a device that is capable of sending and receiving messages and is provided with a unit of Application Software that contains an encryption algorithm. The preferred types of algorithm are a rotary cipher algorithm and a stream cipher algorithm each capable of generating a crypt image using ASCII characters, and a stream cipher algorithm capable of generating a crypt image using printable characters.",HAWTHORNE DAVIES LTD,HAWTHORNE WILLIAM MCMULLEN;;DAVIES JASON PROCTOR,,https://lens.org/181-697-449-033-934,Patent Application,yes,0,0,1,1,0,H04L9/0869;;H04L9/088,H04L9/08,,2,1,057-601-929-103-087,10.1109/sectech.2008.48,"GOOGLE: ""Encryption | Android Open Source Project"", 27 March 2017 (2017-03-27), XP055436692, Retrieved from the Internet <URL:https://source.android.com/security/encryption/> [retrieved on 20171219];;DAVID LISONEK ET AL: ""SMS Encryption for Mobile Communication"", SECURITY TECHNOLOGY, 2008. SECTECH '08. INTERNATIONAL CONFERENCE ON, IEEE, PISCATAWAY, NJ, USA, 13 December 2008 (2008-12-13), pages 198 - 201, XP031379777, ISBN: 978-0-7695-3486-2",PENDING
24,US,A1,US 2005/0232055 A1,092-928-227-239-426,2005-10-20,2005,US 6011605 A,2005-02-17,US 6011605 A;;US 79484701 A,2001-02-27,Multiple chart user interface,"A drag-and-drop user interface (DDUI) can generate multiple charts in an integrated chart report and supports the drag-and-drop method of adding fields to the integrated chart report. When a field is dropped from a field list into a multiple chart drop zone, the DDUI will automatically generate additional charts to represent the data in the dropped field. An additional chart will be generated for each unique entry in a data field. The number of charts can be modified by selecting particular elements in the dropped field, by means of a drop-down menu. The drop-down menu enables the elimination or addition of elements of the dropped field. Each additional field dropped into the multiple chart drop zone will add a chart to the chart report. Conversely, each field dragged out of the multiple chart drop zone will eliminate a chart from the chart report. The DDUI can accommodate various chart types. The multiple chart drop zone can be slightly modified to accommodate the specialized needs of various chart types, for example, x-y, bubble, bar, and pie chart types.",MICROSOFT CORP,COUCKUYT JEFF;;DAVIES PAUL;;CAHILL JASON M,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/092-928-227-239-426,Patent Application,yes,1,50,4,4,0,G06F3/0486;;G06F3/0486;;G06T11/206;;G06T11/206,G06F3/033;;G06F3/048,365/227,0,0,,,,EXPIRED
25,US,A1,US 2002/0118192 A1,146-530-739-924-272,2002-08-29,2002,US 79484701 A,2001-02-27,US 79484701 A,2001-02-27,Multiple chart user interface,"
   A drag-and-drop user interface (DDUI) can generate multiple charts in an integrated chart report and supports the drag-and-drop method of adding fields to the integrated chart report. When a field is dropped from a field list into a multiple chart drop zone, the DDUI will automatically generate additional charts to represent the data in the dropped field. An additional chart will be generated for each unique entry in a data field. The number of charts can be modified by selecting particular elements in the dropped field, by means of a drop-down menu. The drop-down menu enables the elimination or addition of elements of the dropped field. Each additional field dropped into the multiple chart drop zone will add a chart to the chart report. Conversely, each field dragged out of the multiple chart drop zone will eliminate a chart from the chart report. The DDUI can accommodate various chart types. The multiple chart drop zone can be slightly modified to accommodate the specialized needs of various chart types, for example, x-y, bubble, bar, and pie chart types. 
",MICROSOFT CORP,COUCKUYT JEFF;;DAVIES PAUL;;CAHILL JASON M,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2001-02-22),https://lens.org/146-530-739-924-272,Patent Application,yes,6,98,4,4,0,G06F3/0486;;G06F3/0486;;G06T11/206;;G06T11/206,G06F3/033;;G06F3/048,34544;;345/769,0,0,,,,EXPIRED
26,US,B2,US 6906717 B2,163-198-174-442-069,2005-06-14,2005,US 79484701 A,2001-02-27,US 79484701 A,2001-02-27,Multiple chart user interface,"A drag-and-drop user interface (DDUI) can generate multiple charts in an integrated chart report and supports the drag-and-drop method of adding fields to the integrated chart report. When a field is dropped from a field list into a multiple chart drop zone, the DDUI will automatically generate additional charts to represent the data in the dropped field. An additional chart will be generated for each unique entry in a data field. The number of charts can be modified by selecting particular elements in the dropped field, by means of a drop-down menu. The drop-down menu enables the elimination or addition of elements of the dropped field. Each additional field dropped into the multiple chart drop zone will add a chart to the chart report. Conversely, each field dragged out of the multiple chart drop zone will eliminate a chart from the chart report. The DDUI can accommodate various chart types. The multiple chart drop zone can be slightly modified to accommodate the specialized needs of various chart types, for example, x-y, bubble, bar, and pie chart types.",MICROSOFT CORP,COUCKUYT JEFF;;DAVIES PAUL;;CAHILL JASON M,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2001-02-22),https://lens.org/163-198-174-442-069,Granted Patent,yes,15,134,4,4,0,G06F3/0486;;G06F3/0486;;G06T11/206;;G06T11/206,G06F3/033;;G06F3/048,345/440,5,3,004-945-429-442-804;;038-019-518-282-372;;122-161-966-483-436,10.1145/263407.263545;;10.1080/01457639208939775;;10.1177/089443939801600310,"""An interactive visual query environment for exploring data"", Derthick et al.,Proceedings of the 10th annual ACM symposium o User interface software and technology Oct. 1997, p. 189-198.;;Building extraordinary charts and graphs. Revisualize your vital data with Illustrator, FreeHand, and Photoshop; J. Ashford; Macworld; (Oct. 1998) v. 15 n. 10, p. 107-109.;;Visualizing data; P.L. Brooks; DBMS (Aug. 1997) v.10, n.9, p. 38-43, 45, 47.;;2-Dimensional transient heat conduction analysis using spreadsheet; J.W. Baughn and M. Rossi; Heat Transfer Engineering, 1992, v.13, n.2 (Apr.-Jun.), p. 71-79.;;Intervista Worldchart (software review); Social Science Computer Review, (Fall 1998) v.16, n.3, p. 325-327.",EXPIRED
27,US,A1,US 2024/0035489 A1,033-103-300-640-026,2024-02-01,2024,US 202318226660 A,2023-07-26,US 202318226660 A;;US 202263392596 P,2022-07-27,STATOR ASSEMBLY FOR ELECTRIC SUBMERSIBLE PUMP,A stator assembly for an ESP. The assembly can include stators with tabs and corresponding slots that prevent rotation of the stators during use in downhole activities.,EXTRACT MAN COMPANY LLC,RHYS-DAVIES JAMES;;CRANE MITCHELL;;MYSKA JASON,EXTRACT COMPANIES LLC (2024-01-04);;EXTRACT MANAGEMENT COMPANY LLC (2023-12-18),https://lens.org/033-103-300-640-026,Patent Application,yes,0,0,2,2,0,F04D13/10;;F04D29/403;;F04D29/601;;F04D29/601;;F04D29/403;;F04D13/10,F04D29/60;;F04D13/10;;F04D29/40,,0,0,,,,PENDING
28,WO,A1,WO 2024/025956 A1,022-318-897-110-456,2024-02-01,2024,US 2023/0028711 W,2023-07-26,US 202263392596 P,2022-07-27,STATOR ASSEMBLY FOR ELECTRIC SUBMERSIBLE PUMP,A stator assembly for an ESP. The assembly can include stators with tabs and corresponding slots that prevent rotation of the stators during use in downhole activities.,EXTRACT MAN COMPANY LLC;;RHYS DAVIES JAMES;;CRANE MITCHELL;;MYSKA JASON,RHYS-DAVIES JAMES;;CRANE MITCHELL;;MYSKA JASON,,https://lens.org/022-318-897-110-456,Patent Application,yes,5,0,2,2,0,F04D13/10;;F04D29/403;;F04D29/601;;F04D29/601;;F04D29/403;;F04D13/10,H02K5/132;;F04D13/08;;F04D13/10;;H02K1/16;;H02K1/17;;H02K5/128,,0,0,,,,PENDING
29,US,B2,US 7262773 B2,066-810-019-058-579,2007-08-28,2007,US 6011605 A,2005-02-17,US 6011605 A;;US 79484701 A,2001-02-27,Multiple chart user interface,"A drag-and-drop user interface (DDUI) can generate multiple charts in an integrated chart report and supports the drag-and-drop method of adding fields to the integrated chart report. When a field is dropped from a field list into a multiple chart drop zone, the DDUI will automatically generate additional charts to represent the data in the dropped field. An additional chart will be generated for each unique entry in a data field. The number of charts can be modified by selecting particular elements in the dropped field, by means of a drop-down menu. The drop-down menu enables the elimination or addition of elements of the dropped field. Each additional field dropped into the multiple chart drop zone will add a chart to the chart report. Conversely, each field dragged out of the multiple chart drop zone will eliminate a chart from the chart report. The DDUI can accommodate various chart types. The multiple chart drop zone can be slightly modified to accommodate the specialized needs of various chart types, for example, x-y, bubble, bar, and pie chart types.",MICROSOFT CORP,COUCKUYT JEFF;;DAVIES PAUL;;CAHILL JASON M,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/066-810-019-058-579,Granted Patent,yes,1,11,4,4,0,G06F3/0486;;G06F3/0486;;G06T11/206;;G06T11/206,G06T11/20;;G06F3/033;;G06F3/048;;G06F15/00;;G06F17/00,345/440;;715/769;;715/502,3,1,038-019-518-282-372,10.1080/01457639208939775,"Building extraordinary charts and graphs. Revisualize your vital data with Illustrator, FreeHand, and Photoshop; J. Ashford; Macworld; (Oct. 1998) v. 15 n. 10, p. 107-109.;;Visualizing data; P.L. Brooks; DBMS (Aug. 1997) v.10, n.9, p. 38-43, 45, 47.;;2-Dimensional transient heat conduction analysis using spreadsheets; J.W. Baughn and M. Rossi; Heat Transfer Engineering, 1992, v.13, n.2 (Apr.-Jun.), p. 71-79.",EXPIRED
30,US,A1,US 2017/0142481 A1,133-970-872-400-598,2017-05-18,2017,US 201514941408 A,2015-11-13,US 201514941408 A,2015-11-13,SYSTEM AND METHOD FOR PRESENTING ACTIONABLE PROGRAM PERFORMANCE INFORMATION BASED ON AUDIENCE COMPONENTS,"Systems and methods for presenting actionable program performance information correlated with content are disclosed. A method includes obtaining primary content information related to first content distributed to a plurality of viewers during a particular time duration; obtaining secondary content information related to the first content, wherein the secondary content information includes information identified based on the first content; obtaining activity information of the plurality of viewers of the first content during the particular time duration; determining a plurality of activity component information corresponding to a plurality of activity categories; storing the plurality of activity component information to be associated with the first content; and displaying data of at least one of the plurality of activity component information at a first time point along with the first content.",NBCUNIVERSAL MEDIA LLC,CARUANA MICHAEL;;DAVIES CAMERON;;GILBERTSON JASON;;HAQUE MOINUL,NBCUNIVERSAL MEDIA LLC (2015-11-13),https://lens.org/133-970-872-400-598,Patent Application,yes,2,11,2,2,0,H04N21/233;;H04N21/23418;;H04N21/44204;;H04N21/812;;H04N21/4667;;H04N21/44226;;H04N21/44204;;H04N21/812;;H04N21/4667;;H04N21/41;;H04N21/24;;H04N21/23418;;H04N21/233;;H04N21/44226,H04N21/442;;H04N21/466;;H04N21/81,,0,0,,,,ACTIVE
31,US,B2,US 11324548 B2,071-797-130-023-179,2022-05-10,2022,US 201615242191 A,2016-08-19,US 201615242191 A;;US 201562208404 P;;US 201562208138 P,2015-08-21,Transvascular electrosurgical devices and systems and methods of using the same,"A system, apparatus, and method of using the same are disclosed for carrying out a transvascular procedure such as a Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure using energy to create a tract between the hepatic vein and the portal vein. The present invention provides a flexible puncturing solution to effectively perform a transvascular procedure such as a TIPS procedure while minimizing damage to the liver and surrounding soft tissues or organs.",BAYLIS MEDICAL CO INC,UHM YUN;;DAVIES GARETH;;WOO JASON;;MATHUR PRATEEK,BAYLIS MEDICAL COMPANY INC (2016-08-18);;BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED (2022-06-01),https://lens.org/071-797-130-023-179,Granted Patent,yes,21,0,3,3,0,A61B2018/144;;A61B2218/007;;A61B2017/00026;;A61B18/1492;;A61B2018/00428;;A61B2018/00529;;A61B2018/00642;;A61B2017/003;;A61B18/1492;;A61B2018/00529;;A61B2018/00642;;A61B2018/144;;A61B2218/007;;A61B2017/00026;;A61B2018/00404;;A61B2018/00196,A61B18/14;;A61B17/00;;A61B18/00,,2,2,004-151-912-578-539;;011-454-482-337-699,10.1007/s00270-014-0931-0;;24934737;;1515726;;10.1016/s1051-0443(92)72010-7,"Tsauo, Jiaywei; Luo, Xuefeng; Ye, Linchao; Three-Dimensional Path Planning Software-Assisted Transjugular Intrahepatic Portosystemic Shunt: A Technical Modification, (Jun. 17, 2015), Cardiovasc Intervent Radiol. 38:742-746 https://doi.org/10.1007/S00270-014-0931-0.;;Harman, et al. Localization of the Portal Vein for Transjugular Catheterization: Percutaneous Placement ofa Metallic Marker with Real-Time US Guidance. J. Vascular and Interventional Radiology, vol. 3, Iss. 3, Aug. 1992, pp. 545-547. doi.org/10.1016/S1051-0443(92)72010-7 (Year: 1992).",ACTIVE
32,US,A1,US 2017/0049511 A1,102-260-600-432-667,2017-02-23,2017,US 201615242191 A,2016-08-19,US 201615242191 A;;US 201562208404 P;;US 201562208138 P,2015-08-21,Transvascular Electrosurgical Devices and Systems and Methods of using the same,"A system, apparatus, and method of using the same are disclosed for carrying out a transvascular procedure such as a Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure using energy to create a tract between the hepatic vein and the portal vein. The present invention provides a flexible puncturing solution to effectively perform a transvascular procedure such as a TIPS procedure while minimizing damage to the liver and surrounding soft tissues or organs.",BAYLIS MEDICAL CO INC,UHM YUN;;DAVIES GARETH;;WOO JASON;;MATHUR PRATEEK,BAYLIS MEDICAL COMPANY INC (2016-08-18);;BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED (2022-06-01),https://lens.org/102-260-600-432-667,Patent Application,yes,4,9,3,3,0,A61B2018/144;;A61B2218/007;;A61B2017/00026;;A61B18/1492;;A61B2018/00428;;A61B2018/00529;;A61B2018/00642;;A61B2017/003;;A61B18/1492;;A61B2018/00529;;A61B2018/00642;;A61B2018/144;;A61B2218/007;;A61B2017/00026;;A61B2018/00404;;A61B2018/00196,A61B18/14;;A61B6/00;;A61B6/12;;A61B8/12,,1,1,004-151-912-578-539,10.1007/s00270-014-0931-0;;24934737,"Tsauo, Jiaywei; Luo, Xuefeng; Ye, Linchao; Three-Dimensional Path Planning Software-Assisted Transjugular Intrahepatic Portosystemic Shunt: A Technical Modification, (06/17/2015), Cardiovasc Intervent Radiol. 38:742-746 https://doi.org/10.1007/S00270-014-0931-0",ACTIVE
33,US,A1,US 2022/0226043 A1,017-917-778-573-734,2022-07-21,2022,US 202217716020 A,2022-04-08,US 202217716020 A;;US 201615242191 A;;US 201562208404 P;;US 201562208138 P,2015-08-21,Transvascular Electrosurgical Devices and Systems and Methods of using the same,"A system, apparatus, and method of using the same are disclosed for carrying out a transvascular procedure such as a Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure using energy to create a tract between the hepatic vein and the portal vein. The present invention provides a method using a flexible radiofrequency (RF) catheter having a lumen therethrough. The method involves the steps of advancing the flexible RF catheter into a first vessel; advancing a guiding sheath overtop of the flexible RF catheter; steering the guiding sheath to direct a distal tip of the RF catheter towards a second vessel; and, delivering RF energy via the flexible RF catheter, forming a tract from the first vessel and entering the second vessel.",BAYLIS MEDICAL CO INC,UHM YUN;;DAVIES GARETH;;WOO JASON;;MATHUR PRATEEK,BAYLIS MEDICAL COMPANY INC (2016-08-18);;BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED (2022-06-01),https://lens.org/017-917-778-573-734,Patent Application,yes,5,0,3,3,0,A61B2018/144;;A61B2218/007;;A61B2017/00026;;A61B18/1492;;A61B2018/00428;;A61B2018/00529;;A61B2018/00642;;A61B2017/003;;A61B18/1492;;A61B2018/00529;;A61B2018/00642;;A61B2018/144;;A61B2218/007;;A61B2017/00026;;A61B2018/00404;;A61B2018/00196,A61B18/14,,0,0,,,,PENDING
34,US,B2,US 9794625 B2,120-974-809-035-731,2017-10-17,2017,US 201514941408 A,2015-11-13,US 201514941408 A,2015-11-13,System and method for presenting actionable program performance information based on audience components,"Systems and methods for presenting actionable program performance information correlated with content are disclosed. A method includes obtaining primary content information related to first content distributed to a plurality of viewers during a particular time duration; obtaining secondary content information related to the first content, wherein the secondary content information includes information identified based on the first content; obtaining activity information of the plurality of viewers of the first content during the particular time duration; determining a plurality of activity component information corresponding to a plurality of activity categories; storing the plurality of activity component information to be associated with the first content; and displaying data of at least one of the plurality of activity component information at a first time point along with the first content.",NBCUNIVERSAL MEDIA LLC,CARUANA MICHAEL;;DAVIES CAMERON;;GILBERTSON JASON;;HAQUE MOINUL,NBCUNIVERSAL MEDIA LLC (2015-11-13),https://lens.org/120-974-809-035-731,Granted Patent,yes,3,4,2,2,0,H04N21/233;;H04N21/23418;;H04N21/44204;;H04N21/812;;H04N21/4667;;H04N21/44226;;H04N21/44204;;H04N21/812;;H04N21/4667;;H04N21/41;;H04N21/24;;H04N21/23418;;H04N21/233;;H04N21/44226,H04H60/33;;H04N21/24;;H04N21/41;;H04N21/442;;H04N21/466;;H04N21/81,,0,0,,,,ACTIVE
35,US,B1,US 6396688 B1,171-950-775-318-971,2002-05-28,2002,US 53715900 A,2000-03-29,US 53715900 A,2000-03-29,Series fan speed control system,"
    A redundant fan system includes an in-series configuration of adjustable speed fans. A speed controller coupled to the fan system includes a first fan operated at a constant operating speed and a second fan operated at an adjusted operating speed to maintain a speed differential between the first and second fan speeds. A sensing device is connected to the first and second fans and to the speed controller for maintaining the speed differential constant. 
",DELL PRODUCTS LP,DAVIES STEPHEN J;;BOBBITT JIL M;;TUNNELL JASON D,DELL PRODUCTS L.P (2000-03-20),https://lens.org/171-950-775-318-971,Granted Patent,yes,13,79,1,1,0,G06F1/20;;G06F1/206;;H05K7/20836;;H05K7/20836;;G06F1/20;;G06F1/206,G06F1/20;;H05K7/20,361/687;;361/51,0,0,,,,EXPIRED
36,US,A1,US 2009/0086917 A1,071-284-754-172-814,2009-04-02,2009,US 2869808 A,2008-02-08,US 2869808 A;;US 86460307 A,2007-09-28,X-RAY TUBE COOLING SYSTEM,"X-ray tube cooling systems. In one example embodiment, an x-ray tube includes a housing, a window frame attached to the housing, and a window attached to the window frame. The housing defines an aperture through which electrons can pass from a cathode to an anode. The housing also defines an inlet port and an outlet port. The window frame defines an opening through which x-rays can pass. The window covers the opening defined by the window frame. The housing and the window frame are configured such that a liquid can flow from the inlet port to the outlet port through either a first liquid path at least partially defined by the housing or a second liquid path cooperatively defined by the housing and the window frame. The second liquid path is disposed about at least a portion of the opening in the window frame.",VARIAN MED SYS TECH INC,WARBURTON DON LEE;;DAVIES JASON W;;ANDREWS GREGORY C,VARIAN MEDICAL SYSTEMS TECHNOLOGIES INC (2008-03-31);;VARIAN MEDICAL SYSTEMS INC (2008-09-26);;VAREX IMAGING CORPORATION (2017-01-25),https://lens.org/071-284-754-172-814,Patent Application,yes,11,6,2,10,0,H01J35/18;;H01J2235/122;;H05G1/02;;H05G1/025;;H05G1/02;;H01J2235/122;;H01J35/18;;H05G1/025,H01J35/12,378/140;;378/200,0,0,,,,INACTIVE
37,US,A,US 5922272 A,183-693-391-780-236,1999-07-13,1999,US 77662997 A,1997-03-26,GB 9415562 A;;GB 9501841 W,1994-08-02,Manufacture of ceramic articles,A moldable ceramic composition is made by forming the suspension of electrically charged ceramic particles and then coagulating.,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW,DYTECH CORPORATION LIMITED (1997-01-30),https://lens.org/183-693-391-780-236,Granted Patent,yes,12,9,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,264/638;;264/639;;264/650;;264/177.11;;264/211.11;;264/443;;264/41;;264/109,4,0,,,"Portions of a book entitled Organic Additives and Ceramic Processing with Applications in Powder Metallurgy, Ink, and Paint by Daniel J. Shanefield.;;English translation of Patent Abstract of Japanese patent JP 02141455, May 30, 1990 (Toyota Mtor Corp.).;;English translation of Patent Abstract of Japanese patent JP 49046046, Dec. 7, 1974 (Tanabe).;;Organic Additives & Ceramic Processing by Daniel J. Shanefield, May 11, 1995 pp. 151 153.",EXPIRED
38,US,A1,US 2017/0360498 A1,097-314-681-741-120,2017-12-21,2017,US 201515532402 A,2015-12-03,US 201515532402 A;;US 201462087141 P;;IB 2015059337 W,2014-12-03,Devices and Methods for Electrosurgical Navigation,"A method and apparatus or system are disclosed for a procedure with minimal or no fluoroscopy, for example an electrosurgical procedure, and which uses a three dimensional mapping system. The procedure typically involves electrical measurement of the electrode of a needle to determine its position. Some embodiments further include intracardiac echocardiography (ICE) for tracking devices. The apparatus includes a needle with a tip electrode, an electroanatomical mapping (EAM) system, and an electrical generator, wherein a switching device is used to restrictively electrically connect the needle to only one of the mapping system or generator at a given time.",BAYLIS MEDICAL CO INC,DAVIES GARETH;;HARFIELD ELLEN;;HORTON RODNEY;;WELLS DAVID;;WOO JASON,BAYLIS MEDICAL COMPANY INC (2015-11-27),https://lens.org/097-314-681-741-120,Patent Application,yes,13,9,3,3,0,A61B18/1477;;A61B18/1492;;A61B2018/00357;;A61B2018/00577;;A61B2018/00601;;A61B2018/00791;;A61B2018/00827;;A61B2018/00839;;A61B2018/00875;;A61B2018/00892;;A61B2218/002;;A61B2218/007;;A61B34/20;;A61B2034/2051;;A61B18/1233;;A61B18/1477;;A61B18/1492;;A61B2018/00357;;A61B2018/00577;;A61B2018/00601;;A61B2018/00791;;A61B2018/00827;;A61B2018/00839;;A61B2018/00875;;A61B2018/00892;;A61B2218/002;;A61B2218/007;;A61B34/20;;A61B2034/2051;;A61B5/304;;A61B5/283;;A61B5/361;;A61B18/1233;;A61B5/0536;;A61B2017/00053;;A61B2018/00172;;A61B2018/00178;;A61B2018/0091,A61B18/12;;A61B5/308;;A61B5/361;;A61B17/00;;A61B18/00;;A61B18/14;;A61B34/20,,0,0,,,,DISCONTINUED
39,DE,A1,DE 102022122332 A1,091-079-702-338-360,2023-03-09,2023,DE 102022122332 A,2022-09-02,US 202163240729 P,2021-09-03,FAHRRADSTEUERSATZANORDNUNG MIT KOMPRESSIONSRING AUS MULTIMATERIAL,"Ein Fahrrad weist einen Rahmen, eine Vordergabel, ein festes Anschlagelement in Bezug auf den Rahmen, ein Lagerelement, das die Vordergabel bezogen auf den Rahmen zur Drehung um eine Lenkachse stützt, und einen Kompressionsring auf. Der Kompressionsring weist einen Körperabschnitt zwischen dem Lagerelement und der Vordergabel auf und einen Anschlagabschnitt, der drehbar auf das feste Anschlagelement ausgerichtet ist, um eine Überdrehung der Vordergabel bezogen auf den Rahmen zu verhindern. Der Anschlagabschnitt umfasst ein zweites Material, das härter ist als das erste Material des Körperabschnitts. Zum Beispiel kann der Anschlagabschnitt eine Kontaktfläche aufweisen, die das feste Anschlagelement kontaktiert, wenn die Vordergabel ausreichend gedreht wurde, und die Kontaktfläche kann das zweite Material umfassen. In einer Ausführungsform umfasst das zweite Material eins oder mehrere von Aluminium, Titan, Keramik und Stahl. Der Körperabschnitt kann als Überspritzung an dem Anschlagabschnitt gebildet werden.",SPECIALIZED BICYCLE COMPONENTS INC,MCDONALD JASON SCOTT;;SANCHEZ DAVID ALFREDO REYES;;DAVIES JACK ERVIN,,https://lens.org/091-079-702-338-360,Patent Application,no,0,0,2,2,0,B62J11/13;;B62K21/06;;B62K2201/00;;B62K21/20,B62K21/06,,0,0,,,,PENDING
40,US,A1,US 2013/0341818 A1,153-398-182-289-221,2013-12-26,2013,US 201313862893 A,2013-04-15,US 201313862893 A;;GB 0706638 A;;GB 2008001185 W;;US 59456910 A,2007-04-04,HIGH-DIELECTRIC MATERIAL,"A bulk dielectric material comprises a solid composite material comprising a solid matrix material and a plurality of filler elements distributed within the matrix material. The bulk dielectric material has, at a frequency greater than 1 MHz, (i) a permittivity having a real part of magnitude greater than 10 and an imaginary part of magnitude less than 3, and (ii) an electrical breakdown strength greater than 5 kV/mm and has a minimum dimension greater than 2 mm.",MBDA UK LTD;;MBDA UK LTD,DUNLEAVY MICHAEL;;HAQ SAJAD;;REW JASON KARL;;DAVIES JOSEPH MAURICE,MBDA UK LIMITED (2009-01-12),https://lens.org/153-398-182-289-221,Patent Application,yes,6,0,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,B29C39/10,264/101;;427/77,1,1,009-784-262-210-872,10.1021/jp061597t;;16836331,"Wang et al., ""A General Approach to Porous Crystalline TiO2, SrTiO3, and BaTiO3 spheres"", J. Pys. Chem. B 2006, 110, 13835-13840, May 22, 2006",DISCONTINUED
41,AU,A,AU 1995/031838 A,056-506-743-531-567,1996-03-04,1996,AU 1995/031838 A,1995-08-02,GB 9415562 A;;GB 9501841 W,1994-08-02,Manufacture of ceramic articles,,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/056-506-743-531-567,Patent Application,no,0,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,,0,0,,,,PENDING
42,US,A1,US 2023/0074447 A1,155-907-288-241-096,2023-03-09,2023,US 202217902226 A,2022-09-02,US 202217902226 A;;US 202163240729 P,2021-09-03,BICYCLE HEADSET ASSEMBLY WITH MULTI-MATERIAL COMPRESSION RING,"A bicycle includes a frame, a front fork, a fixed stop member fixed in relation to the frame, a bearing member that supports the front fork relative to the frame for rotation about a steering axis, and a compression ring. The compression ring includes a body portion between the bearing member and the front fork and a stop portion rotationally aligned with the fixed stop member to inhibit over-rotation of the front fork relative to the frame. The stop portion comprises a second material that is harder than the first material of the body portion. For example, the stop portion can include a contact surface that contacts the fixed stop member when the front fork is sufficiently rotated, and the contact surface can comprise the second material. In one embodiment, the second material comprises one or more of aluminum, titanium, ceramic, and steel. The body portion can be formed as an overmold on the stop portion.",SPECIALIZED BICYCLE COMPONENTS INC,MCDONALD JASON SCOTT;;SANCHEZ DAVID ALFREDO REYES;;DAVIES JACK ERVIN,SPECIALIZED BICYCLE COMPONENTS INC (2022-08-30);;SPECIALIZED BICYCLE COMPONENTS HOLDING COMPANY INC (2022-08-30),https://lens.org/155-907-288-241-096,Patent Application,no,0,0,2,2,0,B62J11/13;;B62K21/06;;B62K2201/00;;B62K21/20,B62K21/20,,0,0,,,,PENDING
43,EP,A1,EP 2458595 A1,027-702-878-377-436,2012-05-30,2012,EP 12152191 A,2008-04-04,EP 08718986 A;;GB 0706638 A,2007-04-04,A high-dielectric material,"A bulk dielectric material comprises a solid composite material comprising a solid matrix material and a plurality of filler elements distributed within the matrix material. The bulk dielectric material has, at a frequency greater than 1 MHz, (i) a permittivity having a real part of magnitude greater than 10 and an imaginary part of magnitude less than 3, and (ii) an electrical breakdown strength greater than 5 kV/mm and has a minimum dimension greater than 2 mm.",MBDA UK LTD,DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,,https://lens.org/027-702-878-377-436,Patent Application,yes,4,0,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,H01B3/00,,1,0,,,"DATABASE WPI Week 199201, Derwent World Patents Index; AN 1992-001961, XP002483404",ACTIVE
44,WO,A1,WO 2016/088084 A1,090-229-492-986-638,2016-06-09,2016,IB 2015059337 W,2015-12-03,US 201462087141 P,2014-12-03,DEVICES AND METHODS FOR ELECTROSURGICAL NAVIGATION,"A method and apparatus or system are disclosed for a procedure with minimal or no fluoroscopy, for example an electrosurgical procedure, and which uses a three dimensional mapping system. The procedure typically involves electrical measurement of the electrode of a needle to determine its position. Some embodiments further include intracardiac echocardiography (ICE) for tracking devices. The apparatus includes a needle with a tip electrode, an electroanatomical mapping (EAM) system, and an electrical generator, wherein a switching device is used to restrictively electrically connect the needle to only one of the mapping system or generator at a given time.",BAYLIS MEDICAL CO INC;;BAYLIS MEDICAL USA INC,DAVIES GARETH;;HARFIELD ELLEN;;HORTON RODNEY;;WELLS DAVID;;WOO JASON,,https://lens.org/090-229-492-986-638,Patent Application,yes,5,9,3,3,0,A61B18/1477;;A61B18/1492;;A61B2018/00357;;A61B2018/00577;;A61B2018/00601;;A61B2018/00791;;A61B2018/00827;;A61B2018/00839;;A61B2018/00875;;A61B2018/00892;;A61B2218/002;;A61B2218/007;;A61B34/20;;A61B2034/2051;;A61B18/1233;;A61B18/1477;;A61B18/1492;;A61B2018/00357;;A61B2018/00577;;A61B2018/00601;;A61B2018/00791;;A61B2018/00827;;A61B2018/00839;;A61B2018/00875;;A61B2018/00892;;A61B2218/002;;A61B2218/007;;A61B34/20;;A61B2034/2051;;A61B5/304;;A61B5/283;;A61B5/361;;A61B18/1233;;A61B5/0536;;A61B2017/00053;;A61B2018/00172;;A61B2018/00178;;A61B2018/0091,A61B34/00;;A61B5/308;;A61B5/361;;A61B18/00,,0,0,,,,PENDING
45,EP,A1,EP 2145337 A1,126-142-194-081-411,2010-01-20,2010,EP 08718986 A,2008-04-04,GB 2008001185 W;;GB 0706638 A,2007-04-04,A HIGH-DIELECTRIC MATERIAL,,MBDA UK LTD,DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,,https://lens.org/126-142-194-081-411,Patent Application,yes,0,0,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,H01B3/00,,0,0,,,,ACTIVE
46,US,A1,US 2010/0104839 A1,187-248-683-957-013,2010-04-29,2010,US 59456908 A,2008-04-04,GB 0706638 A;;GB 2008001185 W,2007-04-04,HIGH-DIELECTRIC MATERIAL,"A bulk dielectric material can include a solid composite material having a solid matrix material and a plurality of filler elements distributed within the matrix material. The bulk dielectric material can have, at a frequency of greater than 1 MHz, (i) a permittivity with a real part of magnitude greater than 10 and an imaginary part of magnitude less than 3, and (ii) an electrical breakdown strength greater than 5 kV/mm and can have a minimum dimension greater than 2 mm.",MBDA UK LTD,DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,MBDA UK LIMITED (2009-12-01),https://lens.org/187-248-683-957-013,Patent Application,yes,23,1,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,B29C39/02;;B32B7/02;;B29C65/70;;B32B5/00,428/215;;428/220;;264/299;;264/319;;264/101;;264/134;;264/241,0,0,,,,ACTIVE
47,DE,D1,DE 69521513 D1,148-795-047-655-557,2001-08-02,2001,DE 69521513 T,1995-08-02,GB 9415562 A;;GB 9501841 W,1994-08-02,HERSTELLUNG VON KERAMISCHEN ARTIKELN,,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/148-795-047-655-557,Granted Patent,no,0,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,,0,0,,,,EXPIRED
48,US,A1,US 2014/0220660 A1,064-633-449-899-450,2014-08-07,2014,US 201214234500 A,2012-07-27,US 201161512169 P;;US 2012/0048565 W;;US 201214234500 A,2011-07-27,PROCESS FOR THE PRODUCTION OF FILAMENTOUS BACTERIOPHAGE,"The invention relates to culture conditions and methods that allow reproducible production of high titers of filamentous bacteriophage. Culture media comprising high titers of filamentous bacteriophage, as we methods of producing high titers of filamentous phage on a large scale are encompassed.",WRIGHT JASON;;BRADFORD MARC;;SUGAR FRANK;;DAVIES TIM;;MILLSAP KEVIN,WRIGHT JASON;;BRADFORD MARC;;SUGAR FRANK;;DAVIES TIM;;MILLSAP KEVIN,,https://lens.org/064-633-449-899-450,Patent Application,yes,1,1,3,3,0,A61K35/76;;C12N7/02;;C12N2795/00051;;C12N2795/14151;;C12N7/02;;C12N2795/00051;;C12N2795/14151;;A61K35/76;;C12N7/00,C12N7/00;;A61K35/76,435/236;;435/235.1,0,0,,,,DISCONTINUED
49,US,B2,US 8440121 B2,074-662-379-322-538,2013-05-14,2013,US 59456908 A,2008-04-04,GB 0706638 A;;GB 2008001185 W,2007-04-04,High-dielectric material,"A bulk dielectric material can include a solid composite material having a solid matrix material and a plurality of filler elements distributed within the matrix material. The bulk dielectric material can have, at a frequency of greater than 1 MHz, (i) a permittivity with a real part of magnitude greater than 10 and an imaginary part of magnitude less than 3, and (ii) an electrical breakdown strength greater than 5 kV/mm and can have a minimum dimension greater than 2 mm.",DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL;;MBDA UK LTD,DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,MBDA UK LIMITED (2009-12-01),https://lens.org/074-662-379-322-538,Granted Patent,yes,31,0,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,C04B35/00,264/104;;264/134;;264/299;;264/308;;264/349,3,0,,,"International Search Report and Written Opinion issued in PCT/GB2008/001185, mailed Jun. 18, 2008.;;Neves, Bob, ""Permittivity/Dielectric Constant: Do the Math"", From the Lab, Circuittree Magazine (US), Nov. 1996, 2 pages.;;Search Report issued in GB 0706638, dated Aug. 7, 2007, 3 pages.",ACTIVE
50,EP,B1,EP 0773913 B1,089-536-798-732-897,2001-06-27,2001,EP 95927838 A,1995-08-02,GB 9501841 W;;GB 9415562 A,1994-08-02,MANUFACTURE OF CERAMIC ARTICLES,,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/089-536-798-732-897,Granted Patent,yes,0,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,,3,0,,,"REED, J.S., ""Introduction to the Principles of Ceramic Processing"" , 1988, J. WILEY AND SONS, New York, US, pages 200 - 203;;Glass and Technology, vol. 4, 1983, pages 250 - 253, HLÁVAC, J., ""The Technology of Glass and Ceramics"";;RICHERSON, D.W., ""Modern Ceramic Engineering - Properties, Processing and Use in Design"", 1992, M. DEKKER, New York, US, pages 478 - 485",EXPIRED
51,EP,B1,EP 2458595 B1,155-648-267-506-143,2017-11-01,2017,EP 12152191 A,2008-04-04,EP 08718986 A;;GB 0706638 A,2007-04-04,A high-dielectric material,,MBDA UK LTD,DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,,https://lens.org/155-648-267-506-143,Granted Patent,yes,4,0,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,H01B3/00,,1,0,,,"DATABASE WPI Week 199201 Thomson Scientific, London, GB; AN 1992-001961 XP002483404, & JP 3 254011 A (DAISHINKU KK) 13 November 1991 (1991-11-13)",ACTIVE
52,WO,A2,WO 1996/004219 A2,029-954-572-156-183,1996-02-15,1996,GB 9501841 W,1995-08-02,GB 9415562 A,1994-08-02,MANUFACTURE OF CERAMIC ARTICLES,A mouldable ceramic composition is made by forming the suspension of electrically charged ceramic particles and then coagulating.,DYTECH CORP LTD;;SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/029-954-572-156-183,Patent Application,no,0,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,,0,0,,,,PATENTED
53,EP,A2,EP 0773913 A2,036-491-786-099-626,1997-05-21,1997,EP 95927838 A,1995-08-02,GB 9501841 W;;GB 9415562 A,1994-08-02,MANUFACTURE OF CERAMIC ARTICLES,,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/036-491-786-099-626,Patent Application,yes,0,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,,0,0,,,,EXPIRED
54,EP,A1,EP 2736522 A1,057-259-290-130-787,2014-06-04,2014,EP 12746431 A,2012-07-27,US 201161512169 P;;US 2012/0048565 W,2011-07-27,PROCESS FOR THE PRODUCTION OF FILAMENTOUS BACTERIOPHAGE,,NEUROPHAGE PHARMACEUTICALS INC;;COBRA BIOLOG LTD,WRIGHT JASON;;BRADFORD MARC;;SUGAR FRANK;;DAVIES TIM;;MILLSAP KEVIN,,https://lens.org/057-259-290-130-787,Patent Application,yes,0,0,3,3,0,A61K35/76;;C12N7/02;;C12N2795/00051;;C12N2795/14151;;C12N7/02;;C12N2795/00051;;C12N2795/14151;;A61K35/76;;C12N7/00,A61K35/76;;C12N7/02,,0,0,,,,DISCONTINUED
55,WO,A1,WO 2008/122775 A1,170-865-870-068-699,2008-10-16,2008,GB 2008001185 W,2008-04-04,GB 0706638 A,2007-04-04,A HIGH-DIELECTRIC MATERIAL,"A bulk dielectric material comprises a solid composite material comprising a solid matrix material and a plurality of filler elements distributed within the matrix material. The bulk dielectric material has, at a frequency greater than 1 MHz, (i) a permittivity having a real part of magnitude greater than 10 and an imaginary part of magnitude less than 3, and (ii) an electrical breakdown strength greater than 5 kV/mm and has a minimum dimension greater than 2 mm.",MBDA UK LTD;;DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,,https://lens.org/170-865-870-068-699,Patent Application,yes,4,0,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,H01B3/00,,1,0,,,"DATABASE WPI Week 199201, Derwent World Patents Index; AN 1992-001961, XP002483404",PENDING
56,EP,B1,EP 2145337 B1,023-727-482-138-135,2014-08-13,2014,EP 08718986 A,2008-04-04,GB 2008001185 W;;GB 0706638 A,2007-04-04,A HIGH-DIELECTRIC MATERIAL,,MBDA UK LTD,DUNLEAVY MICHAEL;;HAQ SAJAD;;DAVIES JOSEPH MAURICE;;REW JASON KARL,,https://lens.org/023-727-482-138-135,Granted Patent,yes,4,0,10,10,0,H01B3/006;;H01G4/206;;H05K1/024;;H05K1/0373;;H05K1/162;;H05K2201/0116;;H05K2201/0209;;H05K2201/0218;;H05K2201/0254;;Y10T428/24967;;Y10T428/24967;;H05K2201/0254;;H05K2201/0209;;H05K2201/0116;;H05K1/0373;;H01B3/006;;H05K1/162;;H05K1/024;;H05K2201/0218;;H01G4/206;;B29C39/10,H01B3/00,,1,0,,,"DATABASE WPI Week 199201 Derwent Publications Ltd., London, GB; AN 1992-001961 XP002483404 & JP 03 254011 A (DAISHINKU KK) 13 November 1991 (1991-11-13)",ACTIVE
57,US,A1,US 2022/0000537 A1,137-939-969-906-704,2022-01-06,2022,US 202117480804 A,2021-09-21,US 202117480804 A;;US 201715532402 A;;IB 2015059337 W;;US 201462087141 P,2014-12-03,Devices and Methods for Electrosurgical Navigation,"A method and apparatus or system are disclosed for a procedure with minimal or no fluoroscopy, for example an electrosurgical procedure, and which uses a three dimensional mapping system. The procedure typically involves electrical measurement of the electrode of a needle to determine its position. Some embodiments further include intracardiac echocardiography (ICE) for tracking devices. The apparatus includes a needle with a tip electrode, an electroanatomical mapping (EAM) system, and an electrical generator, wherein a switching device is used to restrictively electrically connect the needle to only one of the mapping system or generator at a given time.",BAYLIS MEDICAL CO INC,DAVIES GARETH;;HARFIELD ELLEN;;HORTON RODNEY;;WELLS DAVID;;WOO JASON,BAYLIS MEDICAL COMPANY INC (2015-12-08);;BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED (2022-06-01),https://lens.org/137-939-969-906-704,Patent Application,yes,0,0,3,3,0,A61B18/1477;;A61B18/1492;;A61B2018/00357;;A61B2018/00577;;A61B2018/00601;;A61B2018/00791;;A61B2018/00827;;A61B2018/00839;;A61B2018/00875;;A61B2018/00892;;A61B2218/002;;A61B2218/007;;A61B34/20;;A61B2034/2051;;A61B18/1233;;A61B18/1477;;A61B18/1492;;A61B2018/00357;;A61B2018/00577;;A61B2018/00601;;A61B2018/00791;;A61B2018/00827;;A61B2018/00839;;A61B2018/00875;;A61B2018/00892;;A61B2218/002;;A61B2218/007;;A61B34/20;;A61B2034/2051;;A61B5/304;;A61B5/283;;A61B5/361;;A61B18/1233;;A61B5/0536;;A61B2017/00053;;A61B2018/00172;;A61B2018/00178;;A61B2018/0091,A61B18/12;;A61B5/304;;A61B5/308;;A61B5/361;;A61B34/20,,0,0,,,,PENDING
58,WO,A1,WO 2013/016644 A1,150-821-744-485-854,2013-01-31,2013,US 2012/0048565 W,2012-07-27,US 201161512169 P,2011-07-27,PROCESS FOR THE PRODUCTION OF FILAMENTOUS BACTERIOPHAGE,"The invention relates to culture conditions and methods that allow reproducible production of high titers of filamentous bacteriophage. Culture media comprising high titers of filamentous bacteriophage, as well as methods of producing high titers of filamentous phage on a large scale are encompassed.",NEUROPHAGE PHARMACEUTICALS INC;;COBRA BIOLOG LTD;;WRIGHT JASON;;BRADFORD MARC;;SUGAR FRANK;;DAVIES TIM;;MILLSAP KEVIN,WRIGHT JASON;;BRADFORD MARC;;SUGAR FRANK;;DAVIES TIM;;MILLSAP KEVIN,,https://lens.org/150-821-744-485-854,Patent Application,yes,7,1,3,3,0,A61K35/76;;C12N7/02;;C12N2795/00051;;C12N2795/14151;;C12N7/02;;C12N2795/00051;;C12N2795/14151;;A61K35/76;;C12N7/00,A61K35/76;;C12N7/02,,16,14,027-671-739-248-301;;058-800-050-336-224;;039-150-643-213-800;;143-111-456-463-28X;;037-421-277-177-019;;004-192-737-548-658;;099-589-725-617-339;;096-759-018-661-904;;043-277-910-015-263;;002-099-702-500-321;;024-617-583-671-456;;025-868-138-819-734;;016-672-965-905-993;;027-671-739-248-301,10.1007/s00449-009-0303-3;;19221805;;8723931;;10.2144/96205st05;;pmc2989940;;21040541;;10.1186/1475-2859-9-81;;22714954;;10.1007/s10295-012-1148-3;;12618805;;10.1038/nmat758;;10.1039/b307593a;;10.1007/s00253-005-1922-5;;15703906;;10.1002/bit.22073;;18767194;;pmc373080;;10.1128/mr.50.4.401-427.1986;;3540571;;10.1093/nar/5.12.4495;;pmc342768;;745987;;10.1016/0378-1119(80)90093-1;;6254849;;10.1128/jvi.44.1.32-46.1982;;6292494;;pmc256238;;11338929;;10.1007/s00449-009-0303-3;;19221805,"SUNG-HYE H GRIECO ET AL: ""Maximizing filamentous phage yield during computer-controlled fermentation"", BIOPROCESS AND BIOSYSTEMS ENGINEERING, SPRINGER, BERLIN, DE, vol. 32, no. 6, 17 February 2009 (2009-02-17), pages 773 - 779, XP019741071, ISSN: 1615-7605, DOI: 10.1007/S00449-009-0303-3;;REDDY P ET AL: ""Improved method for the production of M13 phage and single-stranded DNA for DNA sequencing."", BIOTECHNIQUES MAY 1996 LNKD- PUBMED:8723931, vol. 20, no. 5, May 1996 (1996-05-01), pages 854 - 856 , 858, XP002686157, ISSN: 0736-6205;;SAUVAGEAU DOMINIC ET AL: ""Two-stage, self-cycling process for the production of bacteriophages"", MICROBIAL CELL FACTORIES, BIOMED CENTRAL, LONDON, NL, vol. 9, no. 1, 1 November 2010 (2010-11-01), pages 81, XP021077229, ISSN: 1475-2859, DOI: 10.1186/1475-2859-9-81;;SUNG-HYE H GRIECO ET AL: ""Optimization of fermentation parameters in phage production using response surface methodology"", JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY ; OFFICIAL JOURNAL OF THE SOCIETY FOR INDUSTRIAL MICROBIOLOGY, SPRINGER, BERLIN, DE, vol. 39, no. 10, 20 June 2012 (2012-06-20), pages 1515 - 1522, XP035115822, ISSN: 1476-5535, DOI: 10.1007/S10295-012-1148-3;;NAIK RR ET AL., NAT MATER, vol. 1, no. 3, 2002, pages 169 - 172;;FLYNN CE ET AL., J MATER CHEM, vol. 13, no. 10, 2003, pages 2414 - 2421;;ZUO R ET AL., APPL MICROBIOL BIOTECHNOL, vol. 68, no. 4, 2005, pages 505 - 509;;CURTIS SB ET AL., BIOTECHNOL BIOENG, vol. 102, no. 2, 2009, pages 644 - 650;;RASCHED; OBERER, MICROBIOL REV, vol. 50, 1986, pages 401 - 427;;BECK ET AL., NUCLEIC ACIDS RESEARCH, vol. 5, no. 12, 1978, pages 4495 - 4503;;VAN WEZENBEEK ET AL., GENE, vol. 11, 1980, pages 129 - 148;;HILL; PETERSEN, J. VIROL., vol. 44, no. 1, 1982, pages 32 - 46;;MONACI ET AL., CURR OPIN MOL THER., vol. 3, no. 2, April 2001 (2001-04-01), pages 159 - 69;;GRIECO ET AL., BIOPROCESS BIOSYST ENG, vol. 32, no. 6, 2009, pages 773 - 79;;RASCHED; OBERER, MICROBIOLOGY REVIEWS, December 1986 (1986-12-01), pages 401 - 427;;RIESENBERG ET AL., JOURNAL OF BIOTECHNOLOGY, vol. 20, 1991, pages 17 - 28",PENDING
59,DE,T2,DE 69521513 T2,124-955-939-571-964,2002-05-16,2002,DE 69521513 T,1995-08-02,GB 9415562 A;;GB 9501841 W,1994-08-02,HERSTELLUNG VON KERAMISCHEN ARTIKELN,,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/124-955-939-571-964,Granted Patent,no,0,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,,0,0,,,,EXPIRED
60,WO,A3,WO 1996/004219 A3,134-680-256-848-55X,1996-04-18,1996,GB 9501841 W,1995-08-02,GB 9415562 A,1994-08-02,MANUFACTURE OF CERAMIC ARTICLES,A mouldable ceramic composition is made by forming the suspension of electrically charged ceramic particles and then coagulating.,DYTECH CORP LTD;;SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/134-680-256-848-55X,Search Report,yes,5,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,,3,0,,,"DANIEL J. SHANEFIELD: ""Organic Additives and Ceramic Processing"", 11 May 1995, KLUWER ACADEMIC PUBLISHERS, BOSTON,USA, 214430;;PATENT ABSTRACTS OF JAPAN vol. 014, no. 382 (C - 0749) 17 August 1990 (1990-08-17);;DATABASE WPI Week 7502, Derwent World Patents Index; AN 75-02860w",PATENTED
61,GB,A,GB 2291830 A,139-368-746-014-203,1996-02-07,1996,GB 9515814 A,1995-08-02,GB 9415562 A,1994-08-02,Moulding ceramic articles,A method for the moulding of ceramic articles consists in coating particles of ceramic powder by mixing with an aqueous solution of an electrically charged polymeric material such that the particles acquire an electric charge and a suspension is formed; causing the suspension to coagulate to form a moulding composition; moulding the composition; drying and sintering.,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/139-368-746-014-203,Patent Application,no,4,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,B5A ADX           ADX;;B5A A1R158        ADX;;B5A A1R164        ADX;;B5A A1R165        ADX;;B5A A2Q2X         ADX;;B5A A20T14        ADX;;B5A A20T17        ADX;;B5A A20T19        ADX;;B5A A20T3         ADX;;B5A A20T4         ADX,0,0,,,,EXPIRED
62,GB,B,GB 2291830 B,097-316-879-686-533,1998-10-21,1998,GB 9515814 A,1995-08-02,GB 9415562 A,1994-08-02,Manufacture of ceramic articles,,DYTECH CORP LTD,SAMBROOK RODNEY MARTIN;;BINNER JON;;DAVIES JASON;;MCDERMOTT ANDREW MARK,,https://lens.org/097-316-879-686-533,Granted Patent,no,4,0,12,12,0,C04B35/111;;C04B35/628;;C04B35/63424;;C04B35/6365;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B2235/786;;C04B2235/96;;C04B35/63424;;C04B2235/3217;;C04B2235/6021;;C04B2235/77;;C04B35/6365;;C04B2235/96;;C04B35/111;;C04B2235/786;;C04B35/628,C04B35/111;;C04B35/628;;C04B35/636,B5A ADX           ADX;;B5A A1R158        ADX;;B5A A1R164        ADX;;B5A A1R165        ADX;;B5A A2Q2X         ADX;;B5A A20T14        ADX;;B5A A20T17        ADX;;B5A A20T19        ADX;;B5A A20T3         ADX;;B5A A20T4         ADX,0,0,,,,EXPIRED
63,TW,A,TW 200517188 A,001-078-456-856-98X,2005-06-01,2005,TW 93124868 A,2004-08-18,US 49630003 P,2003-08-19,Valve mechanisms for paint or ink brush with integrated reservoir,"An improved fluid control system for a paint brush or applicator system that includes a flexible barrel-type reservoir is disclosed. The disclosed valve systems may be of a ball-valve type, a trumpet-type or a duck-bill type. The valve or control systems help the user regulate the flow of fluid from a flexible barrel reservoir to a brush or applicator tip by adequately restricting flow in response to squeezing pressure applied by the user to the flexible barrel reservoir.",SANFORD LP,GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON,,https://lens.org/001-078-456-856-98X,Patent of Addition,no,0,0,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43M11/06,,0,0,,,,PENDING
64,US,A1,US 2005/0042019 A1,017-863-809-772-349,2005-02-24,2005,US 89656004 A,2004-07-22,US 89656004 A;;US 49630003 P,2003-08-19,Valve mechanisms for paint or ink brush with integrated reservoir,"An improved fluid control system for a paint brush or applicator system that includes a flexible barrel-type reservoir is disclosed. The disclosed valve systems may be of a ball-valve type, a trumpet-type or a duck-bill type. The valve or control systems help the user regulate the flow of fluid from a flexible barrel reservoir to a brush or applicator tip by adequately restricting flow in response to squeezing pressure applied by the user to the flexible barrel reservoir.",GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON,GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON,SANFORD L.P (2004-06-28),https://lens.org/017-863-809-772-349,Patent Application,yes,6,6,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43M11/06,401/186;;401/183;;401/279,0,0,,,,INACTIVE
65,US,S,US D0679254 S,134-199-732-196-003,2013-04-02,2013,US 201129388660 F,2011-03-31,US 201129388660 F;;US 37817610 F,2010-11-01,Plug for tool-releasable solar power connector,,SVELNIS CHRISTINE S;;BURKHARDT JEFFREY S;;DAVIES BRIAN F;;NICHOLSON JASON;;ANDERSON POWER PRODUCTS,SVELNIS CHRISTINE S;;BURKHARDT JEFFREY S;;DAVIES BRIAN F;;NICHOLSON JASON,ANDERSON POWER PRODUCTS INC (2011-03-30),https://lens.org/134-199-732-196-003,Design Right,no,0,4,1,2,0,,,1303;;D13/154;;D13/133,0,0,,,,ACTIVE
66,US,B2,US 6734190 B2,193-055-769-452-696,2004-05-11,2004,US 62927603 A,2003-07-28,US 62927603 A;;US 39914602 P,2002-07-29,Dihydrodipyrazolopyridinylbenzamide and -sulfonamide inhibitors of B7-1,"
    The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection or autoimmune disease. 
",WYETH CORP,GREEN NEAL JEFFREY;;XIANG JASON SHAOYUN;;DAVIES AUDREY MOLINA;;CHEN LIHREN,WYETH (2003-07-21),https://lens.org/193-055-769-452-696,Granted Patent,yes,3,4,2,2,0,A61K31/4745;;A61K31/55;;C07D471/14;;C07D471/14;;A61K31/55;;A61K31/4745,A61K31/4745;;A61K31/55;;C07D471/14,514/293;;546/82,2,2,011-547-022-006-138;;025-225-227-711-953,10.1074/jbc.m110162200;;11741888;;10.1021/jm00171a046;;1975276,"Erbe, D. V.; Wang, S.; Xing, Y.; and Tobin, J.F.; The Journal of Biological Chemistry (2002), vol. 277, 7363-7368.;;Ian T. Forbes et al., Journal of Medicinal Chemistry, 1990, vol. 33, 2640-2645.",EXPIRED
67,GB,B,GB 2386603 B,022-084-151-851-507,2006-09-20,2006,GB 0305952 A,2003-03-17,GB 0206344 A,2002-03-18,Personal cleaning composition,,PZ CUSSONS,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,,https://lens.org/022-084-151-851-507,Granted Patent,no,7,0,8,8,0,A61K8/02;;A61K8/046;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/463;;A61K8/604;;A61K2800/88;;A61Q19/10;;C11D3/0052;;C11D17/041;;A61K8/046;;C11D3/0052;;A61K8/365;;A61K2800/88;;A61K8/19;;A61K8/604;;C11D17/041;;A61K8/44;;A61K8/463;;A61Q19/10;;A61K8/02,A61Q19/10;;A61K8/02;;A61K8/04;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/46;;A61K8/60;;C11D3/00;;C11D17/04,C5D DDX           DDX;;C5D D107          DDX;;C5D D120          DDX;;C5D D122          DDX;;C5D D123          DDX;;C5D D124          DDX;;C5D D141          DDX;;C5D D170          DDX;;C5D D182          DDX;;C5D D184          DDX,0,0,,,,EXPIRED
68,US,S,US D0641324 S,062-870-220-560-076,2011-07-12,2011,US 37817310 F,2010-11-01,US 37817310 F,2010-11-01,Latch for tool-releasable solar power connector,,ANDERSON POWER PRODUCTS,SVELNIS CHRISTINE M;;BURKHARDT JEFFREY S;;DAVIES BRIAN F;;NICHOLSON JASON,ANDERSON POWER PRODUCTS INC (2010-10-04),https://lens.org/062-870-220-560-076,Design Right,no,0,6,1,1,0,,,1303;;D13/154,0,0,,,,ACTIVE
69,PL,A1,PL 359206 A1,135-394-224-743-648,2003-09-22,2003,PL 35920603 A,2003-03-17,GB 0206333 A,2002-03-18,PERSONAL CLEANING PREPARATION,,PZ CUSSONS INTERNAT LTD,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,,https://lens.org/135-394-224-743-648,Patent Application,no,0,0,6,6,0,A61K8/02;;A61K8/02;;A61K2800/222;;A61K2800/222;;A61K2800/52;;A61K2800/52;;A61K2800/88;;A61K2800/88;;A61Q19/10;;A61Q19/10;;C11D3/042;;C11D3/042;;C11D1/523;;C11D1/523;;C11D1/662;;C11D1/662;;C11D1/75;;C11D1/75;;C11D1/88;;C11D1/88;;C11D1/90;;C11D1/90;;C11D3/044;;C11D3/044;;C11D3/10;;C11D3/10;;C11D3/2086;;C11D3/2086;;C11D17/041;;C11D17/041,A61K8/02;;A61Q19/10;;C11D1/52;;C11D1/66;;C11D1/75;;C11D1/88;;C11D1/90;;C11D3/02;;C11D3/10;;C11D3/20;;C11D17/04,,0,0,,,,PENDING
70,US,S,US D0639250 S,160-496-079-943-056,2011-06-07,2011,US 37817610 F,2010-11-01,US 37817610 F,2010-11-01,Plug for tool-releasable solar power connector,,ANDERSON POWER PRODUCTS,SVELNIS CHRISTINE M;;BURKHARDT JEFFREY S;;DAVIES BRIAN F;;NICHOLSON JASON,ANDERSON POWER PRODUCTS INC (2010-10-04),https://lens.org/160-496-079-943-056,Design Right,no,0,13,1,2,0,,,1303;;D13/154,0,0,,,,ACTIVE
71,GB,A,GB 2386603 A,015-701-164-334-127,2003-09-24,2003,GB 0305952 A,2003-03-17,GB 0206344 A,2002-03-18,Personal cleaning composition,"A package of cleaning composition comprises a surfactant, an aqueous acidic component and an aqueous alkaline component, the acid and alkali being provided in separate compartments within the package. On dispensing from the package the acid and alkali react together creating carbon dioxide gas which acts upon the surfactant to create a lather. The acid and alkali components both have a viscosity and less than 4000 cps.",PZ CUSSONS,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,,https://lens.org/015-701-164-334-127,Patent Application,no,7,4,8,8,0,A61K8/02;;A61K8/046;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/463;;A61K8/604;;A61K2800/88;;A61Q19/10;;C11D3/0052;;C11D17/041;;A61K8/046;;C11D3/0052;;A61K8/365;;A61K2800/88;;A61K8/19;;A61K8/604;;C11D17/041;;A61K8/44;;A61K8/463;;A61Q19/10;;A61K8/02,A61K8/02;;A61K8/04;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/46;;A61K8/60;;A61Q19/10;;C11D3/00;;C11D17/04,C5D DDX           DDX;;C5D D107          DDX;;C5D D120          DDX;;C5D D122          DDX;;C5D D123          DDX;;C5D D124          DDX;;C5D D141          DDX;;C5D D170          DDX;;C5D D182          DDX;;C5D D184          DDX,0,0,,,,EXPIRED
72,US,A1,US 2004/0023825 A1,176-580-097-591-907,2004-02-05,2004,US 39056203 A,2003-03-17,GB 0206344 A,2002-03-18,Personal cleaning composition,"
   A package of cleaning composition comprises a surfactant, an aqueous acidic component and an aqueous alkaline component, the acid and alkali being provided in separate compartments within the package. On dispensing from the package the acid and alkali react together creating carbon dioxide gas which acts upon the surfactant to create a lather. The acid and alkali components both have a viscosity and less than 4000 cps. 
",DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,PZ CUSSONS (INTERNATIONAL) LIMITED (2003-05-15),https://lens.org/176-580-097-591-907,Patent Application,yes,0,2,8,8,0,A61K8/02;;A61K8/046;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/463;;A61K8/604;;A61K2800/88;;A61Q19/10;;C11D3/0052;;C11D17/041;;A61K8/046;;C11D3/0052;;A61K8/365;;A61K2800/88;;A61K8/19;;A61K8/604;;C11D17/041;;A61K8/44;;A61K8/463;;A61Q19/10;;A61K8/02,A61K8/02;;A61K8/04;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/46;;A61K8/60;;A61Q19/10;;C11D3/00;;C11D17/04,510/293;;510/295;;510/297,0,0,,,,DISCONTINUED
73,US,B2,US 7467907 B2,197-196-798-062-974,2008-12-23,2008,US 89656004 A,2004-07-22,US 89656004 A;;US 49630003 P,2003-08-19,Valve mechanisms for paint or ink brush with integrated reservoir,"An improved fluid control system for a paint brush or applicator system that includes a flexible barrel-type reservoir is disclosed. The disclosed valve systems may be of a ball-valve type, a trumpet-type or a duck-bill type. The valve or control systems help the user regulate the flow of fluid from a flexible barrel reservoir to a brush or applicator tip by adequately restricting flow in response to squeezing pressure applied by the user to the flexible barrel reservoir.",SANFORD LP,GAYNES STEVEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON,SANFORD L.P (2004-06-28),https://lens.org/197-196-798-062-974,Granted Patent,yes,57,3,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;B43M11/06;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03,401/186;;401/273;;401/206,2,0,,,"International Search Report for PCT/US2004/025877 dated Dec. 29, 2004 (8 pages).;;Written Opinion of the International Searching Authority for PCT/US2004/025877 dated Dec. 29, 2004 (6 pages).",INACTIVE
74,US,B2,US 8221153 B2,167-508-388-306-755,2012-07-17,2012,US 201113077061 A,2011-03-31,US 201113077061 A;;US 32078810 P;;US 38171210 P,2010-04-05,Tool-releasable solar power connector,"An electrical connector housing system includes a plug housing, a receptacle housing, and a latching mechanism. The latching mechanism pivots on pivot posts on one housing and hooks to latching posts on the other housing, thereby securing the mated housings together. Catches on the latch mechanism engage with tabs near the latching posts when the latching mechanism is latched. The catches must be released using a screwdriver or similar tool before opening the latching mechanism and separating the mated housings. A protective barrier can be included to block direct access to the engaged catches and tabs. The housings include overlapping shells which exclude water and dirt, and the latching mechanism at least partially covers and further protects the shells when closed. In embodiments, a retaining mechanism automatically holds the latch open against gravity, facilitating connection and release of the housings with one hand and/or while wearing gloves.",SVELNIS CHRISTINE M;;NICHOLSON JASON;;BURKHARDT JEFFREY S;;DAVIES BRIAN F;;ANDERSON POWER PRODUCTS,SVELNIS CHRISTINE M;;NICHOLSON JASON;;BURKHARDT JEFFREY S;;DAVIES BRIAN F,ANDERSON POWER PRODUCTS INC (2011-03-31),https://lens.org/167-508-388-306-755,Granted Patent,yes,14,1,2,4,0,H01R13/62955;;H01R43/26;;H01R13/62955;;H01R43/26,H01R13/62,439/372,0,0,,,,ACTIVE
75,US,A1,US 2004/0009885 A1,193-892-130-943-070,2004-01-15,2004,US 39033503 A,2003-03-17,GB 0206333 A,2002-03-18,Personal cleaning composition,"
   A packaged cleaning composition comprising a surfactant, an aqueous acid component and an aqueous alkaline component, the acid and alkali components being provided in separate compartments within the package. On dispensing from the package the acid and alkali react together creating carbon dioxide gas which acts upon the surfactant to create a lather. The acid component is buffered to a pH ranging from 2 to 6.5 
",PZ CUSSONS INT LTD,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,PZ CUSSONS (INTERNATIONAL) LIMITED (2003-05-15),https://lens.org/193-892-130-943-070,Patent Application,yes,0,6,6,6,0,A61K8/02;;A61K8/02;;A61K2800/222;;A61K2800/222;;A61K2800/52;;A61K2800/52;;A61K2800/88;;A61K2800/88;;A61Q19/10;;A61Q19/10;;C11D3/042;;C11D3/042;;C11D1/523;;C11D1/523;;C11D1/662;;C11D1/662;;C11D1/75;;C11D1/75;;C11D1/88;;C11D1/88;;C11D1/90;;C11D1/90;;C11D3/044;;C11D3/044;;C11D3/10;;C11D3/10;;C11D3/2086;;C11D3/2086;;C11D17/041;;C11D17/041,A61K8/02;;A61Q19/10;;C11D1/52;;C11D1/66;;C11D1/75;;C11D1/88;;C11D1/90;;C11D3/02;;C11D3/10;;C11D3/20;;C11D17/04,510/279;;510/509,0,0,,,,DISCONTINUED
76,US,A1,US 2003/0080150 A1,017-235-994-835-905,2003-05-01,2003,US 25190802 A,2002-09-20,GB 0122665 A,2001-09-20,Dispenser for personal care composition,"
   A dispenser, in the form of a sachet, made from a water-soluble plastics material, containing a personal care composition including at least one surfactant together with an effervescent base material, the base material including any material or combination of materials that when in contact with a sufficient amount of water liberates gas. 
",COWAN ALISON;;HORNE GRAHAM ROBERT;;DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD,COWAN ALISON;;HORNE GRAHAM ROBERT;;DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD,PZ CUSSONS (INTERNATIONAL) LIMITED (2002-12-18),https://lens.org/017-235-994-835-905,Patent Application,yes,6,52,4,4,0,A61K8/19;;A61K8/19;;A61K8/365;;A61K8/365;;A61K8/442;;A61K8/442;;A61K8/463;;A61K8/463;;A61K8/8129;;A61K8/8129;;A61K2800/222;;A61K2800/222;;A61K2800/87;;A61K2800/87;;A61Q19/10;;A61Q19/10;;C11D17/042;;C11D17/042;;C11D1/146;;C11D1/146;;C11D1/90;;C11D1/90;;C11D1/94;;C11D1/94;;C11D3/0052;;C11D3/0052;;C11D3/10;;C11D3/10;;C11D3/2086;;C11D3/2086,A61K8/19;;A61K8/365;;A61K8/44;;A61K8/46;;A61K8/81;;A61Q19/10;;C11D1/14;;C11D1/90;;C11D1/94;;C11D3/00;;C11D3/10;;C11D3/20;;C11D17/04,222/107,0,0,,,,DISCONTINUED
77,CN,B,CN 102403609 B,008-688-873-721-616,2015-02-11,2015,CN 201110258392 A,2011-09-02,US 38171210 P;;US 201113077061 A,2010-09-10,Tool-releasable solar power connector,,ANDERSON POWER PRODUCTS,SVELNIS CHRISTINE M;;NICHOLSON JASON;;BURKHARDT JEFFREY S;;DAVIES BRIAN F,,https://lens.org/008-688-873-721-616,Granted Patent,no,0,0,2,4,0,,H01R13/502;;H01R13/52;;H01R13/639,,0,0,,,,ACTIVE
78,US,A1,US 2004/0234488 A1,128-961-620-980-359,2004-11-25,2004,US 87308904 A,2004-06-22,US 87308904 A;;GB 0206344 A;;US 39056203 A,2002-03-18,Personal cleaning composition,"
   A package of cleaning composition comprises a surfactant, an aqueous acidic component and an aqueous alkaline component, the acid and alkali being provided in separate compartments within the package. On dispensing from the package the acid and alkali react together creating carbon dioxide gas which acts upon the surfactant to create a lather. The acid and alkali components both have a viscosity and less than 4000 cps. 
",DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,,https://lens.org/128-961-620-980-359,Patent Application,yes,6,1,8,8,0,A61K8/02;;A61K8/046;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/463;;A61K8/604;;A61K2800/88;;A61Q19/10;;C11D3/0052;;C11D17/041;;A61K8/046;;C11D3/0052;;A61K8/365;;A61K2800/88;;A61K8/19;;A61K8/604;;C11D17/041;;A61K8/44;;A61K8/463;;A61Q19/10;;A61K8/02,A61K8/02;;A61K8/04;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/46;;A61K8/60;;A61Q19/10;;C11D3/00;;C11D17/04,424/70.21,0,0,,,,DISCONTINUED
79,CN,A,CN 102403609 A,000-769-585-469-237,2012-04-04,2012,CN 201110258392 A,2011-09-02,US 38171210 P;;US 201113077061 A,2010-09-10,Tool-releasable solar power connector,"An electrical connector housing system includes a plug housing, a receptacle housing, and a latching mechanism. The latching mechanism pivots on pivot posts on one housing and hooks to latching posts on the other housing, thereby securing the mated housings together. Catches on the latch mechanism engage with tabs near the latching posts when the latching mechanism is latched. The catches must be released using a screwdriver or similar tool before opening the latching mechanism and separating the mated housings. A protective barrier can be included to block direct access to the engaged catches and tabs. The housings include overlapping shells which exclude water and dirt, and the latching mechanism at least partially covers and further protects the shells when closed. In embodiments, a retaining mechanism automatically holds the latch open against gravity, facilitating connection and release of the housings with one hand and/or while wearing gloves.",ANDERSON POWER PRODUCTS,SVELNIS CHRISTINE M;;JASON NICHOLSON;;BURKHARDT JEFFREY S;;DAVIES BRIAN F,,https://lens.org/000-769-585-469-237,Patent Application,no,5,4,2,4,0,,H01R13/502;;H01R13/52;;H01R13/639,,0,0,,,,ACTIVE
80,GB,A,GB 2382350 A,040-217-694-928-872,2003-05-28,2003,GB 0221861 A,2002-09-20,GB 0122665 A,2001-09-20,Soluble sachet containing effervescent base material,"A sachet formed from a water soluble plastics material comprises a personal care composition, which includes at least one surfactant together with an effervescent base material, wherein the base material liberates a gas when in contact with a sufficient amount of water. Typically, the base material comprises a carbonate and/or a bicarbonate, e.g. sodium bicarbonate in combination with an acid, such as citric acid. The base material and the surfactant(s) may be provided in powdered or granular form. The surfactant(s) may be anionic, nonionic, cationic, amphoteric or mixtures thereof The plastics material may be polyvinyl alcohol, polyvinyl pyrrolidine, a starch-based polymer, cellulose, or an alginate. The sachet is preferably for addition to bath water.",PZ CUSSONS,COWAN ALISON;;HORNE GRAHAM ROBERT;;DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD,,https://lens.org/040-217-694-928-872,Patent Application,no,4,12,4,4,0,A61K8/19;;A61K8/19;;A61K8/365;;A61K8/365;;A61K8/442;;A61K8/442;;A61K8/463;;A61K8/463;;A61K8/8129;;A61K8/8129;;A61K2800/222;;A61K2800/222;;A61K2800/87;;A61K2800/87;;A61Q19/10;;A61Q19/10;;C11D17/042;;C11D17/042;;C11D1/146;;C11D1/146;;C11D1/90;;C11D1/90;;C11D1/94;;C11D1/94;;C11D3/0052;;C11D3/0052;;C11D3/10;;C11D3/10;;C11D3/2086;;C11D3/2086,A61K8/19;;A61K8/365;;A61K8/44;;A61K8/46;;A61K8/81;;A61Q19/10;;C11D1/14;;C11D1/90;;C11D1/94;;C11D3/00;;C11D3/10;;C11D3/20;;C11D17/04,A5B BFH           BFF/H;;A5B B161          BFF/H;;A5B B170          BFF/H;;A5B B841          BFF/H;;C5D DDX           DDX;;C5D DHG           DHG;;C5D D107          DDX;;C5D D107          DHG;;C5D D120          DDX;;C5D D120          DHG;;C5D D123          DDX;;C5D D123          DHG;;C5D D124          DDX;;C5D D124          DHG;;C5D D141          DDX;;C5D D141          DHG;;C5D D149          DDX;;C5D D149          DHG;;C5D D173          DDX;;C5D D173          DHG;;C5D D181          DDX;;C5D D181          DHG,0,0,,,,DISCONTINUED
81,US,A1,US 2011/0244710 A1,075-455-971-932-268,2011-10-06,2011,US 201113077061 A,2011-03-31,US 201113077061 A;;US 32078810 P;;US 38171210 P,2010-04-05,TOOL-RELEASABLE SOLAR POWER CONNECTOR,"An electrical connector housing system includes a plug housing, a receptacle housing, and a latching mechanism. The latching mechanism pivots on pivot posts on one housing and hooks to latching posts on the other housing, thereby securing the mated housings together. Catches on the latch mechanism engage with tabs near the latching posts when the latching mechanism is latched. The catches must be released using a screwdriver or similar tool before opening the latching mechanism and separating the mated housings. A protective barrier can be included to block direct access to the engaged catches and tabs. The housings include overlapping shells which exclude water and dirt, and the latching mechanism at least partially covers and further protects the shells when closed. In embodiments, a retaining mechanism automatically holds the latch open against gravity, facilitating connection and release of the housings with one hand and/or while wearing gloves.",ANDERSON POWER PRODUCTS,SVELNIS CHRISTINE M;;NICHOLSON JASON;;BURKHARDT JEFFREY S;;DAVIES BRIAN F,ANDERSON POWER PRODUCTS INC (2011-03-31),https://lens.org/075-455-971-932-268,Patent Application,yes,8,9,2,4,0,H01R13/62955;;H01R43/26;;H01R13/62955;;H01R43/26,H01R13/62,439/372,0,0,,,,ACTIVE
82,US,A1,US 2004/0024008 A1,085-309-227-788-680,2004-02-05,2004,US 62927603 A,2003-07-28,US 62927603 A;;US 39914602 P,2002-07-29,Dihydrodipyrazolopyridinylbenzamide and -sulfonamide inhibitors of B7-1,"
    The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection or autoimmune disease. 
",WYETH CORP,GREEN NEAL JEFFREY;;XIANG JASON SHAOYUN;;DAVIES AUDREY MOLINA;;CHEN LIHREN,WYETH (2003-07-21),https://lens.org/085-309-227-788-680,Patent Application,yes,3,2,2,2,0,A61K31/4745;;A61K31/55;;C07D471/14;;C07D471/14;;A61K31/55;;A61K31/4745,A61K31/4745;;A61K31/55;;C07D471/14,514/292;;514/217.07;;546/82;;540/597,0,0,,,,EXPIRED
83,GB,A,GB 2386604 A,034-520-926-382-421,2003-09-24,2003,GB 0305953 A,2003-03-17,GB 0206333 A,2002-03-18,Personal cleansing composition,"A packaged cleaning composition comprising a surfactant, an aqueous acid component and an aqueous alkaline component, the acid and alkali components being provided in separate compartments within the package. On dispensing from the package the acid and alkali react together creating carbon dioxide gas which acts upon the surfactant to create a lather. The acid component is buffered to a pH ranging from 2 to 6.5 to reduce the possibility of irritation of the skin.",PZ CUSSONS,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,,https://lens.org/034-520-926-382-421,Patent Application,no,7,6,6,6,0,A61K8/02;;A61K8/02;;A61K2800/222;;A61K2800/222;;A61K2800/52;;A61K2800/52;;A61K2800/88;;A61K2800/88;;A61Q19/10;;A61Q19/10;;C11D3/042;;C11D3/042;;C11D1/523;;C11D1/523;;C11D1/662;;C11D1/662;;C11D1/75;;C11D1/75;;C11D1/88;;C11D1/88;;C11D1/90;;C11D1/90;;C11D3/044;;C11D3/044;;C11D3/10;;C11D3/10;;C11D3/2086;;C11D3/2086;;C11D17/041;;C11D17/041,A61K8/02;;A61Q19/10;;C11D1/52;;C11D1/66;;C11D1/75;;C11D1/88;;C11D1/90;;C11D3/02;;C11D3/10;;C11D3/20;;C11D17/04,C5D DDX           DDX;;C5D D107          DDX;;C5D D120          DDX;;C5D D122          DDX;;C5D D123          DDX;;C5D D124          DDX;;C5D D141          DDX;;C5D D170          DDX;;C5D D176          DDX;;C5D D182          DDX;;C5D D184          DDX,0,0,,,,DISCONTINUED
84,PL,A1,PL 359205 A1,160-709-231-352-012,2003-09-22,2003,PL 35920503 A,2003-03-17,GB 0206344 A,2002-03-18,PERSONAL CLEANING PREPARATION,,PZ CUSSONS INTERNAT LTD,DAVIES CRAIG JOSEPH;;FULLMAN JASON RONALD;;ATKINSON HELEN PATRICIA;;PAWSON EMMA,,https://lens.org/160-709-231-352-012,Patent Application,no,0,0,8,8,0,A61K8/02;;A61K8/046;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/463;;A61K8/604;;A61K2800/88;;A61Q19/10;;C11D3/0052;;C11D17/041;;A61K8/046;;C11D3/0052;;A61K8/365;;A61K2800/88;;A61K8/19;;A61K8/604;;C11D17/041;;A61K8/44;;A61K8/463;;A61Q19/10;;A61K8/02,A61K8/02;;A61K8/04;;A61K8/19;;A61K8/365;;A61K8/44;;A61K8/46;;A61K8/60;;A61Q19/10;;C11D3/00;;C11D17/04,,0,0,,,,PENDING
85,EP,A1,EP 1656048 A1,130-177-961-787-752,2006-05-17,2006,EP 04780673 A,2004-08-09,US 2004/0025877 W;;US 49630003 P,2003-08-19,VALVE MECHANISMS FOR PAINT OR INK BRUSH WITH INTEGRATED RESERVOIR,,SANFORD LP,GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON E,,https://lens.org/130-177-961-787-752,Patent Application,yes,0,0,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43M11/06,,0,0,,,,ACTIVE
86,WO,A1,WO 2008/074985 A1,140-470-010-346-770,2008-06-26,2008,GB 2007004707 W,2007-12-10,GB 0625387 A,2006-12-21,OBJECT DETECTOR APPARATUS AND METHOD,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyser which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyser is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC;;STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,,https://lens.org/140-470-010-346-770,Patent Application,yes,7,3,13,13,0,B23Q17/24;;B23Q17/24,B23Q17/09;;B23Q17/24,,0,0,,,,PENDING
87,CN,A,CN 101573210 A,053-390-042-260-855,2009-11-04,2009,CN 200780047661 A,2007-12-10,GB 2007004707 W;;GB 0625387 A,2006-12-21,Object detector apparatus and method,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyser which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyser is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC,GORDON STIMPSON VICTOR;;KENNETH DAVIES WILLIAM;;JASON MERRIFIELD BENJAMIN;;MARTIN BARNARD WILLIAM,,https://lens.org/053-390-042-260-855,Patent Application,no,0,2,13,13,0,B23Q17/24;;B23Q17/24,B23Q17/09;;B23Q17/24,,0,0,,,,INACTIVE
88,DE,D1,DE 602004010142 D1,120-117-242-702-583,2007-12-27,2007,DE 602004010142 T,2004-08-09,US 49630003 P;;US 2004/0025877 W,2003-08-19,VENTILMECHANISMEN FÜR PINSEL MIT EINGEBAUTEM RESERVOIR,,SANFORD LP,GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON E,,https://lens.org/120-117-242-702-583,Granted Patent,no,0,0,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A45D34/04;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43K5/18;;B43M11/06,,0,0,,,,ACTIVE
89,WO,A1,WO 2005/018379 A1,143-190-584-558-281,2005-03-03,2005,US 2004/0025877 W,2004-08-09,US 49630003 P,2003-08-19,VALVE MECHANISMS FOR PAINT OR INK BRUSH WITH INTEGRATED RESERVOIR,"An improved fluid control system for a paint brush or applicator system that includes a flexible barrel-type reservoir (21) is disclosed. The disclosed valve systems may be a ball-valve type (24a), a trumpet-type (24) or a duck-bill type. The valve or control systems help the user regulate the flow of fluid from a flexible barrel reservoir (21) to a brush or applicator tip by adequately restricting flow in response to squeezing pressure applied by the user to the flexible barrel reservoir.",SANFORD LP;;GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON E,GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON E,,https://lens.org/143-190-584-558-281,Patent Application,yes,6,0,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43M11/06,,0,0,,,,PATENTED
90,TW,A,TW 200900195 A,002-620-425-578-335,2009-01-01,2009,TW 96149040 A,2007-12-20,GB 0625387 A,2006-12-21,Object detector apparatus and method,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyser which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyser is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,,https://lens.org/002-620-425-578-335,Patent of Addition,no,0,0,13,13,0,B23Q17/24;;B23Q17/24,B23Q17/22;;B23Q17/09;;B23Q17/24,,0,0,,,,ACTIVE
91,JP,A,JP 2009187947 A,053-090-771-357-740,2009-08-20,2009,JP 2009025951 A,2009-02-06,US 2869808 A,2008-02-08,"X-RAY TUBE, AND X-RAY TUBE COOLING SYSTEM","<P>PROBLEM TO BE SOLVED: To prevent thermal stress deformation of a window of an X-ray tube by supporting dissipation of heat generated while the X-ray tube is running. <P>SOLUTION: An X-ray tube cooling system includes a housing, a window frame attached to the housing, and a window attached to the window frame. The housing partitions and forms electron gaps through which electrons can pass from a cathode to an anode. The housing also partitions and forms a first inlet port and a first outlet port. The window frame partitions and forms an X-ray opening through which X-rays can pass. The window covers the X-ray opening. The housing and the window frame are configured so as a liquid can flow from the first inlet port to the first outlet port through either a first liquid path at least partially partitioned and formed by the housing or a second liquid path cooperatively partitioned and formed by the housing and the window frame. The second liquid path is disposed at least a part of a periphery of the X-ray opening. <P>COPYRIGHT: (C)2009,JPO&INPIT",VARIAN MED SYS INC,WARBURTON DON LEE;;DAVIES JASON W;;ANDREWS GREGORY C;;MARK S JONATIS,,https://lens.org/053-090-771-357-740,Patent Application,no,7,0,2,10,0,,H01J35/00;;H01J35/16;;H01J35/18,,0,0,,,,INACTIVE
92,AU,A1,AU 2004/266613 A1,126-549-794-535-741,2005-03-03,2005,AU 2004/266613 A,2004-08-09,US 49630003 P;;US 2004/0025877 W,2003-08-19,Valve mechanisms for paint or ink brush with integrated reservoir,,SANFORD LP,FLADER MICHAEL;;DAVIES-SMITH LEIGHTON;;CANTU JASON E;;GAYNES STEPHEN;;DANZYGER HOWARD,,https://lens.org/126-549-794-535-741,Patent Application,no,0,0,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A45D34/04;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43K5/18;;B43M11/06,,0,0,,,,DISCONTINUED
93,US,S,US D0758590 S,184-930-696-190-491,2016-06-07,2016,US 201429510292 F,2014-11-26,US 201429510292 F,2014-11-26,Switch box,,BAYLIS MEDICAL CO INC,BURACHYNSKY NATALIA;;DAVIES GARETH;;SHAH KRISHAN;;STEPHENSON LYNDSAY;;WELLS DAVID;;WOO JASON,BAYLIS MEDICAL COMPANY INC (2014-11-26);;BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED (2022-06-01),https://lens.org/184-930-696-190-491,Design Right,no,0,7,1,1,0,,,2400;;D24/170,0,0,,,,ACTIVE
94,DE,T2,DE 602004010142 T2,125-441-759-649-144,2008-02-21,2008,DE 602004010142 T,2004-08-09,US 49630003 P;;US 2004/0025877 W,2003-08-19,VENTILMECHANISMEN FÜR PINSEL MIT EINGEBAUTEM RESERVOIR,,SANFORD LP,GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON E,,https://lens.org/125-441-759-649-144,Granted Patent,no,0,4,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A45D34/04;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43K5/18;;B43M11/06,,0,0,,,,ACTIVE
95,TW,B,TW I415708 B,005-440-415-252-092,2013-11-21,2013,TW 96149040 A,2007-12-20,GB 0625387 A,2006-12-21,Object detector apparatus and method,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyzer which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyzer is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,,https://lens.org/005-440-415-252-092,Granted Patent,no,7,0,13,13,0,B23Q17/24;;B23Q17/24,,,0,0,,,,ACTIVE
96,US,B2,US 7688949 B2,035-245-171-947-772,2010-03-30,2010,US 2869808 A,2008-02-08,US 2869808 A;;US 86460307 A,2007-09-28,X-ray tube cooling system,"X-ray tube cooling systems. In one example embodiment, an x-ray tube includes a housing, a window frame attached to the housing, and a window attached to the window frame. The housing defines an aperture through which electrons can pass from a cathode to an anode. The housing also defines an inlet port and an outlet port. The window frame defines an opening through which x-rays can pass. The window covers the opening defined by the window frame. The housing and the window frame are configured such that a liquid can flow from the inlet port to the outlet port through either a first liquid path at least partially defined by the housing or a second liquid path cooperatively defined by the housing and the window frame. The second liquid path is disposed about at least a portion of the opening in the window frame.",VARIAN MED SYS INC,WARBURTON DON LEE;;DAVIES JASON W;;ANDREWS GREGORY C;;JONAITIS MARK S,VARIAN MEDICAL SYSTEMS TECHNOLOGIES INC (2008-03-31);;VARIAN MEDICAL SYSTEMS INC (2008-09-26);;VAREX IMAGING CORPORATION (2017-01-25),https://lens.org/035-245-171-947-772,Granted Patent,yes,11,5,2,10,0,H01J35/18;;H01J2235/122;;H05G1/02;;H05G1/025;;H05G1/02;;H01J2235/122;;H01J35/18;;H05G1/025,H01J35/18,378/140;;378/141;;378/200,0,0,,,,INACTIVE
97,US,B2,US 8537359 B2,050-907-536-444-646,2013-09-17,2013,US 44812807 A,2007-12-10,GB 0625387 A;;GB 2007004707 W,2006-12-21,Object detector apparatus and method,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyzer which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyzer is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN;;RENISHAW PLC,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,RENISHAW PLC (2008-01-09),https://lens.org/050-907-536-444-646,Granted Patent,yes,65,2,13,13,0,B23Q17/24;;B23Q17/24,G01N21/84,356/426,7,0,,,"Excellon Automation Broken Tool Detector Service Manual, 211012-17, Rev. B, Jun. 1985, pp. 6-1, 6-2 and 7-4.;;Optical Tool Breakage Monitoring Unit with Laser, Leuze press release, Feb. 24, 2003, pp. 1-3.;;Leuze Electronic Technical Document and Partial Translation (date unknown, retrieved Jun. 27, 2002).;;Broken Drill Detection System (date unknown, retrieved Jun. 27, 2002).;;Balluff, online product information, retrieved Nov. 30, 2006.;;Office Action issued May 25, 2012 in Japanese Patent Application No. 2009-542188 (with translation).;;Translation of May 9, 2013 Office Action issued in Taiwanese Patent Application No. 096149040.",ACTIVE
98,US,A1,US 2010/0027031 A1,053-063-240-479-905,2010-02-04,2010,US 44812807 A,2007-12-10,GB 0625387 A;;GB 2007004707 W,2006-12-21,OBJECT DETECTOR APPARATUS AND METHOD,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyser which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyser is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,RENISHAW PLC (2008-01-09),https://lens.org/053-063-240-479-905,Patent Application,yes,27,9,13,13,0,B23Q17/24;;B23Q17/24,G01B11/14;;G06F15/00,356/614;;702/150,0,0,,,,ACTIVE
99,EP,B1,EP 1656048 B1,026-049-747-171-168,2007-11-14,2007,EP 04780673 A,2004-08-09,US 2004/0025877 W;;US 49630003 P,2003-08-19,VALVE MECHANISMS FOR PAINT OR INK BRUSH WITH INTEGRATED RESERVOIR,,SANFORD LP,GAYNES STEPHEN;;DAVIES-SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON E,,https://lens.org/026-049-747-171-168,Granted Patent,yes,6,0,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/00;;A45D34/04;;A46B11/02;;A46B11/04;;B05C17/00;;B05C17/03;;B43K5/18;;B43M11/06,,0,0,,,,ACTIVE
100,EP,A1,EP 2114617 A1,029-193-984-768-81X,2009-11-11,2009,EP 07848455 A,2007-12-10,GB 2007004707 W;;GB 0625387 A,2006-12-21,OBJECT DETECTOR APPARATUS AND METHOD,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyzer which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyzer is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,,https://lens.org/029-193-984-768-81X,Patent Application,yes,0,0,13,13,0,B23Q17/24;;B23Q17/24,B23Q17/09;;B23Q17/24,,0,0,,,,ACTIVE
101,CA,A1,CA 2536072 A1,097-579-604-333-928,2005-03-03,2005,CA 2536072 A,2004-08-09,US 49630003 P;;US 2004/0025877 W,2003-08-19,VALVE MECHANISMS FOR PAINT OR INK BRUSH WITH INTEGRATED RESERVOIR,,SANFORD LP,DANZYGER HOWARD;;FLADER MICHAEL;;DAVIES-SMITH LEIGHTON;;GAYNES STEPHEN;;CANTU JASON E,,https://lens.org/097-579-604-333-928,Patent Application,no,0,0,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,B05C17/00;;A46B11/00;;A46B11/02;;A46B11/04;;B05C17/03;;B43M11/06;;F16K1/32,,0,0,,,,DISCONTINUED
102,AT,T1,AT E528106 T1,013-756-915-026-877,2011-10-15,2011,AT 07848455 T,2007-12-10,GB 0625387 A;;GB 2007004707 W,2006-12-21,OBJEKTDETEKTIONSVORRICHTUNG UND -VERFAHREN,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyzer which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyzer is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,,https://lens.org/013-756-915-026-877,Granted Patent,no,0,0,13,13,0,B23Q17/24;;B23Q17/24,,,0,0,,,,INACTIVE
103,EP,B1,EP 2114617 B1,064-679-232-692-073,2011-10-12,2011,EP 07848455 A,2007-12-10,GB 2007004707 W;;GB 0625387 A,2006-12-21,OBJECT DETECTOR APPARATUS AND METHOD,"An object detector apparatus. The object detector apparatus comprises a receiver which is configured to receive a signal from an object having a repetitive motion, in which the signal repeats at a frequency that is dependent on the frequency of the repetitive motion of the object. The object detector apparatus further comprises an analyzer which is configured to sample a signal received by the receiver according to a first set of sampling parameters into a first sampled data set, and to produce an output based on a comparison of the first sampled data set with at least one previously sampled data set. The analyzer is also operable to sample a signal received by the receiver using a second set of sampling parameters which differs to the first set of sampling parameters into a second sampled data set, and to produce an output based on a comparison of the second sampled data set with at least one previously sampled data set.",RENISHAW PLC,STIMPSON VICTOR GORDON;;DAVIES WILLIAM KENNETH;;MERRIFIELD BENJAMIN JASON;;BARNARD WILLIAM MARTIN,,https://lens.org/064-679-232-692-073,Granted Patent,yes,5,1,13,13,0,B23Q17/24;;B23Q17/24,B23Q17/09;;B23Q17/24,,0,0,,,,ACTIVE
104,KR,A,KR 20060119870 A,191-964-416-846-927,2006-11-24,2006,KR 20067003468 A,2006-02-20,US 49630003 P,2003-08-19,VALVE MECHANISMS FOR PAINT OR INK BRUSH WITH INTEGRATED RESERVOIR,"An improved fluid control system for a paint brush or applicator system that includes a flexible barrel-type reservoir (21) is disclosed. The disclosed valve systems may be a ball- valve type (24a), a trumpet-type (24) or a duck-bill type. The valve or control systems help the user regulate the flow of fluid from a flexible barrel reservoir (21) to a brush or applicator tip by adequately restricting flow in response to squeezing pressure applied by the user to the flexible barrel reservoir.",SANFORD LP,GAYNES STEPHEN;;DAVIES SMITH LEIGHTON;;DANZYGER HOWARD;;FLADER MICHAEL;;CANTU JASON E,,https://lens.org/191-964-416-846-927,Patent Application,no,0,4,14,14,0,A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/002;;B05C17/0316;;B43M11/06;;B05C17/00;;B43K5/18;;A46B11/00;;B05C17/002;;A46B11/0041;;A46B11/0079;;A46B2200/205;;B05C17/0316;;B43M11/06,A46B11/02;;A46B11/00;;A46B11/04;;B05C17/00;;B05C17/03;;B43K5/18;;B43M11/06,,0,0,,,,DISCONTINUED
105,US,A1,US 2011/0152285 A1,161-258-948-766-948,2011-06-23,2011,US 98941009 A,2009-04-23,GB 0807532 A;;GB 0819696 A;;GB 2009001058 W,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE;;DAVIES PATRICIA SULING,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE;;DAVIES PATRICIA SULING,F2G LTD (2010-10-12),https://lens.org/161-258-948-766-948,Patent Application,yes,15,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,A61K31/497;;A61P31/10;;C07D409/14,514/253.01;;544/364,4,3,168-449-788-313-849;;073-424-137-358-597;;101-312-400-123-101,10.1016/s0040-4020(01)00525-7;;10.1016/s0223-5234(98)80009-3;;9880479;;pmc88911;;10.1128/cmr.12.1.147,"Yavari et al. (Tetrahedron (2001), 57(27), 5873-5878).;;Dumoulin et al. (European Journal of Medicinal Chemistry (1998), 33(3), 201-207);;McDonnell et al. (Clinical Microbiology Reviews, Jan. 1999, p. 147-179; Vol. 12, Issue 1;;http://www.merckmillipore.com/chemicals/diethyl-ether/MDA_CHEM-100926/p_NgGb.s1Lay4AAAEW8uEfVhTl- (2012)",ACTIVE
106,ES,T3,ES 2535516 T3,128-756-113-388-155,2015-05-12,2015,ES 09734928 T,2009-04-23,GB 0807532 A;;GB 0819696 A;;GB 2009001058 W,2008-04-24,Agentes antifúngicos de pirrol,"Un compuesto que es un derivado de pirrol de formula (I), o una sal farmaceuticamente aceptable del mismo, para su uso en la prevencion o tratamiento de una enfermedad fungica:**Fórmula** donde: R1 representa hidrogeno, alquilo C1-C8, alquenilo C2-C8, 10 alquinilo C2-C8, -COR' o -SO2(alquilo C1-C4) sin sustituir o sustituidos, o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4; A1 representa un enlace o un grupo fenilo, naftilo, grupo heterociclilo de 5 o 6 miembros o heterociclilo de 8 a miembros sin sustituir o sustituido; A2 y A3 son iguales o diferentes y representan cicloalquilo C3-C6 o un grupo arilo C6-C10 o heterociclilo de 5 a 12 miembros sin sustituir o sustituido; A4 es un grupo heterociclilo de 5 a 12 miembros sin sustituir o sustituido en el que 1 o 2 atomos de carbono del anillo estan sustituidos con un grupo seleccionado de >C(>=O), >S(>=O)2, >C(>=NOR7) en el que R7 es hidrogeno o un grupo alquilo C1-C4, >C>=CH2 o >C(-OCH2CH2O-); L1 representa un enlace, un grupo alquileno C1-C6 en el que ninguno, uno o dos grupos -CH2- estan independientemente sustituidos con -O- o -NR'-, o un grupo heterociclilo de 5 a 7 miembros en el que R' es hidrogeno, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir; L2 representa -NR'-, -O-, -CO-, -OCO-, -OCONR'R""-, -CONR'R""- o -SO2-, en la que R' y R"" representan independientemente hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8; L3 representa un enlace o un grupo alquileno C1-C4 en el que ninguno, uno o dos grupos -CH2- estan independientemente sustituidos con -O-, -S- o -NR'-, en la que R' representa hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8; n es 1; R6 representa hidrogeno o alquilo C1-C4; R5 representa un grupo sin sustituir o sustituido seleccionado de arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros, alquilo C1-C8 y cicloalquilo C3-C6, hidrogeno, halogeno o un grupo de formula -B1-B2 o -B3; B1 representa un grupo arilo C6-C10 sin sustituir o sustituido; B2 representa un grupo arilo C6-C10 o heterociclilo de 5 a 12 miembros sin sustituir o sustituido; B3 es un grupo heterociclilo de 5 a 12 miembros sin sustituir o sustituido en el que 1 o 2 atomos de carbono del anillo estan sustituidos con un grupo seleccionado de >C(>=O), >S(>=O)2, >C(>=NOR11) en la que R11 es hidrogeno o un grupo alquilo C1-C4, >C>=CH2 o >C(-OCH2CH2O-); R2 representa arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros, cicloalquilo C3-C6, hidrogeno, halogeno, alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, cicloalquilo C3-C6, -OR', -SR', -SOR', -SO2R', - SO2NR'R"", -SO3H, -NR'R"", -NR'COR',-CO2R', -CONR'R"", -COR', -OCOR', -CF3, -NSO2R' u -OCONR'R"", un grupo alquil (C1-4) -A5, en el que ninguno, uno o dos grupos -CH2- estan reemplazados independientemente por -O-,-S- o -NR'- y en el que A5 representa arilo C6-10 o un grupo heterociclilo de 5 a 12 miembros, en el que R' y R"" representan independientemente hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8, o un grupo de formula -Alk1-X-R', en el que Alk1 es un grupo alquileno C1-C6 sin sustituir o sustituido, X es un grupo -O-, -S-, -NR""-, -CO2-, -CONR""-, -OCO-, -OCONR""- o -SO2-, y R' y R"" se seleccionan independientemente entre hidrogeno y alquilo C1-C4 sin sustituir o sustituido; R3 representa arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros, cicloalquilo C3-C6, hidrogeno, halogeno, alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, cicloalquilo C3-C6, -OR', -SR', -SOR', -SO2R', - SO2NR'R"", -SO3H, -NR'R"", -NR'COR', -CO2R', -CONR'R"", -COR', -OCOR', -CF3, -NSO2R' u -OCONR'R"", o un grupo alquil (C1-4)-A5, en el que ninguno, uno o dos grupos -CH2- estan reemplazados independientemente por -O-,-S- o -NR'- y en el que A5 representa arilo C6-10 o un grupo heterociclilo de 5 a 12 miembros, en el que R' y R"" representan independientemente hidrogeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8; R4 representa hidrogeno, halogeno, fenilo, alquilo C1-C4, alquenilo C2-C4, alquinilo C2-C4, -OR', -CO2R', - CONR'R"", -COR', -CN, -NO2, -NR'R"" o CF3 en las que R' y R"" son independientemente hidrogeno o alquilo C1- C4; Y representa alquileno C1-C8, alquenileno C2-C8 o alquinileno C2-C8;",F2G LTD,SIBLEY GRAHAM;;DOWNHAM ROBERT;;PAYNE LLOYD;;LAW DEREK;;OLIVER JASON;;BIRCH MIKE;;DAVIES GARETH,,https://lens.org/128-756-113-388-155,Granted Patent,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,ACTIVE
107,US,A1,US 2016/0360250 A1,164-789-001-572-173,2016-12-08,2016,US 201514732462 A,2015-06-05,US 201514732462 A,2015-06-05,SYSTEMS AND METHODS FOR DETERMING EFFECTIVENESS OF ASSET INSERTION,"One system herein is operable to determine effectiveness of asset insertion in VOD content. The VOD content is selected by a user through a CPE. The system is operable to analyze upstream internet traffic through a cable television network, to identify household identifications from the upstream internet traffic, and to detect an internet website selected by the user from the upstream internet traffic based on the user's household identification. The system is also operable to couple to a VOD asset insertion system of a headend in the cable television network to detect an asset inserted into the VOD content selected by the CPE, to associate the internet website with the inserted asset, to determine a period of time between insertion of the asset and the selection of the internet website by the user, and to determine an effectiveness of the asset based on the determined period of time.",CANOE VENTURES LLC,CANNEY JASON;;DAVIES DAN;;KNUDSON ED;;PIZZURRO CHRIS;;HASSELL JOEL;;LIU YONG;;MUNHALL MICHAEL,CANOE VENTURES LLC (2015-05-26),https://lens.org/164-789-001-572-173,Patent Application,yes,0,2,2,2,0,H04N21/2408;;H04N21/25883;;H04N21/252;;H04N21/2668;;H04N21/47202;;H04N21/4782;;H04N21/812;;H04N21/44224;;H04N21/2408;;H04N21/25883;;H04N21/252;;H04N21/2668;;H04N21/44204;;H04N21/47202;;H04N21/4782;;H04N21/812;;H04N21/44224,H04N21/24;;H04N21/25;;H04N21/258;;H04N21/2668;;H04N21/442;;H04N21/472;;H04N21/4782;;H04N21/81,,0,0,,,,ACTIVE
108,US,A1,US 2013/0084337 A1,099-031-333-483-412,2013-04-04,2013,US 201213566274 A,2012-08-03,US 201213566274 A;;US 201161515726 P,2011-08-05,PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME,"The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage.",WRIGHT JASON;;HITCHCOCK ANTONY;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN;;NEUROPHAGE PHARMACEUTICALS INC,WRIGHT JASON;;HITCHCOCK ANTONY;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN,NEUROPHAGE PHARMACEUTICALS INC (2012-10-28),https://lens.org/099-031-333-483-412,Patent Application,yes,1,0,7,7,0,C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61P25/28;;C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61K2035/11;;C12N2795/00032,A61K35/76,424/490;;424/93.6;;977/773,3,3,007-931-195-965-945;;036-116-115-550-231;;019-043-246-375-25X,10.1523/jneurosci.23-34-10879.2003;;pmc6740984;;14645482;;pmc368299;;10.1128/aem.70.3.1633-1640.2004;;15006788;;17268058;;10.1248/bpb.30.237,"Lombardo et al., The Journal of Neuroscience, November 26, 2003, 23(34):10879-10883.;;Breitbart et al., Appl. Environ. Microbiol., 2004, 70(3):1633-1640.;;Kanayama et al., Biol. Pharm. Bull., 2007, 30(2):237-241.",DISCONTINUED
109,EP,A1,EP 2739294 A1,174-943-720-260-438,2014-06-11,2014,EP 12746448 A,2012-08-03,US 201161515726 P;;US 2012/0049413 W,2011-08-05,PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME,,NEUROPHAGE PHARMACEUTICALS INC,WRIGHT JASON;;HITCHCOCK ANTONY;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN,,https://lens.org/174-943-720-260-438,Patent Application,yes,0,0,7,7,0,C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61P25/28;;C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61K2035/11;;C12N2795/00032,A61K35/76;;A61P25/28;;C12N7/02,,0,0,,,,DISCONTINUED
110,WO,A1,WO 2013/022717 A1,040-975-300-602-54X,2013-02-14,2013,US 2012/0049413 W,2012-08-03,US 201161515726 P,2011-08-05,PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME,"The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage.",NEUROPHAGE PHARMACEUTICALS INC;;WRIGHT JASON;;HITCHCOCK ANTONY;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN,WRIGHT JASON;;HITCHCOCK ANTONY;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN,,https://lens.org/040-975-300-602-54X,Patent Application,yes,15,1,7,7,0,C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61P25/28;;C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61K2035/11;;C12N2795/00032,A61K35/76;;A61P25/28;;C12N7/02,,5,2,104-271-458-360-59X;;024-617-583-671-456,16080705;;10.1021/bp0500359;;10.1016/0378-1119(80)90093-1;;6254849,"ZHANG JOHN P ET AL: ""Endotoxin removal using a synthetic adsorbent of crystalline calcium silicate hydrate"", BIOTECHNOLOGY PROGRESS, AMERICAN INSTITUTE OF CHEMICAL ENGINEERS, US, vol. 21, no. 4, 3 May 2005 (2005-05-03), pages 1220 - 1225, XP009106802, ISSN: 8756-7938, DOI: 10.1021/BP0500359;;SAMBROOK J.; RUSSELL D. W.: ""Molecular Cloning. A Laboratory Manual,Third Edition"", 2001;;RASCHED; OBERER, MICROBIOLOGY REVIEWS, December 1986 (1986-12-01), pages 401 - 427;;WEZENBEEK ET AL., GENE, vol. 11, 1980, pages 129 - 148;;""Remington's Pharmaceutical Sciences"", MACK PUBLISHING CO.",PENDING
111,TW,B,TW I547562 B,142-613-389-948-597,2016-09-01,2016,TW 101128014 A,2012-08-03,US 201161515726 P,2011-08-05,Pure filamentous bacteriophage and methods of producing same,,NEUROPHAGE PHARMACEUTICALS INC,WRIGHT JASON;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN;;HITCHCOCK ANTONY,,https://lens.org/142-613-389-948-597,Granted Patent,no,2,0,7,7,0,C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61P25/28;;C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61K2035/11;;C12N2795/00032,,,0,0,,,,INACTIVE
112,TW,A,TW 201311897 A,028-431-629-862-013,2013-03-16,2013,TW 101128014 A,2012-08-03,US 201161515726 P,2011-08-05,Pure filamentous bacteriophage and methods of producing same,"The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage.",NEUROPHAGE PHARMACEUTICALS INC,WRIGHT JASON;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN;;HITCHCOCK ANTONY,,https://lens.org/028-431-629-862-013,Patent of Addition,no,0,0,7,7,0,C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61P25/28;;C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61K2035/11;;C12N2795/00032,C12N7/00;;A61K35/76;;A61P25/28,,0,0,,,,INACTIVE
113,HK,A1,HK 1198627 A1,078-083-283-884-797,2015-05-22,2015,HK 14112111 A,2014-12-02,US 2012/0049413 W;;US 201161515726 P,2011-08-05,PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME,,,WRIGHT JASON;;HITCHCOCK ANTONY;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN,,https://lens.org/078-083-283-884-797,Patent Application,no,0,0,7,7,0,C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61P25/28;;C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61K2035/11;;C12N2795/00032,A61K35/76;;A61P/;;C12N/,,0,0,,,,PENDING
114,US,A1,US 2016/0250266 A1,007-035-926-559-946,2016-09-01,2016,US 201514964858 A,2015-12-10,US 201514964858 A;;US 201213566274 A;;US 201161515726 P,2011-08-05,PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME,"The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage.",NEUROPHAGE PHARMACEUTICALS INC,WRIGHT JASON;;HITCHCOCK ANTONY;;SUGAR FRANK;;DAVIES TIM;;ADHIKARI SHREEKANT;;MENON NANDA;;FLORENCE QUENTIN,COBRA BIOLOGICS LTD (2012-04-17);;PROCLARA BIOSCIENCES INC (2012-04-27),https://lens.org/007-035-926-559-946,Patent Application,yes,0,1,7,7,0,C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61P25/28;;C12N7/00;;C12N2795/14151;;A61K35/76;;Y10S977/773;;A61K2035/11;;C12N2795/00032,A61K35/76;;C12N7/00,,0,0,,,,DISCONTINUED
115,US,B2,US 9565458 B2,121-971-342-329-826,2017-02-07,2017,US 201514732462 A,2015-06-05,US 201514732462 A,2015-06-05,Systems and methods for determining effectiveness of asset insertion,"One system herein is operable to determine effectiveness of asset insertion in VOD content. The VOD content is selected by a user through a CPE. The system is operable to analyze upstream internet traffic through a cable television network, to identify household identifications from the upstream internet traffic, and to detect an internet website selected by the user from the upstream internet traffic based on the user's household identification. The system is also operable to couple to a VOD asset insertion system of a headend in the cable television network to detect an asset inserted into the VOD content selected by the CPE, to associate the internet website with the inserted asset, to determine a period of time between insertion of the asset and the selection of the internet website by the user, and to determine an effectiveness of the asset based on the determined period of time.",CANOE VENTURES LLC;;CANOE VENTURES,CANNEY JASON;;DAVIES DAN;;KNUDSON ED;;PIZZURRO CHRIS;;HASSELL JOEL;;LIU YONG;;MUNHALL MICHAEL,CANOE VENTURES LLC (2015-05-26),https://lens.org/121-971-342-329-826,Granted Patent,yes,36,0,2,2,0,H04N21/2408;;H04N21/25883;;H04N21/252;;H04N21/2668;;H04N21/47202;;H04N21/4782;;H04N21/812;;H04N21/44224;;H04N21/2408;;H04N21/25883;;H04N21/252;;H04N21/2668;;H04N21/44204;;H04N21/47202;;H04N21/4782;;H04N21/812;;H04N21/44224,H04H20/14;;H04N21/24;;H04N21/25;;H04N21/258;;H04N21/2668;;H04N21/442;;H04N21/472;;H04N21/4782;;H04N21/81,,0,0,,,,ACTIVE
116,US,S,US D0726229 S,047-886-541-840-696,2015-04-07,2015,US 201429496160 F,2014-07-10,EM 13992730000 F,2014-01-10,Counterweight for wheeled loading shovel vehicle,,BAMFORD EXCAVATORS LTD,TURNER MICHAEL;;MELLOR TOBY;;BURGESS JASON;;DAVIES SIMON;;JONES STUART;;RAMIRES JUAN CARLOS;;BOUGHTON JOHN,J.C. BAMFORD EXCAVATORS LIMITED (2014-11-05),https://lens.org/047-886-541-840-696,Design Right,no,0,9,9,9,0,,,1503;;D15/28,0,0,,,,ACTIVE
117,US,S,US D0749646 S,120-548-780-777-19X,2016-02-16,2016,US 201429496163 F,2014-07-10,EM 13992730000 F,2014-01-10,Counterweight for wheeled loading shovel vehicle,,BAMFORD EXCAVATORS LTD,TURNER MICHAEL;;MELLOR TOBY;;BURGESS JASON;;DAVIES SIMON;;JONES STUART;;RAMIRES JUAN CARLOS;;BOUGHTON JOHN,J.C. BAMFORD EXCAVATORS LIMITED (2014-11-05),https://lens.org/120-548-780-777-19X,Design Right,no,0,7,9,9,0,,,1503;;D15/28,0,0,,,,ACTIVE
118,US,S,US D0723069 S,134-199-190-775-499,2015-02-24,2015,US 201429496162 F,2014-07-10,EM 13992730000 F,2014-01-10,Counterweight for wheeled loading shovel vehicle,,BAMFORD EXCAVATORS LTD,TURNER MICHAEL;;MELLOR TOBY;;BURGESS JASON;;DAVIES SIMON;;JONES STUART;;RAMIRES JUAN CARLOS;;BOUGHTON JOHN,J.C. BAMFORD EXCAVATORS LIMITED (2014-11-05),https://lens.org/134-199-190-775-499,Design Right,no,0,9,9,9,0,,,1503;;D15/28,0,0,,,,ACTIVE
119,US,S,US D0728640 S,151-945-741-076-95X,2015-05-05,2015,US 201429496170 F,2014-07-10,EM 13992730000 F,2014-01-10,Bonnet for wheeled loading shovel vehicle,,BAMFORD EXCAVATORS LTD,TURNER MICHAEL;;MELLOR TOBY;;BURGESS JASON;;DAVIES SIMON;;JONES STUART;;RAMIRES JUAN CARLOS;;BOUGHTON JOHN,J.C. BAMFORD EXCAVATORS LIMITED (2014-11-05),https://lens.org/151-945-741-076-95X,Design Right,no,0,15,9,9,0,,,1503;;D15/31,0,0,,,,ACTIVE
120,US,S,US D0739445 S,180-021-969-811-289,2015-09-22,2015,US 201429496166 F,2014-07-10,EM 13992730000 F,2014-01-10,Bonnet for wheeled loading shovel vehicle,,BAMFORD EXCAVATORS LTD,TURNER MICHAEL;;MELLOR TOBY;;BURGESS JASON;;DAVIES SIMON;;JONES STUART;;RAMIRES JUAN CARLOS;;BOUGHTON JOHN,J.C. BAMFORD EXCAVATORS LIMITED (2014-11-05),https://lens.org/180-021-969-811-289,Design Right,no,0,2,9,9,0,,,1503;;D15/31,0,0,,,,ACTIVE
121,US,B2,US 6900223 B2,092-823-714-130-304,2005-05-31,2005,US 62922703 A,2003-07-28,US 62922703 A;;US 39916102 P,2002-07-29,Dihydrodipyrazolopyridinone inhibitors of B7-1,"The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection, autoimmune disease or graft vs. host disease.",WYETH CORP,GREEN NEAL JEFFREY;;TAM STEVE YIKKAI;;XIANG JASON SHAOYUN;;DAVIES AUDREY MOLINA;;CHEN LIHREN;;STACK GARY PAUL,WYETH (2003-07-21),https://lens.org/092-823-714-130-304,Granted Patent,yes,6,2,2,2,0,A61P37/00;;C07D471/14;;C07D471/14,C07D471/14,514/293;;514/292;;514/275;;514/258;;514/252.04;;546/82;;544/238;;544/331;;544/333,2,2,025-225-227-711-953;;011-547-022-006-138,10.1021/jm00171a046;;1975276;;10.1074/jbc.m110162200;;11741888,"Ian T. Forbes et al., Journal of Medicinal Chemistry, 1990, vol. 33, 2640-2645.;;Erbe, D. V.; Wang, S.; Xing, Y.; and Tobin, J. F.; The Journal of Biological Chemistry (2002), vol. 277, 7363-7368.",EXPIRED
122,US,A1,US 2004/0044024 A1,075-747-327-571-400,2004-03-04,2004,US 62922703 A,2003-07-28,US 62922703 A;;US 39916102 P,2002-07-29,Dihydrodipyrazolopyridinone inhibitors of B7-1,"
    The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection, autoimmune disease or graft vs. host disease. 
",WYETH CORP,GREEN NEAL JEFFREY;;TAM STEVE YIKKAI;;XIANG JASON SHAOYUN;;DAVIES AUDREY MOLINA;;CHEN LIHREN;;STACK GARY PAUL,WYETH (2003-07-21),https://lens.org/075-747-327-571-400,Patent Application,yes,3,3,2,2,0,A61P37/00;;C07D471/14;;C07D471/14,C07D471/14,514/292;;546/82,0,0,,,,EXPIRED
123,US,A1,US 2011/0038462 A1,062-682-960-432-08X,2011-02-17,2011,US 77892710 A,2010-05-12,US 77892710 A;;US 54180209 A;;US 24953409 P;;US 26248009 P,2009-08-14,LIQUID-COOLED APERTURE BODY IN AN X-RAY TUBE,"A liquid-cooled aperture body in an x-ray tube. In one example embodiment, an x-ray tube is configured to be at least partially submerged in a liquid coolant. The x-ray tube includes a cathode at least partially positioned within a cathode housing, an anode at least partially positioned within a can, and an aperture body coupling the cathode housing to the can. The can is formed from a first material and the aperture body is formed from a second material. The aperture body defines an aperture through which electrons may pass between the cathode and the anode. The aperture body further defines at least two exterior surfaces that are each configured to be exposed to the liquid coolant in which the x-ray tube is at least partially submerged.",VARIAN MED SYS INC,DAVIES JASON W;;ANDREWS GREGORY C;;NASEATH GEORGE BENJAMIN;;JOLLEY LINCOLN CURTIS;;KEYES RICHARD ALMA;;SMITH RICKY BURNETT,VARIAN MEDICAL SYSTEMS INC (2010-05-12);;VAREX IMAGING CORPORATION (2017-01-25),https://lens.org/062-682-960-432-08X,Patent Application,yes,15,7,6,8,0,H01J35/16;;H01J2235/122;;H01J2235/168;;H05G1/04;;H05G1/025;;H01J35/16;;H01J2235/168;;H05G1/04;;H01J2235/122;;H05G1/025,H01J35/18;;H01J35/12,378/140;;378/141,0,0,,,,ACTIVE
124,JP,A,JP 2011044427 A,143-331-517-045-44X,2011-03-03,2011,JP 2010180543 A,2010-08-11,US 54180209 A;;US 24953409 P;;US 26248009 P;;US 77892710 A,2009-08-14,LIQUID COOLING OF X-RAY TUBE,"<P>PROBLEM TO BE SOLVED: To provide a cooling mechanism effective against overheat of a vacuum vessel and/or a vacuum vessel window due to back-scattering electrons. <P>SOLUTION: An X-ray tube includes a vacuum vessel and an anode arranged in the vacuum vessel. The anode is structured to receive electrons emitted by an electron emitter. The X-ray tube also includes a vacuum vessel window arranged in a port of the vacuum vessel. The vacuum vessel window includes a first axis and a second axis, the former being shorter than the latter. The X-ray tube also includes a means for guiding flow of a coolant. The means for guiding the flow of the coolant makes the coolant flow over an external surface of the vacuum vessel window in a direction substantially parallel to the first axis. <P>COPYRIGHT: (C)2011,JPO&INPIT",VARIAN MED SYS INC,DAVIES JASON W;;ANDREWS GREGORY C;;NASEATH GEORGE BENJAMIN;;JOLLEY LINCOLN CURTIS;;KEYES RICHARD ALMA;;SMITH RICKY BURNETT,,https://lens.org/143-331-517-045-44X,Patent Application,no,10,1,6,8,0,H01J35/16;;H01J2235/122;;H01J2235/168;;H05G1/04;;H05G1/025;;H01J35/16;;H01J2235/168;;H05G1/04;;H01J2235/122;;H05G1/025,H01J35/00;;H01J35/10;;H01J35/16;;H01J35/18,,0,0,,,,ACTIVE
125,DE,A1,DE 102010039214 A1,011-584-167-352-261,2011-02-17,2011,DE 102010039214 A,2010-08-11,US 54180209 A;;US 24953409 P;;US 26248009 P;;US 77892710 A,2009-08-14,Flüssigkeitskühlung einer Röntgenröhre,"Bei einem Beispiel umfasst eine Röntgenröhre einen evakuierten Behälter und eine Anode, die in dem evakuierten Behälter angeordnet ist. Die Anode ist konfiguriert, um Elektronen zu empfangen, die von einem Elektronenemitter emittiert werden. Die Röntgenröhre umfasst auch ein evakuiertes Behälterfenster, das in einem Anschluss des evakuierten Behälters angeordnet ist. Das evakuierte Behälterfenster umfasst erste und zweite Achsen, wobei die erste Achse im Verhältnis zur zweiten Achse kürzer ist. Die Röntgenröhre umfasst auch Mittel zum Leiten des Kühlmittelflusses. Das Mittel zum Leiten des Kühlmittelflusses veranlasst das Kühlmittel, über eine äußere Oberfläche des evakuierten Behälterfensters in einer Richtung, die zu der ersten Achse im Wesentlichen parallel ist, zu fließen.",VARIAN MED SYS INC,DAVIES JASON W;;ANDREWS GREGORY C;;NASEATH GEORGE BENJAMIN;;JOLLEY LINCOLN CURTIS;;KEYES RICHARD ALMA;;SMITH RICKY BURNETT,"VAREX IMAGING CORPORATION (N.D.GES. DES STAATE, US (2017-06-23)",https://lens.org/011-584-167-352-261,Patent Application,no,0,0,6,8,0,H01J35/16;;H01J2235/122;;H01J2235/168;;H05G1/04;;H05G1/025;;H01J35/16;;H01J2235/168;;H05G1/04;;H01J2235/122;;H05G1/025,H05G1/02;;H01J35/18,,0,0,,,,ACTIVE
126,DE,B4,DE 102010039214 B4,058-411-014-028-292,2020-09-10,2020,DE 102010039214 A,2010-08-11,US 54180209 A;;US 24953409 P;;US 26248009 P;;US 77892710 A,2009-08-14,Flüssigkeitskühlung einer Röntgenröhre,"Röntgenröhre (100), umfassend:einen evakuierten Behälter (104);eine Anode (106), die in dem evakuierten Behälter (104) angeordnet und konfiguriert ist, um Elektronen zu empfangen, die von einem Elektronenemitter emittiert werden;ein evakuiertes Behälterfenster (118), das in einem Anschluss des evakuierten Behälters (104) angeordnet ist, wobei das evakuierte Behälterfenster (118) erste und zweite Achsen umfasst, wobei die erste Achse im Verhältnis zur zweiten Achse kürzer ist; undMittel (136) zum Leiten eines Kühlmittels (105), damit es über eine äußere Oberfläche des evakuierten Behälterfensters (118) in einer Richtung, die zu der ersten Achse im Wesentlichen parallel ist, fließt,wobei das Mittel (136) zum Leiten des Kühlmittels (105) derart ausgebildet ist, dass der Kühlmittelfluss über die äußere Oberfläche gemäß einer unregelmäßigen Verteilung der Rückstreuelektronen, die auf einer inneren Oberfläche des evakuierten Behälterfensters (118) auftreffen, optimiert wird,wobei das Mittel (136) zum Leiten des Kühlmittelflusses ferner Mittel (136) zum Variieren des Kühlmittelflusses über die äußere Oberfläche umfasst, undwobei das Mittel (136) zum Variieren des Kühlmittelflusses eine zugespitzte Öffnung umfasst, die in dem Mittel (136) zum Leiten des Kühlmittelflusses gebildet ist, wobei die zugespitzte Öffnung eine Mitte und zwei Seiten aufweist, wobei die Mitte der zugespitzten Öffnung breiter als die Seiten der zugespitzten Öffnung ist.",VAREX IMAGING CORP (NDGES DES STAATES DELAWARE),DAVIES JASON W;;ANDREWS GREGORY C;;NASEATH GEORGE BENJAMIN;;JOLLEY LINCOLN CURTIS;;KEYES RICHARD ALMA;;SMITH RICKY BURNETT,"VAREX IMAGING CORPORATION (N.D.GES. DES STAATE, US (2017-06-23)",https://lens.org/058-411-014-028-292,Granted Patent,no,6,0,6,8,0,H01J35/16;;H01J2235/122;;H01J2235/168;;H05G1/04;;H05G1/025;;H01J35/16;;H01J2235/168;;H05G1/04;;H01J2235/122;;H05G1/025,H05G1/02;;H01J35/18,,0,0,,,,ACTIVE
127,US,B2,US 8130910 B2,147-843-489-493-265,2012-03-06,2012,US 77892710 A,2010-05-12,US 77892710 A;;US 54180209 A;;US 24953409 P;;US 26248009 P,2009-08-14,Liquid-cooled aperture body in an x-ray tube,"A liquid-cooled aperture body in an x-ray tube. In one example embodiment, an x-ray tube is configured to be at least partially submerged in a liquid coolant. The x-ray tube includes a cathode at least partially positioned within a cathode housing, an anode at least partially positioned within a can, and an aperture body coupling the cathode housing to the can. The can is formed from a first material and the aperture body is formed from a second material. The aperture body defines an aperture through which electrons may pass between the cathode and the anode. The aperture body further defines at least two exterior surfaces that are each configured to be exposed to the liquid coolant in which the x-ray tube is at least partially submerged.",DAVIES JASON W;;ANDREWS GREGORY C;;NASEATH GEORGE BENJAMIN;;JOLLEY LINCOLN CURTIS;;KEYES RICHARD ALMA;;SMITH RICKY BURNETT;;VARIAN MED SYS INC,DAVIES JASON W;;ANDREWS GREGORY C;;NASEATH GEORGE BENJAMIN;;JOLLEY LINCOLN CURTIS;;KEYES RICHARD ALMA;;SMITH RICKY BURNETT,VARIAN MEDICAL SYSTEMS INC (2010-05-12);;VAREX IMAGING CORPORATION (2017-01-25),https://lens.org/147-843-489-493-265,Granted Patent,yes,15,1,6,8,0,H01J35/16;;H01J2235/122;;H01J2235/168;;H05G1/04;;H05G1/025;;H01J35/16;;H01J2235/168;;H05G1/04;;H01J2235/122;;H05G1/025,H01J35/02,378/142;;378/139;;378/140;;378/141;;378/161,0,0,,,,ACTIVE
128,AU,B2,AU 2009/239778 B2,198-570-334-526-420,2014-03-13,2014,AU 2009/239778 A,2009-04-23,GB 0819696 A;;GB 0807532 A;;GB 2009001058 W,2008-04-24,Pyrrole antifungal agents,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",F2G LTD,DAVIES GARETH MORSE;;BIRCH MIKE;;LAW DEREK;;SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;OLIVER JASON DAVID;;PAYNE LLOYD JAMES,,https://lens.org/198-570-334-526-420,Granted Patent,no,2,0,24,26,0,A01N43/36;;A01N43/60;;A01N43/76;;C07D498/04;;A01N43/40;;A01N43/42;;A01N43/84;;A01N43/90;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/5377;;C07D487/04;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;A01N43/36;;A01N43/60;;A01N43/76;;C07D498/04;;A01N43/40;;A01N43/42;;A01N43/84;;A01N43/90;;C07D487/04;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/5377;;A61K45/06,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,5,4,168-449-788-313-849;;076-227-872-906-787;;073-424-137-358-597;;153-633-274-519-255,10.1016/s0040-4020(01)00525-7;;7944906;;10.1002/ardp.19943270808;;10.1016/s0223-5234(98)80009-3;;10.1002/jhet.5570040304,"Yavari, I., et al, Tetrahedron, 2001, 57(27), 5873-8;;Dannhardt, G., et al, Archiv der Pharmazie (1994), 8(327), 509-14;;Dumoulin, H., et al, European Journal of Medicinal Chemistry, 1998, 33(3), 201-7;;Dannhardt, G., et al, Chemiker-Zeitung (1986), 110(3), 124-7;;Archibald, J. L., et al, Journal of Heterocyclic Chemistry, 1967, 4, 335-8",ACTIVE
129,EP,B1,EP 2283006 B1,145-056-972-437-276,2015-02-25,2015,EP 09734928 A,2009-04-23,GB 2009001058 W;;GB 0807532 A;;GB 0819696 A,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/145-056-972-437-276,Granted Patent,yes,1,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,ACTIVE
130,DK,T3,DK 2283006 T3,152-936-846-249-88X,2015-05-26,2015,DK 09734928 T,2009-04-23,GB 0807532 A;;GB 0819696 A;;GB 2009001058 W,2008-04-24,Pyrrolbaserede antisvampemidler,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/152-936-846-249-88X,Granted Patent,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,ACTIVE
131,CA,C,CA 2721944 C,164-177-796-914-634,2016-06-07,2016,CA 2721944 A,2009-04-23,GB 0807532 A;;GB 0819696 A;;GB 2009001058 W,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, Al, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/164-177-796-914-634,Granted Patent,no,0,0,24,26,0,A01N43/36;;A01N43/60;;A01N43/76;;C07D498/04;;A01N43/40;;A01N43/42;;A01N43/84;;A01N43/90;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/5377;;C07D487/04;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;A01N43/36;;A01N43/60;;A01N43/76;;C07D498/04;;A01N43/40;;A01N43/42;;A01N43/84;;A01N43/90;;C07D487/04;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/5377;;A61K45/06,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,ACTIVE
132,CA,A1,CA 2721944 A1,081-956-613-679-402,2009-10-29,2009,CA 2721944 A,2009-04-23,GB 0807532 A;;GB 0819696 A;;GB 2009001058 W,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/081-956-613-679-402,Patent Application,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,ACTIVE
133,PL,T3,PL 2283006 T3,014-495-968-596-447,2015-08-31,2015,PL 09734928 T,2009-04-23,GB 0807532 A;;GB 0819696 A;;EP 09734928 A;;GB 2009001058 W,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/014-495-968-596-447,Patent Application,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,PENDING
134,WO,A1,WO 2009/130481 A1,127-752-902-770-440,2009-10-29,2009,GB 2009001058 W,2009-04-23,GB 0807532 A;;GB 0819696 A,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",F2G LTD;;SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/127-752-902-770-440,Patent Application,yes,13,38,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,11,4,168-449-788-313-849;;078-668-787-190-32X;;179-007-856-363-671;;050-511-615-487-977,10.1016/s0040-4020(01)00525-7;;17531483;;10.1016/j.bmcl.2007.04.071;;10.1016/s0040-4039(00)00755-3;;11922793;;10.1021/ol010297l,"TETRAHEDRON, vol. 57, no. 27, 2001, pages 5873 - 5878;;EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 33, no. 3, 1998, pages 201 - 207;;BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 17, no. 14, 2007, pages 3814 - 3818;;PHOSPHORUS, SULFUR AND SILICON AND THE RELATED ELEMENTS, vol. 177, no. 3, 2002, pages 545 - 553;;TETRAHEDRON LETTERS, vol. 41, no. 25, 2000, pages 4991 - 4995;;JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY (1972-1999, vol. 17, 1992, pages 2175 - 87;;LIEBIGS ANNALEN DER CHEMIE, vol. 1, 1991, pages 67 - 70;;CANADIAN JOURNAL OF CHEMISTRY, vol. 49, no. 6, 1971, pages 919 - 22;;JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 4, no. 3, 1967, pages 335 - 8;;ORGANIC LETTERS, vol. 4, no. 7, 2002, pages 1103 - 1105;;TETRAHEDRON, vol. 34, no. 2, 1978, pages 241 - 5",PENDING
135,EP,A1,EP 2626361 A1,041-358-519-690-858,2013-08-14,2013,EP 13167337 A,2009-04-23,GB 0807532 A;;GB 0819696 A;;EP 09734928 A,2008-04-24,Pyrrole antifungal agents,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof:
  
wherein: 
R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/041-358-519-690-858,Patent Application,yes,3,3,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D487/04;;A01N43/36;;A01N43/60;;A01N43/76;;A61P31/10;;C07D498/04,,5,2,060-908-101-548-398;;017-365-412-179-713,8842991;;10.1016/s0163-4453(96)92700-0;;10064251;;10.1086/515116,"GROLL ET AL., JLNFECT, vol. 33, 1996, pages 23 - 32;;RIBAUD ET AL., CLIN INFECT DIS., vol. 28, 1999, pages 322 - 30;;JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 2;;J. ORG. CHEM., vol. 63, 1998, pages 10048 - 51;;CROWLEY, J. CHEM. SOC., 1957, pages 2931 - 2934",ACTIVE
136,ES,T3,ES 2526083 T3,058-988-297-636-082,2015-01-05,2015,ES 13167337 T,2009-04-23,GB 0807532 A;;GB 0819696 A,2008-04-24,Agentes antifúngicos de pirrol,"Un compuesto que es un derivado de pirrol de fórmula (I), o una sal farmacéuticamente aceptable del mismo, para su uso en la prevención o tratamiento de una enfermedad fúngica:**Fórmula** en la que: R1 representa hidrógeno, alquilo C1-C8, alquenilo C2-C8, alquinilo C2-10 C8, -COR' o -SO2(alquilo C1-C4) sin sustituir o sustituidos, o un grupo -A2, -L2-A2, -L3-A2, -A2-L3-A3 o -A4; A1 representa un enlace o un grupo fenilo, naftilo, grupo heterociclilo de 5 a 6 miembros o heterociclilo de 8 a miembros sin sustituir o sustituido; A2 y A3 son iguales o diferentes y representan cicloalquilo C3-C6 o un grupo arilo C6-C10 o heterociclilo de 5 a 12 miembros sin sustituir o sustituido; A4 es un grupo heterociclilo de 5 a 12 miembros sin sustituir o sustituido en el que 1 o 2 átomos de carbono del anillo están sustituidos con un grupo seleccionado de >C(>=O), >S(>=O)2, >C(>=NOR7) en el que R7 es hidrógeno o un grupo alquilo C1-C4, >C>=CH2 o >C(-OCH2CH2O-); L1 representa un enlace, un grupo alquileno C1-C6 en el que ninguno, uno o dos grupos -CH2- están independientemente sustituidos con -O- o -NR'-, o un grupo heterociclilo de 5 a 7 miembros en el que R' es hidrógeno, alquilo C1-C4 sin sustituir o alquilo C1-C4 sustituido con un grupo alcoxi C1-C4 sin sustituir; L2 representa -NR'-, -O-, -CO-, -OCO-, -OCONR'R""-, -CONR'R""- o -SO2-; L3 representa un enlace o un grupo alquileno C1-C4 en el que ninguno, uno o dos grupos -CH2- están independientemente sustituidos con -O-, -S- o -NR'-; n es 1; R6 representa hidrógeno o alquilo C1-C4; R5 representa un grupo sin sustituir o sustituido seleccionado de arilo C6-C10, un grupo heterociclilo de 5 a 12 miembros, alquilo C1-C8 y cicloalquilo C3-C6, hidrógeno, halógeno o un grupo de fórmula -B1-B2 o -B3; B1 representa un grupo arilo C6-C10 sin sustituir o sustituido; B2 representa un grupo arilo C6-C10 o heterociclilo de 5 a 12 miembros sin sustituir o sustituido; B3 es un grupo heterociclilo de 5 a 12 miembros sin sustituir o sustituido en el que 1 o 2 átomos de carbono del anillo están sustituidos con un grupo seleccionado de >C(>=O), >S(>=O)2, >C(>=NOR11) en la que R11 es hidrógeno o un grupo alquilo C1-C4, >C>=CH2 o >C(-OCH2CH2O-); R2 y R3, junto con los átomos de anillo a los que están unidos, forman un anillo de piperazinilo, morfolinilo o pirrolidinilo; R4 representa hidrógeno, halógeno, fenilo, alquilo C1-C4, alquenilo C2-C4, alquinilo C2-C4, -OR', -CO2R', - CONR'R"", -COR', -CN, -NO2, -NR'R"" o CF3 en las que R' y R"" son independientemente hidrógeno o alquilo C1- C4; Y representa alquileno C1-C8, alquenileno C2-C8 o alquinileno C2-C8; Z representa halógeno, cicloalquilo C3-C6, -OR', -SR', -SOR', -SO2R', -SO2NR'R"", -SO3H, -NR'R"", -NR'COR', - NO2, -CO2R', -CONR'R"", -COR', -OCOR', -CN, -CF3, -NSO2R', -OCONR'R"" o -CR'>=NOR""; a menos que se especifique de otro modo, R' y R"" representan independientemente hidrógeno, alquilo C1-C8, alquenilo C2-C8 o alquinilo C2-C8; a menos que se especifique de otro modo, un grupo o resto alquilo, alquenilo, alquinilo, cicloalquilo, arilo o heteroarilo puede estar sustituido o sin sustituir; y en la que: un grupo sustituido o resto alquilo, alquenilo o alquinilo es dicho grupo o resto alquilo, alquenilo o alquinilo que está sustituido con hasta tres sustituyentes seleccionados de halógeno, hidroxi, amino, (alquil C1- C4)amino, di(alquil C1-C4)amino, alcoxi C1-C4, -S(alquilo C1-C4), -CO2H, -CO2(alquilo C1-C4), fenilo, heterociclilo de 5 o 6 miembros, -CONR'R' y -NR'CO(alquilo C1-C4) en las que R' y R"" son iguales o diferentes y representan hidrógeno o alquilo C1-C4 sin sustituir, en las que los sustituyentes sobre un grupo o resto alquilo, alquenilo o alquinilo sustituido están ellos mismos sin sustituir o, el caso de sustituyentes alcoxi C1-C4, pueden estar adicionalmente sustituidos con metoxi o etoxi sin sustituir; un grupo cicloalquilo sustituido es dicho grupo cicloalquilo que está sustituido con hasta tres sustituyentes seleccionados de alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, Z y -Y-Z en las que Y y Z son como se han definido anteriormente en este documento.",F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/058-988-297-636-082,Granted Patent,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D487/04;;A01N43/36;;A01N43/60;;A01N43/76;;A61P31/10;;C07D498/04,,0,0,,,,ACTIVE
137,EP,A1,EP 2283006 A1,093-920-775-169-422,2011-02-16,2011,EP 09734928 A,2009-04-23,GB 2009001058 W;;GB 0807532 A;;GB 0819696 A,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/093-920-775-169-422,Patent Application,yes,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,1,0,,,See references of WO 2009130481A1,ACTIVE
138,NZ,A,NZ 589010 A,147-758-713-202-164,2012-11-30,2012,NZ 58901009 A,2009-04-23,GB 0807532 A;;GB 0819696 A;;GB 2009001058 W,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,"Disclosed herein is a pyrrole derivative of formula (I), wherein the substituents are as defined within the specification, processes for its preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as agricultural fungicides. Specifically preferred examples include: · 2-(1,5-Dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{ 4-[4-(4,6-dimethyl-pyridin-2-yl)-piperazin-1-yl]-phenyl} -2-oxo-acetamide, · N-{ 4-[4-(4,6-Dimethyl-pyridin-2-yl)-piperazin-1-yl]-phenyl} -2-oxo-2-(1-phenyl-1H-pyrrol-2-yl)-acetamide, · N-{ 4-[4-(4,6-Dimethyl-pyridin-2-yl)-piperazin-1-yl]-phenyl} -2-(5-methyl-1-phenyl-1Hpyrrol-2-yl)-2-oxo-acetamide, · N-{ 4-[4-(4,6-Dimethyl-pyridin-2-yl)-piperazin-1-yl]-phenyl} -2-(5-methyl-1H-pyrrol-2-yl)-2-oxo-acetamide, · 2-[3-(4-Chloro-phenyl)-1-(2-methoxy-ethyl)-1H-pyrrol-2-yl]-N-{ 4-[4-(4,6-dimethyl-pyridin-2-yl)-piperazin-1-yl]-phenyl} -2-oxo-acetamide, · 2-[1-(2-Methoxy-ethyl)-5-methyl-3-phenyl-1H-pyrrol-2-yl]-2-oxo-N-phenyl-1-acetamide, · (2-{ 4-[4-(4,6-dimethyl-pyridin-2-yl)-piperazin-1-yl]-phenylaminooxalyl} -pyrrol-1-yl)-acetic acid methyl ester,",F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/147-758-713-202-164,Patent Application,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,A61P31/10;;A01N43/36;;C07D207/333,,0,0,,,,PENDING
139,US,B2,US 8993574 B2,078-132-791-690-241,2015-03-31,2015,US 98941009 A,2009-04-23,GB 0807532 A;;GB 0819696 A;;GB 2009001058 W,2008-04-24,Pyrrole antifungal agents,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE;;DAVIES PATRICIA SULING;;F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,F2G LTD (2010-10-12),https://lens.org/078-132-791-690-241,Granted Patent,yes,49,6,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D487/04;;A01N43/36;;A01N43/40;;A01N43/42;;A01N43/60;;A01N43/76;;A01N43/84;;A01N43/90;;C07D498/04,514/253.01;;544/364;;514/427,104,42,168-449-788-313-849;;073-424-137-358-597;;101-312-400-123-101;;179-007-856-363-671;;082-524-780-121-593;;153-633-274-519-255;;005-101-078-984-914;;001-238-456-156-836;;069-163-075-034-476;;000-168-006-302-253;;033-970-842-208-903;;031-088-884-898-454;;091-580-409-839-448;;059-936-365-638-63X;;060-766-148-116-567;;028-494-421-159-044;;082-832-526-455-955;;091-792-125-882-107;;139-917-414-896-675;;074-022-163-901-658;;076-227-872-906-787;;073-424-137-358-597;;097-337-103-019-912;;004-694-871-327-186;;157-368-878-373-980;;060-908-101-548-398;;125-190-663-181-256;;062-214-858-572-249;;107-812-744-328-804;;078-668-787-190-32X;;031-312-429-278-02X;;099-799-234-674-203;;061-072-347-279-836;;017-365-412-179-713;;073-622-770-770-672;;094-225-106-312-625;;014-769-575-719-552;;032-838-088-052-630;;018-067-402-237-562;;059-965-899-863-228;;092-933-020-902-40X;;000-575-008-415-735,10.1016/s0040-4020(01)00525-7;;10.1016/s0223-5234(98)80009-3;;9880479;;pmc88911;;10.1128/cmr.12.1.147;;10.1016/s0040-4039(00)00755-3;;10.1039/jr9590000620;;10.1002/jhet.5570040304;;10.1021/jm00253a016;;4151968;;10.1039/p19920002175;;10.1002/ijch.196400006;;10.1139/v71-151;;10.1016/0040-4020(96)00441-3;;10.1021/ja960803f;;10.1016/s0040-4020(00)00774-2;;10.1021/jm0102203;;11754575;;4197003;;10.1002/jps.2600660230;;839424;;38816;;10.1039/jr9490003007;;10.1039/jr9570002931;;10.1002/ardp.19793121104;;7944906;;10.1002/ardp.19943270808;;10.1016/s0223-5234(98)80009-3;;10.1016/s0040-4020(01)93611-7;;10.1021/jo01287a016;;10.1021/ja01463a046;;8842991;;10.1016/s0163-4453(96)92700-0;;8809154;;10.1021/jm960395q;;10.1021/jm049161u;;16451085;;10.3998/ark.5550190.0009.905;;17531483;;10.1016/j.bmcl.2007.04.071;;10.1016/j.tet.2004.11.026;;18385843;;10.1039/b719776d;;10.1016/j.dyepig.2004.10.003;;10064251;;10.1086/515116;;10.1039/jr9350001796;;10.1039/jr9360001098;;10.1080/14756360701811379;;18608761;;10.1021/jo981505z;;7473547;;10.1021/jm00021a009;;10.1073/pnas.0307953101;;pmc387369;;15051887;;10.1016/s0960-894x(00)00322-x;;10937729;;10.1002/chin.200443161,"Yavari et al. (Tetrahedron (2001), 57(27), 5873-5878).;;Dumoulin et al. (European Journal of Medicinal Chemistry (1998), 33(3), 201-207).;;McDonnell et al. Clinical Microbiology Reviews, Jan. 1999, p. 147-179; vol. 12, Issue 1.;;http://www.merckmillipore.com/chemicals/diethyl-ether/MDA-CHEM-100926/p-NgGb.s1Lay4AAAEW8uEfVhTI-(2012).;;Schoichet Laboratory at UCSF (through ZINC database of commercially available small molecules-entered to CHEMCATS Feb. and Mar. 2008; p. 1-64).;;Alvarez, M. et al. (1999). ""Synthesis of 1,2-Dihydropyrrolo[1,2-c]Pyrimidin-1-Ones,"" Journal of Chemical Society 249-255.;;Alves, M.J. et al. (2000). ""Novel Aziridine Esters by the Addition of Aromatic Nitrogen Heterocycles to a 2H-Azirine-3-Carboxylic Ester,"" Tetrahedron Letters 41:4991-4995.;;Ames, D.E. et al. (1959, e-published Jan. 1, 1959). ""The Preparation of Aminoalkylpyrrocolines,"" Journal of Chemical Society 124:620-622.;;Archibald, J.L. et al. (Sep. 1967). ""New Reactions of Pyrroles. II. Preparation and Reactions of Pyrroleglyoxyloyl Derivatives,"" Journal of Heterocyclic Chemistry 4:335-338.;;Archibald, J.L. et al. (1974). ""Benzamidopiperidines. 2. Heterocyclic Compounds Related to Indoramin,"" Journal of Medicinal Chemistry 17(7):736-739.;;Battersby, A.R. et al. (1992, e-published Jan. 1, 1992). ""Synthetic Studies Relevant to Biosynthetic Research on Vitamin B12. Part 10. Construction of the East and West Building Blocks for Synthesis of Isobacteriochlorins,"" Journal of Chemical Society 17:2175-2187.;;Bentov, M. et al. (1964). ""4-Fluoroindole and Derivatives,"" Israel Journal of Chemistry 2:25-28.;;Birchall, G.R. et al. (1971). ""The Chlorination of Pyrroles. Part II,"" Canadian Journal of Chemistry 49:919-922.;;Black, D.S.C. et al. (1996). ""Reaction of Some 4,6-Dimethoxyindoles with Oxalyl Chloride,"" Tetrahedron 52(26):8925-8936.;;Black, D.S.C. et al. (1996). ""The Indol-2-Ylglyoxylamide Moiety: A New Building Block for the Design and Self-Assembly of Hydrogen Bond Networks,"" Journal of American Chemical Society 118(34):8148-8149.;;Black, D.S.C. et al. (2000). ""Formation of C-Amido-Calix[3]Indoles from 2'- and 7'-Indolylglyoxylamides,"" Tetrahedron 56:8513-8524.;;Bohusch, M. et al. (1991). ""Consequences of a Diminution of the Porphyrin pi-System: Attempted Syntheses of Bacteriophin and Chlorophin,"" Liebigs Annalen der Chemie 67-70. (Abstract Only).;;Borthwick, A.D. et al. (Jan. 3, 2002, e-published Dec. 5, 2001). ""Design and synthesis of Pyrrolidine-5,5-trans-Lactams (5-Oxohexahdropyrrolo[3,2-b]Pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 2. Potency and Chirality,"" Journal of Medicinal Chemistry 45(1):1-18.;;Cameron, B.D. et al. (1973). ""The Synthesis and Metabolic Fate of 14C-Viminol, a New Analgesic, in the Rat and the Dog,"" Arzneimittel-Forshung/Drug Res. 23(5):708-712.;;Cardellini, M. et al. (Feb. 1977). ""Indolizine Derivatives with Biological Activity I: N'-Substituted Hydrazides of Indolizine-2-Carboxylic Acid,"" Journal of Pharmaceutical Sciences 66(2):259-262.;;Chemcats. (Jan. 25, 2008). ""Benzo [b] Thiophene-2-Carboxylic Acid, 3-[2-[[(4-Methoxyphenyl) Amino]Oxoacetyl]-1H-Pyrrol-1-y1]-, Methyl Ester,"" Ryan Scientific Screening Library 5 pages.;;Chemcats. (Feb. 13, 2008). ""1H-Pyrrole-2-Acetamide, N-(4-Bromophenyl)-1- (2-Chloro-4-Nitrophenyl) -alpha-Oxo-,"" Ambinter Stock Screening Collection 5 pages.;;Chemcats. (Feb. 18, 2008). ""1H-Pyrrole-2-Acetamide, N- (2,4-Dichlorophenyl)-1-Methyl-alpha-Oxo-,"" Interchim Intermediates 5 pages.;;Chiarino, D. et al. (1978). ""Stereochemistry of Viminol, a Novel Central Analgesic,"" Arzneimittel-Forshung/Drug Res. 28(11):1554-1561.;;Cook, A.H. et al. (1949, e-published Jan. 1, 1949). ""Studies in the Azole Series. Part XXIV. The Interaction of Carbonyl Compounds and 2-Thio-5-Thiazolidone,"" Journal of Chemical Society 633:3007-3012.;;Crowley, K.J. et al. (1957). ""Intermediates for the Synthesis of Optically Active Methyl-Substituted Long-Chain Acids. Part II,"" Journal of the Chemical Society 2931-2934.;;Dannhardt, G. et al. (1979). ""Synthese und Eigenschaften von 2,3-Dihydro-1 H-Pyrrolizinen,"" Arch. Pharm. 312:896-907.;;Dannhardt, G. et al. (1994). ""Nonsteroidal Antiinflammatory Agents, XVIII: C-5 Functionalized 6,7-Diphenyl-2,3-Dihydro-1 H-Pyrrolizines as Inhibitors of Bovine Cyclooxygenase and 5-Lipoxygenase,"" Arch Pharm 327:509-514.;;Dannhardt, V.G. et al. (1986). ""Antiphlogistische 2,3-Dihydro-1H-Pyrrolizine, 11. Mitt. Dihydropyrrolizinyl-Substituierte 2-Aminoethanol- und Glykosäure-Derivate,"" Chemiker-Zeitung 110(3):124-127.;;Dumoulin, H. et al. (1998). ""2-Oxo-2-(Pehn-2-Ylpyrrol-2-Yl)Acetamides as Potential Anxiolytic Agents: Synthesis and Affinity at the Central Benzodiazepine Receptor,"" European Journal of Medicinal Chemistry 33:201-207.;;Dyke, S.F. et al. (1978). ""Pavinane and Isopavinane Alkaloids,"" Tetrahedron 34:241-245.;;Fryer, R.I. et al. (Dec. 1967). ""Quinazolines and 1,4-Benzodiazepines. XXXVII. Synthesis and Rearrangements of a Substituted 5-Phenyl-1 H-1,4-Benzodiazepine,"" Journal of Organic Chemistry 32:3798-3803.;;Galbraith, A. et al. (Jan. 20, 1961). ""The Formation of Cycl[3,2,2]azine Derivatives via the Reaction of Pyrrocoline with Dimethyl Acetylenedicarboxylate,"" Journal of the American Chemical Society 83:453-458.;;Groll, A.H. et al. (1996). ""Trends in the Postmortem Epidemiology of Invasive Fungal Infections at a University Hospital,"" Journal of Infection 33:23-32.;;Hagishita, S. et al. (1996). ""Potent Inhibitors of Secretory Phospholipase A2: Synthesis and Inhibitory Activities of Indolizine and Indene Derivatives,"" Journal of Medicinal Chemistry 39(19):3636-3658.;;Hudack, R.A. et al. (2006, e-published Jan. 14, 2006). ""Design, Synthesis, and Biological Activity of Novel Polycyclic Aza-Amide FKBP12 Ligands,"" Journal of Medicinal Chemistry 49(3):1202-1206.;;Ignatovich, J. et al. (2008). ""Synthesis of Functionalized Benzyl Amines by the Reductive Alkylation of Heterocyclic and Heteroaromatic Amines with Arylaldehydes and preparation of the Intermediates for New Synthetic Biomolecules,"" ARKAT-USA, Inc. (ix):42-51.;;Islam, I. et al. (2007, e-published Apr. 27, 2007). ""Indolinone Based Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors. Part 1: Design, Synthesis and Biological Activity,"" Bioorganic & Medicinal Chemistry Letters 17:3814-3818.;;Keawin, T. et al. (2005, e-published Dec. 10, 2004). ""Reaction of Some 4,6-Dimethoxyindoles with Nitric Acid: Nitration and Oxidative Dimerisation,"" Tetrahedron 61:853-861.;;Mahiout, Z. et al. (2008, e-published Feb. 28, 2008). ""Solvent-Dependent Oxidations of 5-and 6-Azaindoles to Trioxopyrrolopyridines and Functionalised Azaindoles,"" Organic & Biomolecular Chemistry6:1364-1376.;;Nourmohammadian, F. et al. (2005, e-published Jan. 21, 2005). ""An AB Initio Molecular Orbital Study of Structural Isomers of Diketopyrrolopyrrole,"" Dyes and Pigments 67:15-20.;;Pätzel, M. et al. (2005). ""Product Class 5: alpha-Heteroatom-Substituted Alkanamides,"" Science of Synthesis 21:477-535.;;Ribaud, P. et al. (1999). ""Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation,"" Clinical Infectious Diseases 28:322-330.;;Rowe, F.M. et al. (1935, e-published Jan. 1, 1935). ""A Reaction of Certain Diazosulphonates Derived from beta-Naphthol-1-Sulphonic Acid. Part XIII. Fission of the Naphthalene Nucleus and Subsequent Closure in Two Directions,"" Journal of Chemical Society 420:1796-1808.;;Rowe, F.M. et al. (1936, e-published Jan. 1, 1936). ""A Reaction of Certain Diazosulphonates Derived from beta-Naphthol-1-Sulphonic Acid. Part XV. Derivatives of 2'-Nitro-4'-Methyl-Benzene-2-Naphthol-1-Diazosulphonate and Synthesis of 2-(2'-Nitro-4'-Methylphenylamino)Isoindolinone-3-Acetic Acid,"" Journal of Chemical Society 232:1098-1108.;;Roy, K. et al. (Dec. 2008). ""Development of Linear and Nonlinear Predictive QSAR Models and Their External Validation Using Molecular Similarity Principle for Anti-HIV Indolyl Aryl Sulfones,"" Journal of Enzyme Inhibition and Medicinal Chemistry 23(6):980-995.;;Savage, S.A. et al. (1998). ""Efficient Synthesis of 4-, 5-, and 6-Methyl-2,2'-Bipyridine by a Negishi Cross-Coupling Strategy Followed by High-Yield Conversion to Bromo- and Chloromethyl-2,2'-Bipyridines,"" Journal of Organic Chemistry 63(26):10048-10051.;;Scott, M.K. et al. (1995). ""Piperazinylalkyl Heterocycles as Potential Antipsychotic Agents,"" Journal of Medicinal Chemistry 38(21):4198-4210.;;Si, Z. et al. (Apr. 6, 2004). ""Small-Molecule Inhibitors of HIV-1 Entry Block Receptor-Induced Conformational Changes in the Viral Envelope Glycoproteins,"" Proceedings of the National Academy of Sciences 101(14):5036-5041.;;Slassi, A. et al. (2000). ""5-Alkyltryptamine Derivatives as Highly Selective and Potent 5-HT1D Receptor Agonists,"" Bioorganic & Medicinal Chemistry Letters 10:1707-1709.;;Sofan, M.A. et al. (2004). ""Studies on 2,3-Dioxopyrrolidines. Synthesis of Piperazine, Pyrrolo[4,5-b]Indole, Pyrazino [5,6-b]Indole and Arylazo Derivatives of Amino Acids,"" Polish Journal of Chemistry 78:837-842.;;CAS Registry No. 3758-62-1, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 3768-71-6, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 3768-72-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 3768-82-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 4380-46-5, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 4595-83-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 6616-51-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-17-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-18-8, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-19-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-20-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 15940-21-3, created Nov. 16, 1984 last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-22-4, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 15940-23-5, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-24-6, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 15940-25-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 23502-48-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 26883-51-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 31709-75-8, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 31709-76-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 31709-77-0, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 31710-23-3, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 36793-47-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 41596-37-6, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 42060-03-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 42060-05-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 42221-74-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 43084-49-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 53391-28-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 53391-29-0, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 53391-30-3, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 53391-52-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 53391-63-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 65473-58-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 68803-72-5, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 81729-69-3, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 81741-58-4, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 83996-64-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 130761-64-7, created Nov. 30, 1990, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 130761-68-1, created Nov. 30, 1990, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 145045-69-8, created Dec. 25, 1992, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-40-3, created Dec. 29, 1995, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 171854-41-4, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-42-5, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-43-6, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 17854-44-7, created Dec. 29, 1995, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 171845-45-8, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-46-9, created Dec. 29, 1995, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 171854-47-0, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 185030-21-1, created Jan. 15, 1997, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 208765-70-2, created Jul. 22, 1998, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 208765-71-3, created Jul. 22, 1998, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 208765-72-4, created Jul. 22, 1998, last accessed Feb. 2, 2012, 2 pages.",ACTIVE
140,AU,A1,AU 2009/239778 A1,167-958-677-474-331,2009-10-29,2009,AU 2009/239778 A,2009-04-23,GB 0819696 A;;GB 0807532 A;;GB 2009001058 W,2008-04-24,Pyrrole antifungal agents,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DAVIES GARETH MORSE;;PAYNE LLOYD JAMES;;DOWNHAM ROBERT;;LAW DEREK;;BIRCH MIKE;;OLIVER JASON DAVID,,https://lens.org/167-958-677-474-331,Patent Application,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,ACTIVE
141,US,B2,US 9452168 B2,155-623-500-422-851,2016-09-27,2016,US 201514625532 A,2015-02-18,US 201514625532 A;;GB 0807532 A;;GB 0819696 A;;US 98941011 A;;GB 2009001058 W,2008-04-24,Pyrrole antifungal agents,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MICHAEL;;DAVIES GARETH MORSE,F2G LTD (2010-11-01),https://lens.org/155-623-500-422-851,Granted Patent,yes,51,5,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,A01N43/36;;A01N43/40;;A01N43/42;;A01N43/60;;A01N43/76;;A01N43/84;;A01N43/90;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/5377;;A61K45/06;;C07D487/04;;C07D498/04,,101,40,179-007-856-363-671;;082-524-780-121-593;;153-633-274-519-255;;005-101-078-984-914;;001-238-456-156-836;;069-163-075-034-476;;000-168-006-302-253;;033-970-842-208-903;;031-088-884-898-454;;091-580-409-839-448;;059-936-365-638-63X;;060-766-148-116-567;;028-494-421-159-044;;082-832-526-455-955;;091-792-125-882-107;;139-917-414-896-675;;074-022-163-901-658;;076-227-872-906-787;;073-424-137-358-597;;097-337-103-019-912;;004-694-871-327-186;;157-368-878-373-980;;060-908-101-548-398;;125-190-663-181-256;;062-214-858-572-249;;107-812-744-328-804;;078-668-787-190-32X;;031-312-429-278-02X;;099-799-234-674-203;;101-312-400-123-101;;061-072-347-279-836;;017-365-412-179-713;;073-622-770-770-672;;094-225-106-312-625;;014-769-575-719-552;;032-838-088-052-630;;018-067-402-237-562;;059-965-899-863-228;;092-933-020-902-40X;;000-575-008-415-735,10.1016/s0040-4039(00)00755-3;;10.1039/jr9590000620;;10.1002/jhet.5570040304;;10.1021/jm00253a016;;4151968;;10.1039/p19920002175;;10.1002/ijch.196400006;;10.1139/v71-151;;10.1016/0040-4020(96)00441-3;;10.1021/ja960803f;;10.1016/s0040-4020(00)00774-2;;10.1021/jm0102203;;11754575;;4197003;;10.1002/jps.2600660230;;839424;;38816;;10.1039/jr9490003007;;10.1039/jr9570002931;;10.1002/ardp.19793121104;;7944906;;10.1002/ardp.19943270808;;10.1016/s0223-5234(98)80009-3;;10.1016/s0040-4020(01)93611-7;;10.1021/jo01287a016;;10.1021/ja01463a046;;8842991;;10.1016/s0163-4453(96)92700-0;;8809154;;10.1021/jm960395q;;10.1021/jm049161u;;16451085;;10.3998/ark.5550190.0009.905;;17531483;;10.1016/j.bmcl.2007.04.071;;10.1016/j.tet.2004.11.026;;18385843;;10.1039/b719776d;;9880479;;pmc88911;;10.1128/cmr.12.1.147;;10.1016/j.dyepig.2004.10.003;;10064251;;10.1086/515116;;10.1039/jr9350001796;;10.1039/jr9360001098;;10.1080/14756360701811379;;18608761;;10.1021/jo981505z;;7473547;;10.1021/jm00021a009;;10.1073/pnas.0307953101;;pmc387369;;15051887;;10.1016/s0960-894x(00)00322-x;;10937729;;10.1002/chin.200443161,"Types of Fungal Diseases-www.cdc.gov/fungal/diseases/index.html [Nov. 16, 2015].;;(CDC ""Aspergillosis Risk and Prevention""-www.cdc.fungal/diseases/aspergillosis/risk-prevention.html [Nov. 16, 2015].;;Alvarez, M. et al. (1999). ""Synthesis of 1,2-Dihydropyrrolo[1,2-c]Pyrimidin-1-Ones,"" Journal of Chemical Society 249-255.;;Alves, M.J. et al. (2000). ""Novel Aziridine Esters by the Addition of Aromatic Nitrogen Heterocycles to a 2H-Azirine-3-Carboxylic Ester,"" Tetrahedron Letters 41:4991-4995.;;Ames, D.E. et al. (1959, e-published Jan. 1, 1959). ""The Preparation of Aminoalkylpyrrocolines,"" Journal of Chemical Society 124:620-622.;;Anonymous. (Mar. 2006-Nov. 2013). ""Anacor Pharmaceuticals Scientific Presentations"", 7 pages.;;Anonymous. (2012). ""Diethyl Ether,"" Located at <http:www.merckmillipore.com/chemicals/diethyl-ether/MDA-CHEM-100926/p-NgGb.s1Lay4AAAEW8uEfVhTl>, last visited on Jul. 11, 2012, 4 pages.;;Archibald, J.L. et al. (Sep. 1967). ""New Reactions of Pyrroles. II. Preparation and Reactions of Pyrroleglyoxyloyl Derivatives,"" Journal of Heterocyclic Chemistry 4:335-338.;;Archibald, J.L. et al. (1974). ""Benzamidopiperidines. 2. Heterocyclic Compounds Related to Indoramin,"" Journal of Medicinal Chemistry 17(7):736-739.;;Battersby, A.R. et al. (1992, e-published Jan. 1, 1992). ""Synthetic Studies Relevant to Biosynthetic Research on Vitamin B12. Part 10. Construction of the East and West Building Blocks for Synthesis of Isobacteriochlorins,"" Journal of Chemical Society 17:2175-2187.;;Bentov, M. et al. (1964). ""4-Fluoroindole and Derivatives,"" Israel Journal of Chemistry 2:25-28.;;Birchall, G.R. et al. (1971). ""The Chlorination of Pyrroles. Part II,"" Canadian Journal of Chemistry 49:919-922.;;Black, D.S.C. et al. (1996). ""Reaction of Some 4,6-Dimethoxyindoles with Oxalyl Chloride,"" Tetrahedron 52(26):8925-8936.;;Black, D.S.C. et al. (1996). ""The Indol-2-Ylglyoxylamide Moiety: A New Building Block for the Design and Self-Assembly of Hydrogen Bond Networks,"" Journal of American Chemical Society 118(34):8148-8149.;;Black, D.S.C. et al. (2000). ""Formation of C-Amido-Calix[3]Indoles from 2'- and 7'-Indolylglyoxylamides,"" Tetrahedron 56:8513-8524.;;Bohusch, M. et al. (1991). ""Consequences of a Diminution of the Porphyrin pi-System: Attempted Syntheses of Bacteriophin and Chlorophin,"" Liebigs Annalen der Chemie 67-70. (Abstract Only).;;Borthwick, A.D. et al. (Jan. 3, 2002, e-published Dec. 5, 2001). ""Design and synthesis of Pyrrolidine-5,5-trans-Lactams (5-Oxohexahdropyrrolo[3,2-b]Pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 2. Potency and Chirality,"" Journal of Medicinal Chemistry 45(1):1-18.;;Cameron, B.D. et al. (1973). ""The Synthesis and Metabolic Fate of 14C-Viminol, a New Analgesic, in the Rat and the Dog,"" Arzneimittel-Forshung/Drug Res. 23(5):708-712.;;Cardellini, M. et al. (Feb. 1977). ""Indolizine Derivatives with Biological Activity I: N'-Substituted Hydrazides of Indolizine-2-Carboxylic Acid,"" Journal of Pharmaceutical Sciences 66(2):259-262.;;Chemcats. (Jan. 25, 2008). ""Benzo [b] Thiophene-2-Carboxylic Acid, 3-[2-[[(4-Methoxyphenyl) Amino]Oxoacetyl]-1H-Pyrrol-1-y1]-, Methyl Ester,"" Ryan Scientific Screening Library 5 pages.;;Chemcats. (Feb. 13, 2008). ""1H-Pyrrole-2-Acetamide, N-(4-Bromophenyl)-1-(2-Chloro-4-Nitrophenyl)-alpha-Oxo-,"" Ambinter Stock Screening Collection 5 pages.;;Chemcats. (Feb. 18, 2008). ""1H-Pyrrole-2-Acetamide, N-(2,4-Dichlorophenyl)-1-Methyl-alpha-Oxo-,"" Interchim Intermediates 5 pages.;;Chiarino, D. et al. (1978). ""Stereochemistry of Viminol, a Novel Central Analgesic,"" Arzneimittel-Forshung/Drug Res. 28(11):1554-1561.;;Cook, A.H. et al. (1949, e-published Jan. 1, 1949). ""Studies in the Azole Series. Part XXIV. The Interaction of Carbonyl Compounds and 2-Thio-5-Thiazolidone,"" Journal of Chemical Society 633:3007-3012.;;Crowley, K.J. et al. (1957). ""Intermediates for the Synthesis of Optically Active Methyl-Substituted Long-Chain Acids. Part II,"" Journal of the Chemical Society 2931-2934.;;Dannhardt, G. et al. (1979). ""Synthese und Eigenschaften von 2,3-Dihydro-1H-Pyrrolizinen,"" Arch. Pharm. 312:896-907.;;Dannhardt, G. et al. (1994). ""Nonsteroidal Antiinflammatory Agents, XVIII: C-5 Functionalized 6,7-Diphenyl-2,3-Dihydro-1H-Pyrrolizines as Inhibitors of Bovine Cyclooxygenase and 5-Lipoxygenase,"" Arch Pharm 327:509-514.;;Dannhardt, V.G. et al. (1986). ""Antiphlogistische 2,3-Dihydro-1H-Pyrrolizine, 11. Mitt. Dihydropyrrolizinyl-Substituierte 2-Aminoethanol- und Glykosäure-Derivate,"" Chemiker-Zeitung 110(3):124-127.;;Dumoulin, H. et al. (1998). ""2-Oxo-2-(Pehn-2-Ylpyrrol-2-Yl)Acetamides as Potential Anxiolytic Agents: Synthesis and Affinity at the Central Benzodiazepine Receptor,"" European Journal of Medicinal Chemistry 33:201-207.;;Dyke, S.F. et al. (1978). ""Pavinane and Isopavinane Alkaloids,"" Tetrahedron 34:241-245.;;Fryer, R.I. et al. (Dec. 1967). ""Quinazolines and 1,4-Benzodiazepines. XXXVII. Synthesis and Rearrangements of a Substituted 5-Phenyl-1H-1,4-Benzodiazepine,"" Journal of Organic Chemistry 32:3798-3803.;;Galbraith, A. et al. (Jan. 20, 1961). ""The Formation of Cycl[3,2,2]azine Derivatives via the Reaction of Pyrrocoline with Dimethyl Acetylenedicarboxylate,"" Journal of the American Chemical Society 83:453-458.;;Groll, A.H. et al. (1996). ""Trends in the Postmortem Epidemiology of Invasive Fungal Infections at a University Hospital,"" Journal of Infection 33:23-32.;;Hagishita, S. et al. (1996). ""Potent Inhibitors of Secretory Phospholipase A2: Synthesis and Inhibitory Activities of Indolizine and Indene Derivatives,"" Journal of Medicinal Chemistry 39(19):3636-3658.;;Hudack, R.A. et al. (2006, e-published Jan. 14, 2006). ""Design, Synthesis, and Biological Activity of Novel Polycyclic Aza-Amide FKBP12 Ligands,"" Journal of Medicinal Chemistry 49(3):1202-1206.;;Ignatovich, J. et al. (2008). ""Synthesis of Functionalized Benzyl Amines by the Reductive Alkylation of Heterocyclic and Heteroaromatic Amines with Arylaldehydes and preparation of the Intermediates for New Synthetic Biomolecules,"" ARKAT-USA, Inc. (ix):42-51.;;Islam, I. et al. (2007, e-published Apr. 27, 2007). ""Indolinone Based Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors. Part 1: Design, Synthesis and Biological Activity,"" Bioorganic & Medicinal Chemistry Letters 17:3814-3818.;;Keawin, T. et al. (2005, e-published Dec. 10, 2004). ""Reaction of Some 4,6-Dimethoxyindoles with Nitric Acid: Nitration and Oxidative Dimerisation,"" Tetrahedron 61:853-861.;;Mahiout, Z. et al. (2008, e-published Feb. 28, 2008). ""Solvent-Dependent Oxidations of 5- and 6-Azaindoles to Trioxopyrrolopyridines and Functionalised Azaindoles,"" Organic & Biomolecular Chemistry 6:1364-1376.;;Mao, W. et al. (Date Unknown) ""AN2718 Has Broad Spectrum Antifungal Activity Necessary for the Topical Treatment of Skin and Nail Fungal Infections,"" P2422, 7 pages.;;McDonell et al. (Jan. 1999). ""Antiseptics and Disinfectants: Activity, Action, and Resistance"", Clinical Microbiology Reviews 12(1) 147-149.;;Nourmohammadian, F. et al. (2005, e-published Jan. 21, 2005). ""An AB Initio Molecular Orbital Study of Structural Isomers of Diketopyrrolopyrrole,"" Dyes and Pigments 67:15-20.;;Pätzel, M. et al. (2005). ""Product Class 5: alpha-Heteroatom-Substituted Alkanamides,"" Science of Synthesis 21:477-535.;;Plattner, J.J. et al. (Date Unknown). ""Medicinal Chemistry of AN2690, A Novel Broad-Spectrum Antifungal Agent in Development for the Topical Treatment of Onychomycosis,"" Poster #775, Anacor Pharmaceuticals, 1 page.;;Ribaud, P. et al. (1999). ""Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation,"" Clinical Infectious Diseases 28:322-330.;;Rowe, F.M. et al. (1935, e-published Jan. 1, 1935). ""A Reaction of Certain Diazosulphonates Derived from beta-Naphthol-1-Sulphonic Acid. Part XIII. Fission of the Naphthalene Nucleus and Subsequent Closure in Two Directions,"" Journal of Chemical Society 420:1796-1808.;;Rowe, F.M. et al. (1936, e-published Jan. 1, 1936). ""A Reaction of Certain Diazosulphonates Derived from beta-Naphthol-1-Sulphonic Acid. Part XV. Derivatives of 2'-Nitro-4'-Methyl-Benzene-2-Naphthol-1-Diazosulphonate and Synthesis of 2-(2'-Nitro-4'-Methylphenylamino)Isoindolinone-3-Acetic Acid,"" Journal of Chemical Society 232:1098-1108.;;Roy, K. et al. (Dec. 2008). ""Development of Linear and Nonlinear Predictive QSAR Models and Their External Validation Using Molecular Similarity Principle for Anti-HIV Indolyl Aryl Sulfones,"" Journal of Enzyme Inhibition and Medicinal Chemistry 23(6):980-995.;;Savage, S.A. et al. (1998). ""Efficient Synthesis of 4-, 5-, and 6-Methyl-2,2'-Bipyridine by a Negishi Cross-Coupling Strategy Followed by High-Yield Conversion to Bromo- and Chloromethyl-2,2'-Bipyridines,"" Journal of Organic Chemistry 63(26):10048-10051.;;Scott, M.K. et al. (1995). ""Piperazinylalkyl Heterocycles as Potential Antipsychotic Agents,"" Journal of Medicinal Chemistry 38(21):4198-4210.;;Si, Z. et al. (Apr. 6, 2004). ""Small-Molecule Inhibitors of HIV-1 Entry Block Receptor-Induced Conformational Changes in the Viral Envelope Glycoproteins,"" Proceedings of the National Academy of Sciences 101(14):5036-5041.;;Slassi, A. et al. (2000). ""5-Alkyltryptamine Derivatives as Highly Selective and Potent 5-HT1D Receptor Agonists,"" Bioorganic & Medicinal Chemistry Letters 10:1707-1709.;;Sofan, M.A. et al. (2004). ""Studies on 2,3-Dioxopyrrolidines. Synthesis of Piperazine, Pyrrolo[4,5-b]Indole, Pyrazino [5,6-b]Indole and Arylazo Derivatives of Amino Acids,"" Polish Journal of Chemistry 78:837-842.;;CAS Registry No. 3758-62-1, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 3768-71-6, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 3768-72-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 3768-82-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 4380-46-5, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 4595-83-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 6616-51-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-17-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-18-8, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-19-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-20-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 15940-21-3, created Nov. 16, 1984 last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-22-4, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 15940-23-5, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 15940-24-6, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 15940-25-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 23502-48-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 26883-51-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 31709-75-8, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 31709-76-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 31709-77-0, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 31710-23-3, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 36793-47-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 41596-37-6, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 42060-03-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 42060-05-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 42221-74-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 43084-49-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 53391-28-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 53391-29-0, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 53391-30-3, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 53391-52-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 53391-63-2, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 65473-58-7, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 68803-72-5, created Nov. 16, 1984, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 81729-69-3, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 81741-58-4, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 83996-64-9, created Nov. 16, 1984, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 130761-64-7, created Nov. 30, 1990, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 130761-68-1, created Nov. 30, 1990, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 145045-69-8, created Dec. 25, 1992, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-40-3, created Dec. 29, 1995, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 171854-41-4, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-42-5, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-43-6, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 17854-44-7, created Dec. 29, 1995, last accessed Feb. 2, 2012, 1 page.;;CAS Registry No. 171845-45-8, created Dec. 29, 1995, last accessed Feb. 2, 2012, 2 pages.;;CAS Registry No. 171854-46-9, created Dec. 29, 1995, last accessed Feb. 2, 2012, 1 page.",ACTIVE
142,JP,A,JP 2015051984 A,101-680-376-784-258,2015-03-19,2015,JP 2014208999 A,2014-10-10,GB 0807532 A;;GB 0819696 A,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,"PROBLEM TO BE SOLVED: To provide a compound that is useful in prevention or treatment of a fungal disease and may also be used as agricultural fungicides, and provide a complex in which the compound and a second antifungal agent are formulated for simultaneous or successive administration.SOLUTION: The present invention relates to a pyrrole derivative of the general formula (I) represented by 2-(1,5-dimethyl-3-phenyl-1 H-pyrrole-2-yl)-N-{4-[4-(4,6-dimethyl-pyridine-2-yl)-piperazine-1-yl]-phenyl}-2-oxo-acetamide, and pharmaceutically and agriculturally acceptable salts thereof.",F2G LTD,GRAHAM EDWARD MORRIS SIBLEY;;ROBERT DOWNHAM;;LLOYD JAMES PAYNE;;DEREK LAW;;JASON DAVID OLIVER;;MIKE BIRCH;;GARETH MORSE DAVIES,,https://lens.org/101-680-376-784-258,Patent Application,no,4,1,24,26,0,A01N43/36;;A01N43/60;;A01N43/76;;C07D498/04;;A01N43/40;;A01N43/42;;A01N43/84;;A01N43/90;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/5377;;C07D487/04;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;A01N43/36;;A01N43/60;;A01N43/76;;C07D498/04;;A01N43/40;;A01N43/42;;A01N43/84;;A01N43/90;;C07D487/04;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/5377;;A61K45/06,A61K31/40;;A01N43/60;;A01P3/00;;A61K31/137;;A61K31/4025;;A61K31/404;;A61K31/407;;A61K31/415;;A61K31/4164;;A61K31/4174;;A61K31/4196;;A61K31/422;;A61K31/4439;;A61K31/454;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K31/505;;A61K31/506;;A61K31/5375;;A61K31/5377;;A61K31/5383;;A61K31/55;;A61K31/7048;;A61K31/7072;;A61K45/00;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D207/333;;C07D207/34;;C07D213/36;;C07D401/12;;C07D401/14;;C07D403/12;;C07D405/12;;C07D405/14;;C07D409/14;;C07D413/12;;C07D413/14;;C07D487/04;;C07D498/04,,6,0,,,"JPN6015042983; Ａｒｃｈｉｖ ｄｅｒ Ｐｈａｒｍａｚｉｅ Ｖｏｌ．３２７， Ｎｏ．８, 1994, ｐ．５０９-５１４;;JPN6015042985; Ｃｈｅｍｉｋｅｒ-Ｚｅｉｔｕｎｇ Ｖｏｌ．１１０， Ｎｏ．３, 1986, ｐ．１２４-１２７;;JPN6015042987; Ａｒｃｈｉｖ ｄｅｒ Ｐｈａｒｍａｚｉｅ Ｖｏｌ．３１２， Ｎｏ．１１, 1979, ｐ．８９６-９０７;;JPN6015042983; Ａｒｃｈｉｖ ｄｅｒ Ｐｈａｒｍａｚｉｅ Ｖｏｌ．３２７， Ｎｏ．８, 1994, ｐ．５０９-５１４;;JPN6015042985; Ｃｈｅｍｉｋｅｒ-Ｚｅｉｔｕｎｇ Ｖｏｌ．１１０， Ｎｏ．３, 1986, ｐ．１２４-１２７;;JPN6015042987; Ａｒｃｈｉｖ ｄｅｒ Ｐｈａｒｍａｚｉｅ Ｖｏｌ．３１２， Ｎｏ．１１, 1979, ｐ．８９６-９０７",ACTIVE
143,DK,T3,DK 2626361 T3,177-728-642-920-281,2015-01-19,2015,DK 13167337 T,2009-04-23,GB 0807532 A;;GB 0819696 A;;EP 09734928 A,2008-04-24,PYRROL-ANTIMYKOTIKA,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/177-728-642-920-281,Granted Patent,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D487/04;;A01N43/36;;A01N43/60;;A01N43/76;;A61P31/10;;C07D498/04,,0,0,,,,ACTIVE
144,EP,B1,EP 2626361 B1,154-654-909-659-964,2014-10-15,2014,EP 13167337 A,2009-04-23,GB 0807532 A;;GB 0819696 A;;EP 09734928 A,2008-04-24,Pyrrole antifungal agents,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/154-654-909-659-964,Granted Patent,yes,3,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D487/04;;A01N43/36;;A01N43/60;;A01N43/76;;A61P31/10;;C07D498/04,,0,0,,,,ACTIVE
145,PT,E,PT 2283006 E,077-802-216-339-168,2015-06-29,2015,PT 09734928 T,2009-04-23,GB 0807532 A;;GB 0819696 A,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,,F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MIKE;;DAVIES GARETH MORSE,,https://lens.org/077-802-216-339-168,Granted Patent,no,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,C07D401/12;;A01N43/40;;A01N43/42;;A61P31/10,,0,0,,,,ACTIVE
146,US,A1,US 2015/0238500 A1,159-135-382-000-043,2015-08-27,2015,US 201514625532 A,2015-02-18,US 201514625532 A;;GB 0807532 A;;GB 0819696 A;;US 98941011 A;;GB 2009001058 W,2008-04-24,PYRROLE ANTIFUNGAL AGENTS,"The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.",F2G LTD,SIBLEY GRAHAM EDWARD MORRIS;;DOWNHAM ROBERT;;PAYNE LLOYD JAMES;;LAW DEREK;;OLIVER JASON DAVID;;BIRCH MICHAEL;;DAVIES GARETH MORSE,F2G LTD (2010-11-01),https://lens.org/159-135-382-000-043,Patent Application,yes,0,0,24,26,0,A61K31/5377;;A61K31/5377;;A01N43/36;;A01N43/36;;A01N43/40;;A01N43/40;;A01N43/42;;A01N43/42;;A01N43/60;;A01N43/60;;A01N43/76;;A01N43/76;;A01N43/84;;A01N43/84;;A01N43/90;;A01N43/90;;A61K31/4025;;A61K31/4025;;A61K31/4439;;A61K31/4439;;A61K31/4709;;A61K31/4709;;A61K31/4725;;A61K31/4725;;A61K31/496;;A61K31/496;;A61K31/4985;;A61K31/4985;;A61K45/06;;A61P11/00;;A61P11/06;;A61P31/10;;A61P43/00;;C07D487/04;;C07D487/04;;C07D498/04;;C07D498/04,A61K31/5377;;A01N43/36;;A01N43/40;;A01N43/42;;A01N43/60;;A01N43/84;;A01N43/90;;A61K31/4025;;A61K31/4439;;A61K31/4709;;A61K31/4725;;A61K31/496;;A61K31/4985;;A61K45/06,,2,0,,,"Types of Fungal Diseases""-www.cdc.gov/fungal/diseases/index.html [11/16/2015];;(CDC ""Aspergillosis Risk and Prevention"" -www.cdc.fungal/diseases/aspergillosis/risk-prevention.html [11/16/2015]",ACTIVE
147,US,A1,US 2022/0247653 A1,176-539-933-123-62X,2022-08-04,2022,US 202117229835 A,2021-04-13,US 202117229835 A;;US 202163144335 P,2021-02-01,EARLY DEPLOYMENT CONNECTIVITY TESTING,"Techniques are described for verifying connectivity in a virtualized computing environment comprising networked computing devices having internal endpoints that are configured with operational connectivity to external endpoints. A connectivity test component is configured to execute as a virtual resource in the virtualized computing environment, execute protocol-aware connectivity tests that enable detection of connectivity errors between the internal endpoints and external endpoints, and instantiate or access network interfaces for establishing connectivity between the internal endpoints and external endpoints. A configuration file defines connectivity types between the internal endpoints and external endpoints. Based on the configuration file, the connectivity test component is executed in the virtualized computing environment. An output is generated by the connectivity test component that is indicative of results of connectivity attempts in accordance with the configuration file.",MICROSOFT TECHNOLOGY LICENSING LLC,DAVIES PHILIP JOEL;;PHILLIPS JONATHAN;;MADDEN STEPHEN CHRISTOPHER;;EDMONDS ANDREW CHRISSIE;;ORBELL STEVEN EDWARD;;MCCURDY ANDREW;;GALLAGHER CATHERINE;;DACKINS JASON,MICROSOFT TECHNOLOGY LICENSING LLC (2021-04-09),https://lens.org/176-539-933-123-62X,Patent Application,yes,1,1,1,3,0,H04L43/0811;;H04L43/50;;H04L41/0866;;H04L43/20;;H04L41/0895;;H04L41/0806;;H04L41/122;;G06F9/45533;;G06F8/60;;H04L43/0811;;H04L41/0866;;G06F9/45533,G06F9/455,,1,0,,,"Nevot, DESCRIPTION OF SERVICE INSTANCES IN A VIRTUALISED NETWORK ENVIRONMENT, June 2018, <https://upcommons.upc.edu/bitstream/handle/2117/128162/Degree%20Thesis_Julia%20Igual.pdf?sequence=1&isAllowed=y> (Year: 2018)",PENDING
148,EP,A1,EP 4285562 A1,038-998-895-215-679,2023-12-06,2023,EP 22705198 A,2022-01-14,US 202163144335 P;;US 202117229835 A;;US 2022/0012400 W,2021-02-01,EARLY DEPLOYMENT CONNECTIVITY TESTING,,MICROSOFT TECHNOLOGY LICENSING LLC,DAVIES PHILIP JOEL;;PHILLIPS JONATHAN;;MADDEN STEPHEN CHRISTOPHER;;EDMONDS ANDREW CHRISSIE;;ORBELL STEVEN EDWARD;;MCCURDY ANDREW;;GALLAGHER CATHERINE;;DACKINS JASON,,https://lens.org/038-998-895-215-679,Patent Application,yes,0,0,2,3,0,H04L43/0811;;H04L43/50;;H04L41/0866,H04L43/0811;;H04L41/0866;;H04L43/50,,0,0,,,,PENDING
149,WO,A1,WO 2022/031877 A1,063-532-355-351-196,2022-02-10,2022,US 2021/0044587 W,2021-08-05,US 202063061334 P,2020-08-05,COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS,"Disclosed herein are compositions and methods for the treatment of bronchiolitis obliterans syndrome (BOS), in particular, in association with hematopoietic stem cell transplant (HSCT recipients, and methods for patients for effective treatment of same using protein and functional biomarkers. In certain aspect, the disclosed compositions and methods may be used for early identification of individuals likely to develop BOS such that optimal treatment may be provided, wherein the methods may employ detection and assessment of one or both of a biomarker and lung function.",CHILDRENS HOSPITAL MED CT,MYERS KASIANI;;ZIADY ASSEM;;SZCZESNIAK RHONDA;;WOODS JASON;;WALKUP LAURA;;DAVIES STELLA;;SKALA EMILY;;MOUSA NADEEM;;TOWE CHRISTOPHER;;GECILI EMRAH,,https://lens.org/063-532-355-351-196,Patent Application,yes,1,2,1,1,0,C12Q1/6883;;C12Q2600/158;;A61P11/00;;G01N33/6884;;G01N2800/50;;G01N2800/245;;G01N2800/12,G01N33/50;;C12Q1/6809;;C12Q1/6883;;G01N33/68,,2,2,011-892-352-933-898;;064-781-738-635-309,10.1111/ajt.13750;;26887344;;pmc4956556;;16741151;;10.1164/rccm.200601-071oc,"LIU X., YUE Z., YU J., DAGUINDAU E., KUSHEKHAR K., ZHANG Q., OGATA Y., GAFKEN P. R., INAMOTO Y., GRACON A., WILKES D. S., HANSEN J: ""Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation"", AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL MUNKSGAARD, DK, vol. 16, no. 8, 1 August 2016 (2016-08-01), DK , pages 2342 - 2351, XP055907005, ISSN: 1600-6135, DOI: 10.1111/ajt.13750;;VERLEDEN GEERT M., VANAUDENAERDE BART M., DUPONT LIEVEN J., VAN RAEMDONCK DIRK E.: ""Azithromycin Reduces Airway Neutrophilia and Interleukin-8 in Patients with Bronchiolitis Obliterans Syndrome"", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMERICAN THORACIC SOCIETY, US, vol. 174, no. 5, 1 September 2006 (2006-09-01), US , pages 566 - 570, XP055907008, ISSN: 1073-449X, DOI: 10.1164/rccm.200601-071OC",PENDING
150,WO,A1,WO 2022/164653 A1,117-994-453-857-59X,2022-08-04,2022,US 2022/0012400 W,2022-01-14,US 202163144335 P;;US 202117229835 A,2021-02-01,EARLY DEPLOYMENT CONNECTIVITY TESTING,"Techniques are described for verifying connectivity in a virtualized computing environment comprising networked computing devices having internal endpoints that are configured with operational connectivity to external endpoints. A connectivity test component is configured to execute as a virtual resource in the virtualized computing environment, execute protocol-aware connectivity tests that enable detection of connectivity errors between the internal endpoints and external endpoints, and instantiate or access network interfaces for establishing connectivity between the internal endpoints and external endpoints. A configuration file defines connectivity types between the internal endpoints and external endpoints. Based on the configuration file, the connectivity test component is executed in the virtualized computing environment. An output is generated by the connectivity test component that is indicative of results of connectivity attempts in accordance with the configuration file.",MICROSOFT TECHNOLOGY LICENSING LLC,DAVIES PHILIP JOEL;;PHILLIPS JONATHAN;;MADDEN STEPHEN CHRISTOPHER;;EDMONDS ANDREW CHRISSIE;;ORBELL STEVEN EDWARD;;MCCURDY ANDREW;;GALLAGHER CATHERINE;;DACKINS JASON,,https://lens.org/117-994-453-857-59X,Patent Application,yes,2,0,2,3,0,H04L43/0811;;H04L43/50;;H04L41/0866,H04L43/0811;;H04L41/0866;;H04L43/50,,0,0,,,,PENDING
151,WO,A2,WO 2021/078971 A2,136-780-376-442-301,2021-04-29,2021,EP 2020079954 W,2020-10-23,GB 201915480 A,2019-10-25,"IMPROVED NANOPORE SENSING DEVICE, COMPONENTS AND METHOD OF MANUFACTURE","The invention relates to a method of forming a sensing device for supporting a plurality of nanopores upon an array of wells. The method involves providing a substrate, said substrate having a surface having an array of electrodes located thereon for connecting to or for configuring upon an electronic circuit. Separately, a well array structure is provided, which has an array of walls defining through-holes for defining wells. The substrate and well array structures are aligning said array of electrodes define, at least in part, a portion of the bases of respective wells at the bottom of the through holes. The resulting sensing device overcomes problems with known sensing devices by employing a substrate and/or well array structure, or hybrid thereof, that employs alternative materials or manufacturing processes.",OXFORD NANOPORE TECH LTD,ORTIZ BAHAMON PEDRO;;MACKETT PAUL;;GREASTY ROBERT;;MCKENDRY JONATHAN;;HYDE JASON;;JACKSON MARK;;WILTSHIRE RICHARD;;DAVIES RHODRI;;HYLAND MARK;;CLARKE JAMES;;SANGHERA GURDIAL,,https://lens.org/136-780-376-442-301,Patent Application,yes,14,3,7,7,0,G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0663;;B01L2300/0645;;B01L2200/025;;B29C65/48;;B29C65/70;;B81C1/00087;;B81C1/00206;;B81C1/00214;;B81C1/00222;;B81C1/00238;;G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0645;;B01L2300/0829;;B01L2300/161;;B29C43/18;;B29C43/206;;B29K2033/12;;B29K2883/00;;B29L2031/34,G01N33/487;;B01L3/00,,7,7,022-890-244-669-778;;118-120-895-753-324;;004-309-727-148-024;;012-996-273-745-023;;039-455-222-722-33X;;025-628-926-373-144;;038-024-516-216-888,19735126;;10.1021/la902417m;;pmc389821;;10.1073/pnas.69.12.3561;;4509315;;21336266;;10.1038/nnano.2011.12;;pmc3071889;;10.1126/science.1225624;;pmc3716461;;23161995;;19380741;;pmc2683137;;10.1073/pnas.0901054106;;10.1021/ja1087612;;pmc3076064;;21121604;;19146373;;10.1021/ja808128s,"GONZALEZ-PEREZ ET AL., LANGMUIR, vol. 25, 2009, pages 10447 - 10450;;MONTALMUELLER, PROC. NATL. ACAD. SCI. USA., vol. 69, 1972, pages 3561 - 3566;;YUSKO ET AL., NATURE NANOTECHNOLOGY, vol. 6, 2011, pages 253 - 260;;LANGECKER ET AL., SCIENCE, vol. 338, 2012, pages 932 - 936;;STODDART D ET AL., PROC NATL ACAD SCI, vol. 106, no. 19, pages 7702 - 7;;LIEBERMAN KR ET AL., J AM CHEM SOC, vol. 132, no. 50, 2010, pages 17961 - 72;;HERON AJ ET AL., J AM CHEM SOC, vol. 131, no. 5, 2009, pages 1652 - 3",PENDING
152,WO,A3,WO 2021/078971 A3,104-859-881-543-489,2021-06-10,2021,EP 2020079954 W,2020-10-23,GB 201915480 A,2019-10-25,NANOPORE SENSING DEVICE,"The invention relates to a method of forming a sensing device (100) for supporting a plurality of nanopores upon an array of wells (10). The method involves providing a substrate, said substrate (102) having a surface (104) having an array of electrodes (6) located thereon for connecting to or for configuring upon an electronic circuit. Separately, a well array structure (108) is provided, which has an array of walls (110) defining through-holes (112) for defining wells (10). The substrate (102) and the well array structure (108) are aligning said array of electrodes (6) to define, at least in part, a portion of the bases of respective wells (10) at the bottom of the through holes (112).",OXFORD NANOPORE TECH LTD,ORTIZ BAHAMON PEDRO;;MACKETT PAUL;;GREASTY ROBERT;;MCKENDRY JONATHAN;;HYDE JASON;;JACKSON MARK;;WILTSHIRE RICHARD;;DAVIES RHODRI;;HYLAND MARK;;CLARKE JAMES;;SANGHERA GURDIAL,,https://lens.org/104-859-881-543-489,Search Report,yes,3,0,7,7,0,G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0663;;B01L2300/0645;;B01L2200/025;;B29C65/48;;B29C65/70;;B81C1/00087;;B81C1/00206;;B81C1/00214;;B81C1/00222;;B81C1/00238;;G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0645;;B01L2300/0829;;B01L2300/161;;B29C43/18;;B29C43/206;;B29K2033/12;;B29K2883/00;;B29L2031/34,G01N33/487;;B01L3/00,,0,0,,,,PENDING
153,US,A1,US 2023/0330121 A1,144-766-691-868-07X,2023-10-19,2023,US 202118019322 A,2021-08-05,US 202118019322 A;;US 202063061344 P;;US 2021/0044587 W,2020-08-05,COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS,"Disclosed herein are compositions and methods for the treatment of bronchiolitis obliterans syndrome (BOS), in particular, in association with hematopoietic stem cell transplant (HSCT recipients, and methods for patients for effective treatment of same using protein and functional biomarkers. In certain aspect, the disclosed compositions and methods may be used for early identification of individuals likely to develop BOS such that optimal treatment may be provided, wherein the methods may employ detection and assessment of one or both of a biomarker and lung function.",CHILDRENS HOSPITAL MED CT,ZIADY ASSEM;;MYERS KASIANI;;DAVIES STELLA M;;SZCZESNIAK RHONDA;;GECILI EMRAH;;SKALA EMILY J;;MOUSA NADEEM AYOUB ALI;;TOWE CHRISTOPHER;;WALKUP LAURA;;WOODS JASON,,https://lens.org/144-766-691-868-07X,Patent Application,yes,0,0,2,2,0,C12N2770/20022;;A61K39/12;;A61P31/14;;C12N2770/20034;;G01N33/56983;;G01N2333/165;;G01N2469/20;;G01N33/56983;;A61K39/215;;C12N2770/20034;;G01N2333/165;;C12N7/00;;A61P11/00;;A61K31/18;;A61K31/22;;A61K31/40;;A61K31/7052;;G01N33/6884;;G01N2800/12;;G01N2800/245;;G01N2800/50,A61K31/7052;;A61K31/18;;A61K31/22;;A61K31/40;;A61P11/00;;G01N33/68,,0,0,,,,PENDING
154,US,S,US D0747747 S,060-745-854-917-916,2016-01-19,2016,US 201429496158 F,2014-07-10,EM 13992730000 F,2014-01-10,Wheeled loading shovel vehicle,,BAMFORD EXCAVATORS LTD,TURNER MIKE;;MELLOR TOBY;;MACMILLAN DUNCAN;;TRACEY LUKE;;HYDE NEIL;;GASKIN ANDY;;PAY LAURIE;;PRINCE MARK;;BURGESS JASON;;DAVIES SIMON;;JONES STUART;;RAMIRES JUAN CARLOS;;BOUGHTON JOHN;;UNDERWOOD DAMIAN,J.C. BAMFORD EXCAVATORS LIMITED (2014-11-05),https://lens.org/060-745-854-917-916,Design Right,no,0,6,9,9,0,,,1209;;D15/25,0,0,,,,ACTIVE
155,US,S,US D0742424 S,128-349-207-585-397,2015-11-03,2015,US 201429496159 F,2014-07-10,EM 13992730000 F,2014-01-10,Wheeled loading shovel vehicle,,BAMFORD EXCAVATORS LTD,TURNER MICHAEL;;MELLOR TOBY;;MACMILLAN DUNCAN;;TRACEY LUKE;;HYDE NEIL;;GASKIN ANDY;;PAY LAURIE;;PRINCE MARK;;BURGESS JASON;;DAVIES SIMON;;JONES STUART;;RAMIRES JUAN CARLOS;;BOUGHTON JOHN;;UNDERWOOD DAMIAN,J.C. BAMFORD EXCAVATORS LIMITED (2014-11-05),https://lens.org/128-349-207-585-397,Design Right,no,0,9,9,9,0,,,1209;;D15/25,0,0,,,,ACTIVE
156,GB,A,GB 2590775 A,114-776-043-727-843,2021-07-07,2021,GB 202016872 A,2020-10-23,GB 201915480 A,2019-10-25,"Improved nanopore sensing device, components and method of manufacture","A method of forming a nanopore sensing device, comprises providing a substrate 102 having a surface with an array of electrodes 6 for connecting to an electronic circuit. Separately, a well array structure 108 is provided, which has an array of walls defining through holes for defining wells. The substrate and well array structures are aligned so that the array of electrodes define, at least in part, a portion of the bases of respective wells at the bottom of the through holes. The well array structure may be moulded onto the substrate (figs 4(a) to 4(f)). Alternatively, a structure having an array of walls defining through holes may be aligned and adhered to a substrate having an array of electrodes, on which a patterned adhesive surface 114 is provided. Alternatively, a substrate having an electrically conducting layer on a backside may be provided, on which vias penetrating through the substrate are formed, and at least partially filled with conductive filling material to form electrodes. A portion of the electrically conducting layer may be removed to form electrical contacts, and part of the front side of the substrate removed to form an array of wells (figs 13(a) to 13(e)).",OXFORD NANOPORE TECH LTD,PEDRO MIGUEL ORTIZ BAHAMON;;PAUL RAYMOND MACKETT;;ROBERT GREASTY;;JONATHAN EDWARD MCKENDRY;;JASON ROBERT HYDE;;MARK DAVID JACKSON;;RICHARD KENNETH JOHN WILTSHIRE;;RHODRI RHYS DAVIES;;MARK HYLAND;;JAMES ANTHONY CLARKE;;GURDIAL SINGH SANGHERA,,https://lens.org/114-776-043-727-843,Patent Application,no,3,0,7,7,0,G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0663;;B01L2300/0645;;B01L2200/025;;B29C65/48;;B29C65/70;;B81C1/00087;;B81C1/00206;;B81C1/00214;;B81C1/00222;;B81C1/00238;;G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0645;;B01L2300/0829;;B01L2300/161;;B29C43/18;;B29C43/206;;B29K2033/12;;B29K2883/00;;B29L2031/34,G01N33/487;;B29C65/48;;B29C65/70;;B81C1/00,,0,0,,,,PENDING
157,EP,A2,EP 4049028 A2,000-133-380-204-477,2022-08-31,2022,EP 20807669 A,2020-10-23,GB 201915480 A;;EP 2020079954 W,2019-10-25,NANOPORE SENSING DEVICE,,OXFORD NANOPORE TECH PLC,ORTIZ BAHAMON PEDRO MIGUEL;;MACKETT PAUL RAYMOND;;GREASTY ROBERT;;MCKENDRY JONATHAN EDWARD;;HYDE JASON ROBERT;;JACKSON MARK DAVID;;WILTSHIRE RICHARD KENNETH JOHN;;DAVIES RHODRI RHYS;;HYLAND MARK;;CLARKE JAMES ANTHONY;;SANGHERA GURDIAL SINGH,,https://lens.org/000-133-380-204-477,Patent Application,yes,0,0,7,7,0,G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0663;;B01L2300/0645;;B01L2200/025;;B29C65/48;;B29C65/70;;B81C1/00087;;B81C1/00206;;B81C1/00214;;B81C1/00222;;B81C1/00238;;G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0645;;B01L2300/0829;;B01L2300/161;;B29C43/18;;B29C43/206;;B29K2033/12;;B29K2883/00;;B29L2031/34,G01N33/487;;B01L3/00,,0,0,,,,PENDING
158,US,A1,US 2022/0396013 A1,093-214-748-516-574,2022-12-15,2022,US 202017771179 A,2020-10-23,GB 201915480 A;;EP 2020079954 W,2019-10-25,NANOPORE SENSING DEVICE,"The invention relates to a method of forming a sensing device for supporting a plurality of nanopores upon an array of wells. The method involves providing a substrate, said substrate having a surface having an array of electrodes located thereon for connecting to or for configuring upon an electronic circuit. Separately, a well array structure is provided, which has an array of walls defining through-holes for defining wells. The substrate and well array structures are aligning said array of electrodes define, at least in part, a portion of the bases of respective wells at the bottom of the through holes. The resulting sensing device overcomes problems with known sensing devices by employing a substrate and/or well array structure, or hybrid thereof, that employs alternative materials or manufacturing processes.",OXFORD NANOPORE TECH PLC,ORTIZ BAHAMON PEDRO MIGUEL;;MACKETT PAUL RAYMOND;;GREASTY ROBERT;;MCKENDRY JONATHAN EDWARD;;HYDE JASON ROBERT;;JACKSON MARK DAVID;;WILTSHIRE RICHARD KENNETH JOHN;;DAVIES RHODRI RHYS;;HYLAND MARK;;CLARKE JAMES ANTHONY;;SANGHERA GURDIAL SINGH,OXFORD NANOPORE TECHNOLOGIES PLC (2022-09-02),https://lens.org/093-214-748-516-574,Patent Application,yes,0,0,7,7,0,G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0663;;B01L2300/0645;;B01L2200/025;;B29C65/48;;B29C65/70;;B81C1/00087;;B81C1/00206;;B81C1/00214;;B81C1/00222;;B81C1/00238;;G01N33/48721;;B01L3/5085;;B01L2200/12;;B01L2300/0645;;B01L2300/0829;;B01L2300/161;;B29C43/18;;B29C43/206;;B29K2033/12;;B29K2883/00;;B29L2031/34,B29C43/20;;B01L3/00;;B29C43/18,,0,0,,,,PENDING
159,ES,T3,ES 2605363 T3,005-263-327-645-65X,2017-03-14,2017,ES 07802383 T,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,Derivados y análogos de N-etilquinolonas y de N-etilazaquinolonas,"Un compuesto de fórmula (I) o una sal, un solvato o un N-óxido del mismo farmacéuticamente aceptables: **Fórmula** en la que: dos de Z1, Z2, Z3 y Z4 son independientemente CR1c o N y el resto son independientemente CR1c; o Z3 y Z4 representan conjuntamente S y uno de Z1 y Z2 es CR1c o N y el otro es independientemente CR1c; R1a, R1b y R1c se eligen independientemente entre hidrógeno; halógeno; ciano; alquilo (C1-6); alquiltio (C1-6); trifluorometilo; trifluorometoxi; carboxi; hidroxi opcionalmente sustituido con alquilo (C1-6) o alquilo (C1-6) sustituido con alcoxi (C1-6); alquilo (C1-6) sustituido con alcoxi (C1-6); hidroxialquilo (C1-6); un grupo amino opcionalmente N-sustituido con uno o dos grupos alquilo (C1-6), formilo, alquilcarbonilo (C1-6) o alquilsulfonilo (C1-6); o aminocarbonilo en donde el grupo amino está opcionalmente sustituido con alquilo (C1-4); o dos de R1a, R1b y R1c en átomos de carbono adyacentes pueden formar conjuntamente un grupo etilendioxi; R2 es hidrógeno o alquilo (C1-4), o junto con R6 forma Y según se define a continuación; A es un grupo (i): **Fórmula** en el que: R3 es según se ha definido para R1a, R1b y R1c o es oxo o aminometilo y n es 1 o 2; o A es un grupo (ii)**Fórmula** W1, W2 y W3 son CR4R8; o W2 y W3 son CR4R8 y W1 representa un enlace entre W3 y N; X es O, CR4R8 o NR6; un R4 es según se ha definido para R1a, R1b y R1c y el resto y R8 son hidrógeno, o un R4 y R8 son conjuntamente oxo y el resto son hidrógeno; R6 es hidrógeno o alquilo (C1-6); o junto con R2 forma Y; R7 es hidrógeno; halógeno; hidroxi opcionalmente sustituido con alquilo (C1-6); o alquilo (C1-6); Y es CR4R8CH2; CH2CR4R8; (C>=O); CR4R8; CR4R8(C>=O); o (C>=O)CR4R8; o cuando X es CR4R8, R8 y R7 representan conjuntamente un enlace; U se selecciona entre CO y CH2; y R5 es un sistema anular bicíclico heterocíclico opcionalmente sustituido (B): **Fórmula** que contiene hasta cuatro heteroátomos en cada anillo, en el que el anillo heterocíclico (B) tiene un anillo (a) aromático que es un anillo pirimidínico opcionalmente sustituido en el que: X1 es C; X2 es N; X3 y X5 son C; y Y1 es un grupo conector de 2 átomos -N-CR14-; y un anillo (b) no aromático e Y2 es un grupo conector de 3-4 átomos, siendo cada átomo de Y2 seleccionado independientemente entre N, NR13, O, S(O)x, CO, CR14 o CR14R15 incluyendo al menos un heteroátomo, con O, S, CH2 o NR13 unido a X5, donde R13 es distinto de hidrógeno, y NHCO unido a través de un N a X3, u O, S, CH2 o NH unido a X3; cada uno de R14 y R15 se elige independientemente entre: H; alquiltio (C1-4); halo; carboxialquilo (C1-4); alquilo (C1-4); alcoxicarbonilo (C1-4); alquilcarbonilo (C1-4); alcoxi (C1-4) alquilo (C1-4); hidroxi; hidroxialquilo (C1- 4); alcoxi (C1-4); nitro; ciano; carboxi; amino o aminocarbonilo opcionalmente mono o disustituido con alquilo (C1-4); o R14 y R15 pueden representar conjuntamente oxo; cada R13 es independientemente H; trifluorometilo; alquilo (C1-4) opcionalmente sustituido con hidroxi, alcoxi (C1-6), alquiltio (C1-6), halo o trifluorometilo; alquenilo (C2-4); alcoxicarbonilo (C1-4); alquilcarbonilo (C1-4); alquilsulfonilo (C1-6); aminocarbonilo en el que el grupo amino está opcionalmente mono o disustituido con alquilo (C1-4); cada x es independientemente 0, 1 o 2.",GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT;;DAVIES DAVID;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN;;HOFFMAN JAMES;;JONES GRAHAM;;MILES TIMOTHY;;PEARSON NEIL;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO;;ROSSI JASON;;ZHANG LIHUA(LILY),,https://lens.org/005-263-327-645-65X,Granted Patent,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D401/14;;A61K31/519;;A61K31/538;;A61P31/04;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,ACTIVE
160,US,A1,US 2023/0228732 A1,179-022-436-909-602,2023-07-20,2023,US 202118010823 A,2021-04-29,US 202118010823 A;;GB 202016874 A;;GB 202105787 A;;US 202063040455 P;;GB 2021051029 W,2020-06-17,NANOPORE SUPPORT STRUCTURE AND MANUFACTURE THEREOF,"There is disclosed a nanopore support structure comprising a wall layer comprising walls defining a plurality of wells, and overhangs extending from the walls across each of the wells, the overhang defining an aperture configured to support a membrane suitable for insertion of a nanopore. There is further disclosed a nanopore sensing device comprising a nanopore support structure, and methods of manufacturing the nanopore support structure and the nanopore sensing device.",OXFORD NANOPORE TECH PLC,XIE PING;;MILLIS JUSTIN;;HEALY KEN;;CLARKE JAMES ANTHONY;;HYDE JASON ROBERT;;WILTSHIRE RICHARD KENNETH JOHN;;MCKENDRY JONATHAN EDWARD;;GREASTY ROBERT;;BROWN CLIVE GAVIN;;PERA LOANA;;SANGHERA GURDIAL SINGH;;HYLAND MARK;;ORTIZ BAHAMON PEDRO MIGUEL;;JACKSON MARK DAVID;;MACKETT PAUL RAYMOND;;DAVIES RHODRI RHYS,OXFORD NANOPORE TECHNOLOGIES PLC (2023-03-16),https://lens.org/179-022-436-909-602,Patent Application,yes,0,0,7,7,0,G01N33/48721;;B01L3/502707;;B01L3/502715;;B01L2300/0816;;B01L2300/0861;;B01L2300/0896;;B82Y5/00;;G01N27/308;;G01N33/48721,G01N33/487;;B01L3/00;;B82Y5/00;;G01N27/30,,0,0,,,,PENDING
161,WO,A1,WO 2021/255414 A1,058-861-496-501-57X,2021-12-23,2021,GB 2021051029 W,2021-04-29,US 202063040455 P;;GB 202016874 A;;GB 202105787 A,2020-06-17,NANOPORE SUPPORT STRUCTURE AND MANUFACTURE THEREOF,"There is disclosed a nanopore support structure comprising a wall layer comprising walls defining a plurality of wells, and overhangs extending from the walls across each of the wells, the overhang defining an aperture configured to support a membrane suitable for insertion of a nanopore. There is further disclosed a nanopore sensing device comprising a nanopore support structure, and methods of manufacturing the nanopore support structure and the nanopore sensing device.",OXFORD NANOPORE TECH LTD,XIE PING;;MILLIS JUSTIN;;HEALY KEN;;CLARKE JAMES ANTHONY;;HYDE JASON ROBERT;;WILTSHIRE RICHARD KENNETH JOHN;;MCKENDRY JONATHAN EDWARD;;GREASTY ROBERT;;BROWN CLIVE GAVIN;;PERA IOANA;;SANGHERA GURDIAL SINGH;;HYLAND MARK;;ORTIZ BAHAMON PEDRO MIGUEL;;JACKSON MARK DAVID;;MACKETT PAUL RAYMOND;;DAVIES RHODRI RHYS,,https://lens.org/058-861-496-501-57X,Patent Application,yes,30,3,7,7,0,G01N33/48721;;B01L3/502707;;B01L3/502715;;B01L2300/0816;;B01L2300/0861;;B01L2300/0896;;B82Y5/00;;G01N27/308;;G01N33/48721,G01N33/487,,9,9,054-067-927-805-791;;022-890-244-669-778;;118-120-895-753-324;;012-996-273-745-023;;039-455-222-722-33X;;025-628-926-373-144;;038-024-516-216-888;;013-231-232-734-856;;143-177-059-047-751,10.1088/0953-8984/22/32/325107;;21386489;;19735126;;10.1021/la902417m;;pmc389821;;10.1073/pnas.69.12.3561;;4509315;;10.1126/science.1225624;;pmc3716461;;23161995;;19380741;;pmc2683137;;10.1073/pnas.0901054106;;10.1021/ja1087612;;pmc3076064;;21121604;;19146373;;10.1021/ja808128s;;10.1016/j.snb.2014.03.111;;31724865;;10.1021/acs.nanolett.9b04446,"AFFERRANTE ET AL., J. PHYS.: CONDENS. MATTER, vol. 22, 2010, pages 325107;;GONZALEZ-PEREZ ET AL., LANGMUIR, vol. 25, 2009, pages 10447 - 10450;;MONTALMUELLER, PROC. NATL. ACAD. SCI. USA., vol. 69, 1972, pages 3561 - 3566;;LANGECKER ET AL., SCIENCE, vol. 338, 2012, pages 932 - 936;;STODDART D ET AL., PROC NATL ACAD SCI, vol. 106, no. 19, pages 7702 - 7;;LIEBERMAN KR ET AL., J AM CHEM SOC, vol. 132, no. 50, 2010, pages 17961 - 72;;HERON AJ ET AL., J AM CHEM SOC., vol. 131, no. 5, 2009, pages 1652 - 3;;SAHA SHIMUL CHANDRA; THEI FEDERICO; DE PLANQUE MAURITS R.R.; MORGAN HYWEL: ""Scalable micro-cavity bilayer lipid membrane arrays for parallel ion channel recording"", SENSORS AND ACTUATORS B: CHEMICAL, vol. 199, 1 January 1900 (1900-01-01), NL , pages 76 - 82, XP028850648, ISSN: 0925-4005, DOI: 10.1016/j.snb.2014.03.111;;KANG XINQI, ALIBAKHSHI MOHAMMAD AMIN, WANUNU MENI: ""One-Pot Species Release and Nanopore Detection in a Voltage-Stable Lipid Bilayer Platform"", NANO LETTERS, vol. 19, no. 12, 11 December 2019 (2019-12-11), US , pages 9145 - 9153, XP055910095, ISSN: 1530-6984, DOI: 10.1021/acs.nanolett.9b04446",PENDING
162,CR,A,CR 10587 A,140-341-370-839-009,2009-02-26,2009,CR 10587 A,2009-01-28,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,DERIVADOS Y ANALOGOS DE N-ETILQUINOLONAS Y N-ETILAZAQUINOLONAS,Compuestos biciclicos que contienen nitrogeno y su uso como agentes antibacterianos.,GLAXO GROUP LTD,BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS ESTEVEN;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO HARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/140-341-370-839-009,Patent Application,no,0,0,11,38,0,,A61P31/04;;A61P31/06;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,DISCONTINUED
163,EP,A1,EP 4168798 A1,015-773-772-290-44X,2023-04-26,2023,EP 21724743 A,2021-04-29,US 202063040455 P;;GB 202016874 A;;GB 202105787 A;;GB 2021051029 W,2020-06-17,NANOPORE SUPPORT STRUCTURE AND MANUFACTURE THEREOF,,OXFORD NANOPORE TECH PLC,XIE PING;;MILLIS JUSTIN;;HEALY KEN;;CLARKE JAMES ANTHONY;;HYDE JASON ROBERT;;WILTSHIRE RICHARD KENNETH JOHN;;MCKENDRY JONATHAN EDWARD;;GREASTY ROBERT;;BROWN CLIVE GAVIN;;PERA IOANA;;SANGHERA GURDIAL SINGH;;HYLAND MARK;;ORTIZ BAHAMON PEDRO MIGUEL;;JACKSON MARK DAVID;;MACKETT PAUL RAYMOND;;DAVIES RHODRI RHYS,,https://lens.org/015-773-772-290-44X,Patent Application,yes,0,0,7,7,0,G01N33/48721;;B01L3/502707;;B01L3/502715;;B01L2300/0816;;B01L2300/0861;;B01L2300/0896;;B82Y5/00;;G01N27/308;;G01N33/48721,G01N33/487,,0,0,,,,PENDING
164,PE,A1,PE 20081551 A1,014-627-459-112-936,2009-01-09,2009,PE 2007000927 A,2007-07-18,US 91305707 P;;EP 07381041 A;;US 80785006 P,2006-07-20,DERIVADOS DE QUINOLONA COMO ANTIBACTERIANOS,"REFERIDA A UN COMPUESTO DERIVADO DE QUINOLONA DE FORMULA (I), DONDE Z1, Z2, Z3 Y Z4 SON CR1C O N Y EL RESTO SON CR1C O Z3 Y Z4 JUNTOS SON S Y UNO DE Z1 Y Z2 ES CR1C O N Y EL OTRO ES CR1C; R1a, R1b Y R1c SON H, HALOGENO, CIANO, ALQUILO C1-C6, ENTRE OTROS; R2 ES H O ALQUILO C1-C4 O JUNTO CON R6 FORMAN UN GRUPO Y; A ES UNA ESTRUCTURA (ia) O (ib); R3 ES R1a, R1b Y R1c O ES OXO O AMINOMETILO; n ES 1 O 2; Y ES CR4R8CH2, CH2CR4R8, (C=O), ENTRE OTROS; R4 ES R1a, R1b, ENTRE OTROS; U ES CO, CH2; R5 ES UN SISTEMA DE ANILLOS DE FORMULA (B); X1 ES C, N O CR14; X2 ES N, NR13, O, CO, ENTRE OTROS; X3 Y X5 SON N O C; Y1 ES UN GRUPO ENLAZADOR DE 0 A 4 ATOMOS TAL COMO N, NR13, O, CO, ENTRE OTROS; Y2 ES UN GRUPO ENLAZADOR DE 2 A 6 ATOMOS TAL COMO N, NR13, O, CO, ENTRE OTROS; R14 ES H, ALQUILO C1-C4, HALO, ALCOXI C1-C4, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-(2-{4-[(2,3-DIHIDRO[1,4]DIOXINO[2,3-c]PIRIDIN-7-ILMETIL)AMINO]-1-PIPERIDINILETIL)-7-(METILOXI)-2(1H)-QUINOLINONA, 1-(2-{4-[(2,3-DIHIDRO[1,4]DIOXINO[2,3-c]PIRIDIN-7-ILMETIL)AMINO]-1-PIPERIDINILETIL)-7-FLUORO-2(1H)-QUINOLINONA, 1-(2-{4-[(2,3-DIHIDRO[1,4]DIOXINO[2,3-c]PIRIDIN-7-ILMETIL)AMINO]-1-PIPERIDINILETIL)-5-FLUORO-2(1H)-QUINOLINONA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTIBACTERIANOS Y SON UTILES EN EL TRATAMIENTO DE INFECCIONES DEL TRACTO RESPIRATORIO, DE LA PIEL, DEL TRACTO URINARIO, ENTRE OTROS",GLAXO GROUP LTD,DABBS STEVEN;;BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO LIARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON;;ZHANG LILY,,https://lens.org/014-627-459-112-936,Patent Application,no,0,0,11,38,0,,A61P31/04;;A61P31/06;;C07D491/04;;C07D497/00;;C07D497/04;;C07D498/00;;C07D498/04;;C07D513/00;;C07D513/04;;C07D519/00,,0,0,,,,ACTIVE
165,ZA,B,ZA 200810632 B,023-432-933-607-546,2009-10-28,2009,ZA 200810632 A,2008-12-17,US 80785006 P,2006-07-20,Derivativs and analogs of N-ethylquinolones and N-ethylazaquinolones,,GLAXO GROUP LTD,LLUIS BALLELL;;DAVID BARROS;;GERALD BROOKS;;JULIA CASTRO PICHEL;;STEVEN DABBS;;DAINES ROBERT A;;THOMAS DAVIES DAVID;;MARIA FIANDOR ROMAN JOSE;;ILARIA GIORDANO;;JOSEPH HENNESSY ALAN;;HOFFMAN JAMES B;;ELGIN JONES GRAHAM;;JAMES MILES TIMOTHY;;DAVID PEARSON NEL;;ISRAIL PENDRAK;;REMUINAN BLANCO MODESTO J;;ANTHONY ROSSI JASON;;LIHUA ZHANG,,https://lens.org/023-432-933-607-546,Granted Patent,no,0,0,1,38,0,,A61P/;;C07D/,,0,0,,,,ACTIVE
166,NO,L,NO 20090313 L,126-000-279-612-45X,2009-04-20,2009,NO 20090313 A,2009-01-20,EP 07381041 A;;US 80785006 P;;US 91305707 P;;EP 2007057422 W,2006-07-20,Derivater og analoger av N-etylkinoloner og N-etylazakinoloner,Bisykliske nitrogeninneholdende forbindelser og deres anvendelse som antibakterielle midler.,GLAXO GROUP LTD,BROOKS GERALD;;PEARSON NEIL DAVID;;DAVIES DAVID THOMAS;;JONES GRAHAM ELGIN;;HENNESSY ALAN JOSEPH;;MILES TIMOTHY JAMES;;BALLELL LLUIS;;BARROS DAVID;;PICHEL JULIA CASTRO;;DABBS STEVEN;;DAINES ROBERT A;;ROMAN JOSE MARIA FIANDOR;;GIORDANO ILARIA;;HOFFMAN JAMES B;;PENDRAK ISRAIL;;BLANCO MODESTO J REMUINAN;;ROSSI JASON ANTHONY;;ZHANG LIHUA,"GLAXO GROUP LTD, GB (2013-05-21)",https://lens.org/126-000-279-612-45X,Abstract,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D497/04;;C07D513/04;;C07D519/00,,0,0,,,,DISCONTINUED
167,SG,A1,SG 173374 A1,063-740-166-207-642,2011-08-29,2011,SG 2011051232 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/063-740-166-207-642,Patent Application,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,,,0,0,,,,PENDING
168,CA,A1,CA 2658261 A1,188-063-830-718-73X,2008-01-24,2008,CA 2658261 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.</ SDOAB>,GLAXO GROUP LTD,HOFFMAN JAMES B;;BROOKS GERALD;;CASTRO PICHEL JULIA;;BARROS DAVID;;DAINES ROBERT A;;DABBS STEVEN;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;PENDRAK ISRAIL;;BALLELL LLUIS;;PEARSON NEIL DAVID;;DAVIES DAVID THOMAS;;HENNESSY ALAN JOSEPH;;MILES TIMOTHY JAMES;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY;;REMUINAN BLANCO MODESTO J;;JONES GRAHAM ELGIN,,https://lens.org/188-063-830-718-73X,Patent Application,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,INACTIVE
169,BR,A2,BR PI0715522 A2,071-775-281-884-825,2013-05-21,2013,BR PI0715522 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,derivados e anÁlogos de n-etil quinolonas e n-etil azaquinolonas,DERIVADOS E ANÁLOGOS DE N-ETIL QUINOLONAS E N-ETIL AZAQUINOLONAS. Compostos contendo nitrogênio bicíclicos e seu uso como antibacterianos.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;PICHEL JULIA CASTRO;;ROMAN JOSE MARIA FLANDOR;;BLANCO MODESTO J REMUINAN;;BROOKS GERALD;;DABBS STEVEN;;DAVIES THOMAS DAVID;;GIORDANO ILARIA;;HENESSY JOSEPH ALAN;;MILES THIMOTHY JAMES;;PEARSON NEIL DAVID;;JONES ELGIN GRAHAM;;DAINES ROBERT A;;HOFFMAN JAMES B;;PENDRAK ISRAIL;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/071-775-281-884-825,Patent Application,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,DISCONTINUED
170,MA,B1,MA 30640 B1,075-438-033-369-742,2009-08-03,2009,MA 31632 A,2009-02-11,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,DERIVES ET ANALOGUES DE N-ETHYLQUINOLONES ET DE N-ETHYLAZAQUINOLONES,Composés azotés bicycliques et leur utilisation comme agents antibactériens.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;PENDRAK ISRAIL;;ZHANG LIHUA LILY,,https://lens.org/075-438-033-369-742,Granted Patent,no,0,0,11,38,0,,,,0,0,,,,ACTIVE
171,WO,A1,WO 2008/009700 A1,137-184-471-747-82X,2008-01-24,2008,EP 2007057422 W,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD;;BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/137-184-471-747-82X,Patent Application,yes,54,46,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,A61P31/04;;C07D491/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,16,6,077-295-491-167-117;;047-694-298-888-668;;090-569-962-836-476;;019-261-751-989-901;;034-363-526-426-249;;062-197-246-740-270,10.1002/0471220574;;11128277;;10.1002/1521-3765(20001117)6:22<4140::aid-chem4140>3.0.co;2-5;;14618572;;10.1002/anie.200300594;;10.1055/s-1971-21790;;12098315;;10.1021/jo020074o;;10.2307/1591770;;1417601,"ALI A Y ET AL: ""Synthesis and antimicrobial activities of some quinoxalinonyl amino acid and peptide derivatives."", INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC, INCL. MEDICINAL, PUBLICATIONS & INFORMATIONS DIRECTORATE, NEW DELHI, IN, vol. 42, no. 11, 2003, pages 2835 - 2845, XP008085070, ISSN: 0019-5103;;DESHMUKH M B ET AL: ""Synthesis of Biological activity of some New 1-Substituted-quinolone Derivatives"", JOURNAL OF THE INDIAN CHEMICAL SOCIETY, THE INDIAN CHEMICAL SOCIETY, CALCUTTA, IN, vol. 74, no. 1, 1997, pages 52 - 53, XP008085069, ISSN: 0019-4522;;SMITH, M.B.; MARCH, J.M.: ""Advanced Organic Chemistry"", 2001, WILEY-INTERSCIENCE;;T.W. GREENE; P.G.M. WUTS: ""Protective Groups in Organic Synthesis"", 1999, WILEY-INTERSCIENCE;;BAXTER, P.N.W.; KHOURY, R.G.; LEHN, J.M.; BAUM, G.; FENSKE, D., CHEMISTRY-A EUROPEAN JOURNAL, vol. 6, no. 22, 2000, pages 4140;;IRELAND ET AL., J. AMER. CHEM. SOC., 1973, pages 7829;;SYNLETT, vol. 15, 2003, pages 2428 - 2439;;ANGEWANDTE CHEMIE, vol. 42, 2003, pages 5400 - 5449;;T.A. WILLIAMSON: ""Heterocyclic Compounds"", vol. 6, 1957, pages: 324;;""Comprehensive Heterocyclic Chemistry"", vol. 3;;""Comprehensive Heterocyclic Chemistry"", vol. 2;;N.V. SAZONOV; T.S. SAFONOVA, KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, 1971, pages 1285 - 1288;;PEACE; CARMAN; WULFMAN, SYNTHESIS, 1971, pages 658 - 661;;KERINS, FERGAL; O'SHEA, DONAL F., J. ORG. CHEM., vol. 67, no. 14, 2002, pages 4968;;J. BIGS; P. SYKES, J. CHEMICAL SOCIETY, 1959, pages 1849 - 55;;TANNER, A.C.; WU, C.C.: ""Adaptation of sensitive broth micro dilution technique to antimicrobial susceptibility testing of Mycoplasma gallisepticum"", AVIAN DISEASES, vol. 36, 1992, pages 74 - 717",PENDING
172,UA,C2,UA 99440 C2,155-062-625-464-134,2012-08-27,2012,UA A200900417 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/155-062-625-464-134,Limited Patent,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D471/04;;C07D487/04;;C07D497/00;;C07D498/04;;C07D513/04,,0,0,,,,EXPIRED
173,MY,A,MY 152183 A,012-227-751-976-779,2014-08-29,2014,MY PI20090223 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,BICYCLIC NITROGEN CONTAINING COMPOUNDS OF FORMULA (I) AND THEIR USE AS ANTIBACTERIALS.,GLAXO GROUP LTD,LLUIS BALLELL;;JOSEPH HENNESSY ALAN;;HOFFMAN JAMES B;;ELGIN JONES GRAHAM;;JAMES MILES TIMOTHY;;DAVID PEARSON NEIL;;ISRAIL PENDRAK;;REMUINAN BLANCO MODESTO J;;ANTHONY ROSSI JASON;;LILY ZHANG LIHUA;;DAVID BARROS;;GERALD BROOKS;;JULIA CASTRO PICHEL;;STEVEN DABBS;;DAINES ROBERT A;;THOMAS DAVIES DAVID;;MARIA FIANDOR ROMAN JOSE;;ILARIA GIORDANO,,https://lens.org/012-227-751-976-779,Granted Patent,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04,,0,0,,,,ACTIVE
174,US,A1,US 2009/0270374 A1,102-332-799-751-111,2009-10-29,2009,US 37438907 A,2007-07-18,US 37438907 A;;EP 07381041 A;;US 80785006 P;;US 91305707 P;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,BALLELL LLIUS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;ZHANG LIHUA LILY,BALLELL LLIUS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;ZHANG LIHUA LILY,GLAXO GROUP LIMITED (2007-08-10),https://lens.org/102-332-799-751-111,Patent Application,yes,1,12,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,A61K31/436;;A61K31/542;;A61K31/4365;;A61K31/4375;;A61K31/498;;A61K31/4985;;A61K31/5025;;A61K31/53;;A61K31/5383;;A61P31/04;;C07D401/14;;C07D405/14;;C07D411/14;;C07D413/14;;C07D417/14,514/224.2;;546/115;;514/302;;514/301;;546/114;;544/105;;514/230.5;;544/235;;514/248;;546/122;;514/300;;544/354;;514/249;;546/90;;514/291;;544/350;;514/250;;544/48;;544/183;;514/243,0,0,,,,ACTIVE
175,AU,B2,AU 2007/275188 B2,190-560-447-521-677,2013-03-07,2013,AU 2007/275188 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,CASTRO PICHEL JULIA;;FIANDOR ROMAN JOSE MARIA;;REMUINAN BLANCO MODESTO J;;MILES TIMOTHY JAMES;;BROOKS GERALD;;DAVIES DAVID THOMAS;;ROSSI JASON ANTHONY;;PEARSON NEIL DAVID;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;BALLELL LLUIS;;DAINES ROBERT A;;ZHANG LIHUA LILY;;GIORDANO ILARIA;;JONES GRAHAM ELGIN;;DABBS STEVEN;;PENDRAK ISRAIL;;BARROS DAVID,,https://lens.org/190-560-447-521-677,Granted Patent,no,2,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,INACTIVE
176,AU,A1,AU 2007/275188 A1,195-284-604-794-745,2008-01-24,2008,AU 2007/275188 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones,,GLAXO GROUP LTD,JONES GRAHAM ELGIN;;PICHEL JULIA CASTRO;;PEARSON NEIL DAVID;;DAINES ROBERT A;;ROMAN JOSE MARIA FIANDOR;;HOFFMAN JAMES B;;DABBS STEVEN;;ROSSI JASON ANTHONY;;BALLELL LLUIS;;ZHANG LIHUA LILY;;PENDRAK ISRAIL;;DAVIES DAVID THOMAS;;BLANCO MODESTO J REMUINAN;;GIORDANO ILARIA;;BROOKS GERALD;;BARROS DAVID;;MILES TIMOTHY JAMES;;HENNESSY ALAN JOSEPH,,https://lens.org/195-284-604-794-745,Patent Application,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,A61P31/04;;A61P31/06;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,INACTIVE
177,KR,A,KR 20090031785 A,193-491-812-197-506,2009-03-27,2009,KR 20097003427 A,2007-07-18,EP 07381041 A;;US 80785006 P;;US 91305707 P;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/193-491-812-197-506,Patent Application,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04,,0,0,,,,INACTIVE
178,TW,B,TW I422589 B,188-873-352-449-129,2014-01-11,2014,TW 96126271 A,2007-07-19,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,Compounds,,GLAXO GROUP LTD,DABBS STEVEN;;BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/188-873-352-449-129,Granted Patent,no,1,0,11,38,0,,,,0,0,,,,INACTIVE
179,TW,A,TW 200817417 A,152-964-853-875-510,2008-04-16,2008,TW 96126271 A,2007-07-19,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,Compounds,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,DABBS STEVEN;;BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/152-964-853-875-510,Patent of Addition,no,0,0,11,38,0,,C07D498/04;;A61K31/436;;A61K31/4985;;A61K31/5383;;A61P31/04;;C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/056,,0,0,,,,INACTIVE
180,NZ,A,NZ 573644 A,147-220-380-718-255,2011-09-30,2011,NZ 57364407 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,"Disclosed herein are n-ethylquinolone and n-ethylazaquinolone derivatives of formula (I) wherein A is non-aromatic nitrogen containing heterocyclic moiety, R5 is a pyrimidine heterocyclic substituent and the other substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and the use of the compounds in the treatment of bacterial infections.",GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/147-220-380-718-255,Patent Application,no,0,0,11,38,0,,C07D519/00;;A61P31/04;;A61P31/06;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04,,0,0,,,,DISCONTINUED
181,EP,B1,EP 2044077 B1,011-067-129-224-319,2016-10-05,2016,EP 07802383 A,2007-07-18,EP 2007057422 W;;US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 07802383 A,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,GLAXO GROUP LIMITED (2013-05-01),https://lens.org/011-067-129-224-319,Granted Patent,yes,1,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D401/14;;A61K31/519;;A61K31/538;;A61P31/04;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,ACTIVE
182,CA,C,CA 2658261 C,090-271-442-439-301,2015-04-07,2015,CA 2658261 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/090-271-442-439-301,Granted Patent,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,INACTIVE
183,EA,B1,EA 016470 B1,085-877-402-331-035,2012-05-30,2012,EA 200970140 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/085-877-402-331-035,Granted Patent,no,2,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,2,0,,,"ALI A.Y. ET AL.: ""Synthesis and antimicrobial activities of some quinoxalinonyl amino acid and peptide derivatives"", INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC, INCL. MEDICINAL, PUBLICATIONS & INFORMATIONS DIRECTORATE, NEW DELHI, IN, vol. 42, no. 11, 2003, pages 2835-2845, XP008085070, ISSN: 0019-5103, the whole document;;DESHMUKH M.V. ET AL.: ""Synthesis of Biological activity of some New 1-Substituted-quinolone Derivatives"", JOURNAL OF THE INDIAN CHEMICAL SOCIETY, THE INDIAN CHEMICAL SOCIETY, CALCUTTA, IN, vol. 74, no. 1, 1997, pages 52-53, XP008085069, ISSN: 0019-4522, the whole document",ACTIVE
184,CR,A,CR 20150080 A,087-737-411-710-481,2015-04-06,2015,CR 20150080 A,2015-02-17,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,DERIVADOS Y ANALOGOS DE N-ETILQUINOLONAS Y N-ETILAZAQUINOLONAS,Compuestos bicíclicos que contienen nitrógeno y su uso como agentes antibacterianos.,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/087-737-411-710-481,Patent Application,no,0,0,11,38,0,,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,PENDING
185,EP,A1,EP 2044077 A1,046-476-079-338-584,2009-04-08,2009,EP 07802383 A,2007-07-18,EP 2007057422 W;;US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 07802383 A,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,,GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,GLAXO GROUP LIMITED (2013-05-01),https://lens.org/046-476-079-338-584,Patent Application,yes,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D401/14;;A61K31/519;;A61K31/538;;A61P31/04;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,ACTIVE
186,WO,A8,WO 2008/009700 A8,197-338-673-108-087,2008-02-28,2008,EP 2007057422 W,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD;;BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;ZHANG LIHUA LILY,,https://lens.org/197-338-673-108-087,Patent Application,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,PENDING
187,US,B2,US 8071592 B2,094-810-980-596-924,2011-12-06,2011,US 37438907 A,2007-07-18,US 37438907 A;;EP 07381041 A;;US 80785006 P;;US 91305707 P;;EP 2007057422 W,2006-07-20,Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones,Bicyclic nitrogen containing compounds and their use as antibacterials.,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;ZHANG LIHUA LILY;;GLAXO GROUP LTD,BALLELL LLUIS;;BARROS DAVID;;BROOKS GERALD;;CASTRO PICHEL JULIA;;DABBS STEVEN;;DAINES ROBERT A;;DAVIES DAVID THOMAS;;FIANDOR ROMAN JOSE MARIA;;PENDRAK ISRAIL;;REMUINAN BLANCO MODESTO J;;ROSSI JASON ANTHONY;;GIORDANO ILARIA;;HENNESSY ALAN JOSEPH;;HOFFMAN JAMES B;;JONES GRAHAM ELGIN;;MILES TIMOTHY JAMES;;PEARSON NEIL DAVID;;ZHANG LIHUA LILY,GLAXO GROUP LIMITED (2007-08-10),https://lens.org/094-810-980-596-924,Granted Patent,yes,9,3,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61K31/519;;A61K31/5383;;C07D497/04;;C07D498/04,514/230.5;;544/105;;544/279;;514/264.1,4,2,001-516-175-552-397;;006-339-151-174-691,10.1016/s0169-409x(01)00097-7;;11325474;;10.1021/ar00046a004,"Vippagunta et al, ""Crystalline Solids"" Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).;;Gavezzotti, ""Are Crystal Structures Predictable?"" Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).;;Ali A. Y, et al.: ""Synthesis and Antimicrobial activities of some quinoxalinonyl amino acid and peptide derivatives."" Indian Journal of Chemistry, Section B: Organic, Inc. Medicinal, Publications and Informations directorate, New Delhi, In, vol. 42, No. 11, 2003, pp. 2835-2845, XP008085070; ISSN: 0019-5103; The whole document.;;Deshmukh M. B. et al.: Synthesis of biological activity of some new 1-Substituted-quinolone Derivatives Journal of the Indian Chemical Society, The Indian Chemical Society, Calcutta, In. vol. 74, No. 1, 1997, pp. 52-53, XP008085069, ISSN: 0019-4522, the whole document.",ACTIVE
188,CN,B,CN 101516889 B,116-950-913-903-825,2013-07-31,2013,CN 200780034963 A,2007-07-18,EP 2007057422 W;;US 80785006 P;;US 91305707 P;;EP 07381041 A,2006-07-20,Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones,,GLAXO GROUP LTD,HENNESSY ALAN JOSEPH;;REMUINAN BLANCO MODESTO J;;ZHANG LIHUA LILY;;BALLELL LLUIS;;HOFFMAN JAMES B;;BARROS DAVID;;JONES GRAHAM ELGIN;;PEARSON NEIL DAVID;;DAVIES DAVID THOMAS;;ROSSI JASON ANTHONY;;MILES TIMOTHY JAMES;;DABBS STEVEN;;FIANDOR ROMAN JOSE MARIA;;GIORDANO ILARIA;;BROOKS GERALD;;CASTRO PICHEL JULIA;;PENDRAK ISRAIL;;DAINES ROBERT A,,https://lens.org/116-950-913-903-825,Granted Patent,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,ACTIVE
189,MX,A,MX 2009000797 A,102-273-545-156-294,2009-01-29,2009,MX 2009000797 A,2007-07-18,US 80785006 P;;US 91305707 P;;EP 07381041 A;;EP 2007057422 W,2006-07-20,DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES.,Bicyclic nitrogen containing compounds and their use as antibacterials.,GLAXO GROUP LTD,DAINES ROBERT A;;BROOKS GERALD;;JONES GRAHAM ELGIN;;PEARSON NEIL DAVID;;DAVIES DAVID THOMAS;;HENNESSY ALAN JOSEPH;;MILES TIMOTHY JAMES;;BALLELL LLUIS;;BARROS DAVID;;CASTRO PICHEL JULIA;;FIANDOR ROMAN JOSE MARIA;;REMUINAN BLANCO MODESTO J;;DABBS STEVEN;;LLARIA GIORDANO;;HOFFMAN JAMES B;;PENDRAK ISRAIL;;ROSSI JASON ANTHONY;;ZHANG LIHUA LYLI,,https://lens.org/102-273-545-156-294,Patent Application,no,0,0,26,38,0,C07D401/14;;C07D405/14;;C07D409/14;;C07D417/14;;C07D471/04;;C07D491/04;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00;;A61K31/519;;A61K31/538;;A61P31/04;;A61P31/06;;C07D491/04;;C07D513/04;;C07D497/04;;C07D498/04;;C07D491/04;;C07D401/14;;C07D498/04;;C07D513/04;;C07D405/14;;C07D519/00;;C07D417/14;;C07D497/04;;C07D409/14;;C07D471/04;;A61K31/538;;A61K31/519,C07D491/04;;A61P31/04;;A61P31/06;;C07D497/04;;C07D498/04;;C07D513/04;;C07D519/00,,0,0,,,,ACTIVE
